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2ABSTRACT
Premature infants are exposed to multiple invasive procedures as part of their essential medical 
care.  It is not known, however, if nociceptive information is processed by the cortex at this age. 
The fundamental question to be addressed by this thesis is whether premature infants display 
cortical responses to noxious stimulation.
This  thesis  describes  a  series  of studies  where  the  question  of cortical  pain  processing  is 
addressed by directly  measuring cortical responses to  noxious  stimulation using near-infrared 
spectroscopy  (NIRS)  and  electroencephalography  (EEG).  The  NIRS  results  show  that, 
following  an  acute  noxious  event,  the  contralateral  somatosensory  cortex  is  functionally 
activated  in  infants  from  25  weeks  postmenstrual  age  (PMA).  Awake  infants  have  a  larger 
cortical response than asleep infants and, in the awake group, the size of the response increases 
with PMA.
The magnitude of the haemodynamic response correlates with pain scores calculated using the 
premature  infant pain profile  (PIPP),  although  infants who do not display  a change  in  facial 
expression can still process noxious stimuli at the cortical level.  Latency to response is longest 
in the youngest infants using either the haemodynamic response or change in facial expression as 
an output measure.
The underlying pain-related neuronal  activity in the  cortex has been  investigated using EEG. 
Nociceptive-specific event related potentials have been observed in infants from 31-42 weeks 
PMA, with a recognisable N-P complex visible in the contralateral somatosensory cortex in 82% 
of studies.  Noxious stimulation can evoke specific patterns of neural activity within the cortex 
of preterm and term infants that can be observed on a single-trial basis.
The  studies  represent  the  first  measurements  of cortical  activation  in  the  immature  preterm 
cortex  following a noxious  event.  The fact that noxious  information  is transmitted to higher 
levels  of the  central  nervous  system  highlights  the  importance  of developing  a  systematic 
approach to reduce pain and improve analgesic strategies in this vulnerable population.
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15CHAPTER 1: INTRODUCTION
1.1 Pain Processing in the Premature Infant
1.1.1 An overview of neonatal pain
To treat infant pain successfully and improve developmental outcome, we must understand the 
neurobiological mechanisms involved in processing noxious information (Fitzgerald, 2005).  As 
infants are unable to report pain verbally, our understanding of pain processing in this vulnerable 
group  has  relied  heavily  upon  measures  of nociception,  such  as  reflex  responses  to  noxious 
stimulation and behavioural and physiological responses (Andrews and Fitzgerald,  1999; Craig 
et al.,  1993).  The distinction between nociception and pain is fundamental to our understanding 
of pain processing.  While nociception can involve the activity of central pathways at the level of 
primary sensory neurones and spinal and brainstem circuits, pain perception has an emotional 
and  affective  component  that  requires  higher-level  cortical  processing  (Treede  et  al.,  1999). 
Nociception  refers  only  to  the  biological  signal  processing  of  the  noxious  input  and  is 
independent of conscious perception.  Pain has been defined by The International Association 
for the Study of Pain (IASP) as an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage.  An additional note is 
included with the definition, which states that the  inability to communicate verbally does not 
negate the possibility that an individual is experiencing pain and is in need of appropriate pain- 
relieving treatment.
Studies  in  neonates  have  used  a  number  of  indirect  methods  to  demonstrate  that  noxious 
stimulation  can  activate  sensory  pathways,  resulting  in  a  wide  range  of  physiological, 
biochemical, and behavioural responses (McNair et al., 2004; Franck et al., 2000).  Other more 
direct neurophysiological methods use nociceptive spinal flexion reflex responses to study the 
postnatal development of the nociceptive responses to single and repetitive noxious stimulation 
(Andrews and Fitzgerald, 2002; Andrews et al., 2002; Andrews and Fitzgerald,  1999; Andrews 
and Fitzgerald,  1994). Despite these observations, which show that infants are able to mount a 
strong and organised response to noxious stimulation, the question remains as to how much pain 
human infants actually experience.  The anatomical and functional  immaturity of the nervous 
system, especially at  levels higher than the spinal cord, means that the conscious perception of 
pain may not be achievable until the neural circuitry is developed sufficiently (Fitzgerald, 2005; 
Lee et al., 2005). It is feasible that the strong behavioural and physiological responses observed 
in premature infants may be entirely mediated at the spinal or brainstem level with little or no
16cortical involvement.  This would imply that these infants do not experience true pain.  A recent 
study demonstrated that infants below 32 weeks postconceptional age (PCA) with parenchymal 
brain  injury  (often  associated  with  white  matter  damage)  had  the  same  behavioural  and 
physiological  pain  responses  as  normal  age-matched  controls  (Oberlander et  al.,  2002).  This 
suggests  that  in  infants  below  32  weeks  PCA,  these  responses  may  largely  be  mediated 
subcortically.  If the neonatal cortex had an important role in mediating these responses, it would 
be anticipated that severe brain injury would affect these pain scores.  It is therefore possible that 
nociceptive afferent input either does not reach the cortex in preterm human infants before 32 
weeks, or that the cortical circuits cannot be activated before this time.
The study by Oberlander and colleagues refers to infant maturity in terms of postconceptional 
age  (PCA),  which  represents  the  number  of  weeks  since  conception  or  post  fertilisation. 
Clinicians often use gestational age or postmenstrual age (PMA), which represents the number 
of weeks since the first day of the woman’s last menstrual period.  PMA or gestational age is 
therefore approximately two weeks greater than the PCA or developmental age.  In this thesis, 
results are reported in terms of PMA.  When other work is cited, however,  infant maturity is 
described using the terminology present in the original article.
1.1.2  The emergence of pain assessment methods for neonates
For many years,  it was thought that neonates do not feel pain.  The theory was based on the 
premise that infants have an immature central nervous system (CNS) and are thus incapable of 
pain  experience  (Agarwal  et  al.,  1985).  Early  studies  concluded  that  neonatal  responses  to 
noxious events did not involve the infant cortex, and that perception and localisation of pain was 
therefore  not possible  (Agarwal  et  al.,  1985).  The  neonate’s  inability  to  remember pain  was 
considered indicative that infants do not process pain in the same way as adults (Agarwal et al., 
1985)  and it was  speculated that a high pain threshold may be  essential  to protect the  infant 
during childbirth (Bondy,  1980).  In the late  1980’s direct methods emerged to assess neonatal 
responses to noxious  stimulation and as a result these assertions were  questioned.  A review 
written in  1986, concluded that it can no longer be assumed that neonates do not feel pain and 
that such assumptions need to be proven (Owens,  1986).  The methods that emerged to assess 
neonatal pain are discussed in the ensuing paragraphs.
Early  suggestions  that  infants  feel  pain  came  from  studies  conducted  in  1984,  which
demonstrated  that  an  increase  in  heart rate and crying could be  observed  in  newborn  infants
following a heel  lance (Owens and Todt,  1984). The authors concluded that infants were thus
17capable of feeling pain and that infant pain can be reliably measured in a clinical setting.  Since 
this time, changes in physiological activity in response to both innocuous and noxious events 
have been extensively studied (Stevens and Johnston,  1994;  Craig et al.,  1993;  Porter,  1989). 
Some studies have shown, however, that an increase in heart rate can occur following both a heel 
lance and a control procedure, so the usefulness of heart rate, as an indicator of neonatal pain, 
has been questioned (Craig et al., 1993).  It was concluded that change in heart rate may reflect a 
generalised state of physiological stress as opposed to a specific response to a noxious stimulus. 
Further  difficulties  associated  with  the  use  of heart  rate  as  an  index  of neonatal  pain  were 
demonstrated in a study in preterm infants aged 26-31  weeks PCA (Johnston et al.,  1995). The 
authors demonstrated that although a greater maximum heart rate was observed in response to a 
heel  lance  compared  with  a  control  event,  the  response  was  the  least  robust  in  the  younger 
infants (Johnston et al., 1995).
Studies of cry, as an index of neonatal pain, have shown that intensity and duration of cry are the 
most useful parameters, as they both increase with increasing pain intensity (Owens and Todt, 
1984).  Nevertheless, since crying is the primary method by which infants express their basic 
needs,  it is difficult to know whether crying occurs as a direct result of pain, or due to other 
factors, such as hunger or excessive heat or cold.  The use of cry as an index of neonatal pain 
requires complex analysis and, as it can be pharmacologically and mechanically suppressed in 
the  intensive  care  environment,  there  are  considerable  difficulties  associated  with  the 
interpretation.  A further method which has been used to assess neonatal responses to noxious 
stimulation  is  emotional  sweating  (Gladman  and  Chiswick,  1990;  Harpin  and  Rutter,  1982). 
Sweating can be assessed by measuring either palmar water loss (Harpin and Rutter,  1982) or 
plantar skin conductance  (Gladman and Chiswick,  1990).  A  study of 124  infants  found that 
infants undergoing a heel  lance,  who were greater than 37 weeks PCA,  had a raised level of 
palmar water loss, which returned to baseline when the infants settled (Harpin and Rutter, 1982). 
Palmar sweating and plantar skin conductance have not been observed in infants less than 36 
weeks PCA, which means their use for pain assessment in preterm infants in the intensive care 
environment is limited (Gladman and Chiswick, 1990; Harpin and Rutter, 1982).
Other  measures  of the  physiological  component  of pain  include  changes  in  respiration  rate, 
transcutaneous partial pressure of oxygen (Tcp0 2) and carbon dioxide (Tcp0 2), blood pressure 
and  endorphin  levels.  Respiratory  rate  has been used to  monitor the  autonomic  response  to 
noxious  procedures  (Craig  et  al.,  1993;  Brown,  1987;  Rawlings  et  al.,  1980).  Where  both 
accelerated breathing  (Brown,  1987;  Rawlings  et  al.,  1980)  and breath-holding  (Craig  et  al.,
181993)  have  been  reported,  however,  the  natural  physiological  variability  in  respiratory  rate 
renders it unusable as a sole indicator of neonatal pain (Porter, 1989). Attempts to use changes in 
transcutaneous  partial  pressure  of oxygen  (Tcp02)  and  carbon  dioxide  (TcpC02)  as  neonatal 
pain  indicators  (Porter,  1989;  Rawlings  et  al.,  1980)  have  also  yielded  conflicting  results. 
Marked decreases in Tcp02  have been reported following circumcision (Rawlings et al.,  1980), 
however, when the same measures were used by Craig et al. (1993) they reported no distinction 
between the response to a heel lance or sham procedure. Changes in oxygen saturation appear to 
be  more reliably reported;  a number of studies have  shown a reduction in oxygen  saturation 
following a heel lance and other invasive procedures (Stevens and Johnston,  1994; Craig et al., 
1993).  Once again,  this  cannot be used as a sole measure of neonatal pain because there are 
many situations where oxygen saturation in a preterm infant may fluctuate.
An  alternative  approach  used  in  neonatal  pain  assessment  is  to  consider  the  behavioural 
responses following noxious procedures.  Specific facial features were shown to occur following 
painful  procedures  and methods  of analysing  facial  responses  to  pain,  such  as  the  maximum 
discriminative  facial  movement  coding  system  (MAX)  and  the  facial  action  coding  system 
(FACS) were developed (McGrath and Unruh,  1987). These systems were eventually revised to 
create the neonatal facial coding system (NFCS) (Grunau and Craig,  1987). Grunau and Craig 
(1987) studied the facial response in  140 healthy infants following a heel lance and found that 
facial activity can be used as a reliable measure of pain processing.  They demonstrated that the 
response  was  dependent  on  sleep  state  and  questioned  the  dogma  that  infant  responses  to 
noxious stimulation only consisted of uncoordinated whole body movements.  Since this time, 
facial  expression  has  repeatedly  been  used  to  assess  neonatal  pain  and  is  now  an  important 
component of current clinical pain assessment tools (Grunau et al.,  1998;  Stevens et al.,  1996; 
Craig et al.,  1994;  Stevens and Johnston,  1994;  Craig et al.,  1993).  This is discussed in more 
detail in Section 1.1.3.  Body movements, such as leg extension, finger splay, and hand to mouth 
movements, have also been used in neonatal pain assessment (Craig et al.,  1993; Porter,  1989; 
Franck,  1986);  however,  as  the  responses  are  less  specific  than  facial  responses,  body 
movements are considered a less effective measure of neonatal pain (Craig et al.,  1993; Porter, 
1989).  In addition, there is the disadvantage that body movements are often mechanically or 
pharmacologically suppressed, and can therefore be difficult to investigate under normal clinical 
conditions  (Porter,  1989).  A  further  tool  that  has  been  used  to  study  responses  to  noxious 
stimulation in neonates is the spinal flexion reflex response.  It has been used successfully in the 
neonatal  intensive  care  environment,  and  has  yielded  useful  information  on  human 
somatosensory  development  (Andrews  and  Fitzgerald,  2000;  Andrews  and  Fitzgerald,  1999;
19Andrews and Fitzgerald,  1994).  In both preterm and full-term human neonates, this reflex can 
be  evoked  with  low  intensity  mechanical  stimulation  and  has  a  lower  threshold  than  the 
nociceptive  flexion  reflex  in  adults  (Andrews  and Fitzgerald,  2000;  Andrews  and Fitzgerald, 
1999; Andrews and Fitzgerald, 1994).
In  1987,  studies  by  Anand  and  Aynsley-Green  provided  the  first  objective  evidence  that 
neonates  mount  a  substantial  stress  response  during  surgery.  The  study  demonstrated  that 
infants who received fentanyl during surgery had improved postoperative outcome (Anand et al., 
1987). The importance of providing adequate analgesia during and after surgical procedures was 
highlighted, which further challenged the belief that infants were incapable of pain perception. 
Despite this pioneering work,  conducted over 20 years ago, pain-control  in neonates remains 
sporadic and suboptimal.  The problem that underlies neonatal pain research is that we do not 
know whether these measures provide an objective measure of pain processing.  While it is clear 
that neonatal pain assessment is dependent on the level of the nervous system from which the 
pain response  emanates,  there  is  a  lack of evidence regarding whether the  neonatal  cortex  is 
involved in pain responses measured using these behavioural and physiological  indicators.  If 
these behavioural  and physiological  responses  to nociception are mediated subcortically,  they 
may not reflect true pain experience.
1.1.3  Current clinical pain assessment tools
Based on the measures discussed in Section 1.1.2, a number of pain assessment tools have been 
designed to quantify pain responses in premature infants.  The most commonly used scales for 
preterm infants are the premature infant pain profile (PIPP), neonatal infant pain score (NIPS), 
neonatal facial coding system (NFCS), CRIES and COMFORT (van Dijk et al., 2000; Stevens et 
al.,  1996; Krechel and Bildner,  1995; Craig et al.,  1994; Lawrence et al.,  1993; Ambuel et al., 
1992; Grunau and Craig, 1987). The NFCS was the first pain assessment tool to describe a set of 
10 facial  features that can be observed in infants  following a noxious procedure (Grunau and 
Craig,  1987). The scoring system calculates a pain intensity score based on whether 10 specific 
facial actions are either present or absent during specified phases of a noxious procedure.  These 
facial actions include, eye squeeze, brow bulge, nasolabial furrow, lip purse, open lips, vertical 
mouth stretch,  horizontal  mouth,  taut tongue, tongue protrusion and chin quiver (Grunau and 
Craig,  1987).  The  NFCS  was  initially  developed  and  validated  by  videoing  infants  during 
painful  and  non-painful  procedures.  This  meant that the  video  footage  could  be  intensively 
analysed in a frame-by-frame approach.  The feasibility and validity of using the NFCS at the 
bedside in real time has also been shown (Grunau et al., 1998).
20The  best validated  pain  scale  for premature  infants  is  the  PIPP,  which  has  been  specifically 
developed to assess neonatal pain (Stevens et al.,  1996).  It uses three  facial  actions  from the 
NFCS and is based on the behavioural observations that an infant experiencing acute pain has 
eyes that are forcefully closed, a brow that is lowered and furrowed,  and nasal roots that are 
broadened and bulged with a deepened nasolabial furrow (Grunau and Craig,  1987). The seven 
other facial actions were eliminated because they were not considered to be specific or sensitive 
indicators of pain (Stevens et al.,  1996). In addition, the PIPP also scores change in heart rate 
and oxygen saturation, and includes a weighting factor for gestational age and behavioural state. 
Each indicator is used to calculate a composite numerical score that attempts to quantify pain 
experience.  An example score sheet is given in Figure  1.1.  Weighting factors were introduced 
into the  PIPP  to  increase  the  score  for the  infants  who  are  considered  least able  to  mount a 
response following a noxious procedure.  In a clinical setting, this may be a useful way to ensure 
that pain processing in the youngest and sickest infants is not under treated, but as a research 
tool,  a weighting  factor that arbitrarily  increases the pain  score  is  less useful  and potentially 
misleading.
Infant Study Number;
Date/time:__________
Event:______________
Process
Chart
Observe infant 
15 s
Observe baseline
Heart rate__
Oxygen 
saturation .. 
Observe infant 
30 s
Indicator 
Gestational age 
Behavioral slate
Hcait tale
M ax___
Oxygen
saturation
M in___
Brow bulge
0
36 weeks and 
more 
active/awake 
eyes open 
facial
movements
0-4 beats; mi ri 
increase 
0-2.49?  decrease
None
0-9% of time
Eye squeeze 
Nasolabial turrow  None
None
0-9Vc of time
I
32-35 w eeks.6 
days 
quiet/awake 
eyes open 
no facial 
movements
5-14 bedtvnnn 
increase 
2.5-4.99? decrease
Minimum
JO-399?  of tunc
Minimum
10-399?  of time
Minimum
28-31  w eeks.6 
days 
active/sleep 
eyes closed 
facial
movements
15-24  beats;'miti 
increase 
5.0-7.49?  decrease
Moderate 
40-699? of time
Moderate
40-69% of time
Moderate
less than 28 
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25 beats/min or 
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7.59?  or more 
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709?  of time or 
more 
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709?  of time or 
more 
Maximum
Figure 1.1 Premature infant pain profile
An example score sheet used to calculate the PIPP score (Stevens et al., 1996).
211.1.4 Latency between noxious stimulation and PIPP facial expression indicators
One of the difficulties associated with the use of neonatal pain assessment tools is that change in 
facial  expression has been reported to be  of limited use in very preterm infants.  It has been 
consistently shown that the most premature infants have the least robust responses (Johnston et 
al., 1995; Craig et al.,  1993). Facial pain expressions may be weak or absent before 28-32 weeks 
and  it  is  widely  acknowledged  that  babies  less  than  27  weeks  are  challenging  to  score 
(Ballantyne et al.,  1999).  Some studies suggest that the youngest premature infants are able to 
demonstrate  little  or no  facial  response to pain (Johnston  et  al.,  1999).  Stevens  et  al.  (1996) 
found  that  the  total  facial  pain  coding  score  was  lower  for babies  less  than  28  weeks,  and 
accounted for this observation by introducing a weighting factor to the PIPP score.  The reason 
why younger infants have  lower facial  pain  scores remains unclear.  It may be that the very 
immature central nervous  system (CNS)  is unable to mount a co-ordinated contraction of the 
facial  muscles  involved  in the behavioural  response,  thus preventing  a fully developed  facial 
response  to  pain.  An  alternative  explanation  may  be  that  the  scoring  system  used  in  these 
studies does not evaluate pain behaviour for the appropriate time-period required to observe the 
full manifestation of the response.  A time window of only  10 seconds after the noxious event 
has been used to assess the pain response in some studies (Ogawa et al., 2005). According to the 
PIPP, a facial expression score is calculated by determining the percentage of time, during a 30- 
second time window, that an infant demonstrates three different facial expressions following an 
acute noxious event.  If the youngest infants have a longer latency to response, it is possible that 
the low scores reflect the delay in response rather than an infant’s inability to mount a response. 
In the youngest premature infants, particular care must be taken when interpreting clinical pain 
scores that use change in facial expression as an indicator of pain processing.
1.1.5 Noxious procedures in premature infants
Advances in neonatal intensive care have led to the survival of very premature infants.  The UK 
has the highest rate of low birthweight babies in Western Europe:  12% of babies need some level 
of special care at birth (~ 80,000 per annum) and 2.5% need neonatal intensive care (~  17,000 
per annum) (Green, 2005). To maintain their wellbeing and compensate for their physiological 
instability, multiple  invasive procedures are performed as part of their essential medical  care. 
Estimates  suggest that  on  average  an  infant receiving  intensive  care  will  undergo  14  painful 
procedures per day (Simons et al., 2003).  A meta-analysis of 5 studies conducted between 1995 
and 2003 showed that 603 infants in intensive care, aged between 23 and 42 weeks gestational 
age, underwent a total of 38,426 invasive procedures while in intensive care (D'Apolito, 2006).
22Repeated  exposure  to  noxious  procedures  is  a  particular  concern  in  the  preterm  neonatal 
population because  it  occurs  at a  time  when  the  infant  should be  developing  in  a protective 
uterine environment where sensory input would be limited (Anand, 2000).  Furthermore, there is 
evidence that exposure to painful  stimuli in the neonatal period leads to long-term changes in 
pain processing  (Peters  et  al.,  2005;  Grunau et al.,  2001a;  Anand,  2000;  Porter et al.,  1999; 
Taddio et al., 1997).
There  is  a  lack  of  information  about  effective  pain  management  strategies  in  neonates. 
Analgesia is provided in less than 35% of procedures that health-care professionals consider to 
be painful (Simons et al., 2003) and in the UK over 80% of neonatal units still do not have any 
pain  assessment  protocol  in  place  (Redshaw  and  Hamilton,  2005).  A  recent  report, 
commissioned by the premature baby charity BLISS, found that less than 60% of units regularly 
use  analgesia  for  pain  relief.  The  report  stated  that  the  most  regularly  used  methods  for 
comforting  babies  during  painful  procedures  are  gentle  touch,  talking  to  the  infant,  and 
swaddling (Green, 2005).  Only 48% of parents reported that infants were given pain-relieving 
drugs to make them more comfortable (Green, 2005), and a survey of medical staff showed that, 
while 90% believed that infants feel pain as severely as adults, most procedures are performed 
without analgesia or comfort measures (Porter et al.,  1997).  Clearly, pain in adults and older 
children would not be managed in this way.
In humans,  normal  gestation  lasts between 37  and 40 weeks.  During this time,  the foetus  is 
dependent on the maternal host to provide support for all its respiratory and nutritive needs.  If 
an infant is bom before this time then its survival may be threatened and it may be necessary for 
life support to be provided by an intensive care unit.  There are approximately 220 units offering 
neonatal intensive care in the UK and the number of infants requiring specialist care is rising. 
Of  the  42,500  infants  that  the  Department  of  Health  estimates  are  bom  prematurely, 
approximately 300 are bom at less than 24 weeks and 2880 are bom at less than 28 weeks.  The 
increase in the number of infants being bom prematurely is partly due to improved obstetric care 
and improved fertility treatment.  Better obstetric care means that infants are identified as having 
problems earlier during pregnancy.  Consequently, these infants are likely to be delivered earlier 
to prevent the problems developing.  More women are having babies later in life and as a result 
there has been an increase in the number of obstetric complications, and number of premature 
births.  Improved fertility treatment has led to an increase in the number of multiple gestation 
pregnancies, which is a known risk factor for premature birth.  It is also significant that England 
has  the  highest  rate  of teenage  pregnancy  in  Europe;  teenage  mothers  have  a  higher risk  of
23delivering  a  premature  or  low  birth  weight  baby.  The  increase  in  the  number  of teenage 
pregnancies  has  contributed  to  the  increase  in  number  of  premature  births  (Radshaw  and 
Hamilton, 2005).  Increased survival of younger infants means that the duration of stay has also 
increased, particularly for the extremely low birth weight infants.  A national survey of neonatal 
unit organisation and policy found that the duration of stay ranged from 4-140 days with a mean 
of 56 days (Green, 2005).
1.1.6  Long term consequences of early pain exposure in human neonates
A number of studies in humans have suggested that exposure to pain in the neonatal period can 
lead to long term developmental consequences (Grunau et al., 2006).  While animal models have 
shown that long-term changes in pain processing are evident following early pain exposure (Ren 
et al., 2004; Torsney and Fitzgerald, 2003; Bhutta et al., 2001; Ruda et al., 2000; Anand et al., 
1999;  Reynolds  and  Fitzgerald,  1995),  the  effect  of early  pain  experience  in  man  has  been 
difficult  to  assess  and  has  produced  conflicting  results.  In  1995,  The  Lancet  published  a 
frequently cited study which showed that exposure to pain in the neonatal period had long-term 
developmental consequences.  The study showed that boys circumcised at birth had an increased 
response to routine vaccination at 4-6 months of age compared to uncircumcised boys (Taddio et 
al.,  1995).  A  subsequent  follow-up  study,  which  provided  further  evidence  to  support  this 
finding,  demonstrated  that  boys  treated  with  lidocaine-prilocaine  cream  (EMLA)  during 
circumcision had lower pain responses when they were vaccinated 4-6 months later than those 
treated with a placebo; an uncircumcised control-group demonstrated the lowest pain responses 
(Taddio et al.,  1997). Further studies suggested that children aged 4.5 years, who were formerly 
extremely low birth weight (ELBW) infants, are more likely to experience unexplained stomach 
aches,  headaches  and  other  complaints  as  compared  with  age-matched  term-born  controls 
(Grunau et al., 1994b).
Other studies appear inconsistent with these findings.  Premature infants and full-term infants,
age-matched  in  terms  of  developmental  age,  have  been  shown  to  demonstrate  the  same
behavioural  responses  to  finger-lancing,  undertaken  for  the  purpose  of  blood  collection
(Oberlander et al., 2000) and parents of 18 month old toddlers report that premature infants have
decreased  reactivity  to  pain  compared  to  term-born  aged-matched  controls  (Grunau  et  al.,
1994a).  In agreement with these findings, a study of children who were 9-14 years of age, which
compared the responses of children who had received neonatal intensive care with age-matched
controls, found that the ex-neonatal intensive care unit (ex-NICU) groups exhibited elevated heat
pain  thresholds  compared  to  controls.  Despite  the  fact  that  the  ex-NICU  children  were
24hyposensitive to thermal pain, it was also demonstrated that the ex-NICU children had greater 
perceptual  sensitisation  (Hermann  et  al.,  2006).  Greater perceptual  sensitisation  refers  to  the 
gradual increase in subjective pain intensity during prolonged noxious stimulation.
Peters and colleagues  demonstrated that infants who had undergone  surgery in the  first three 
months of life only showed higher sensitivity to subsequent surgery if it was performed in the 
same dermatome (Peters et al., 2005). The evidence in humans for the long-term consequences 
of early  pain  experience  is  limited,  and  interpretations  of these  findings  are  complicated  by 
confounding factors, including'comorbidity, and social and family factors.  A more recent study, 
using quantitative sensory testing (QST), showed that children who experienced tissue injury in 
early  infancy  during  thoracic  heart  surgery had altered responses  to  mechanical  and  thermal 
stimulation  in  later  life  (Schmelzle-Lubiecki,  2005).  At  10  years  of age,  infants  who  had 
undergone  surgery  during  the  neonatal  period  showed  a  decreased  sensitivity  to  tactile 
stimulation  at the  site  of the  scar compared to  the unaffected contralateral  site.  It  was  also 
shown that infants were significantly less sensitive to touch at a different site compared to an 
age-matched  control  group,  suggesting  non-somatotopic  changes  have  occurred  that  affect 
sensory processing.  The study concluded that the children who had undergone surgery during 
infancy had a baseline hyposensitivity to touch.  While QST has been useful is assessing pain 
processing in older children and adults it is clearly an inappropriate and unsuitable tool for the 
neonatal population because  it requires active attention and feedback from the  subjects being 
tested.  These  studies highlight the importance of developing an effective  strategy to manage 
pain while infants are in the intensive care environment.
1.1.7  Nociception and pain perception
Nociception  is  the  process  whereby primary  sensory  neurones  detect  pain-producing  stimuli. 
The  activation  of nociceptors  is usually caused by  stimuli  capable  of causing tissue  damage, 
such as noxious heat, intense pressure, or irritant chemicals, but not by innocuous stimuli such as 
warming  or light touch (Julius  and Basbaum,  2001).  The nociceptors  are  first-order afferents 
with free nerve endings.  The basic task of nociceptors is the transduction and transmission of 
noxious information to the spinal cord.  The afferent fibres are classified in terms of structure, 
diameter and conduction velocity.  Noxious potentials are propagated by C and AS fibres.  C 
fibres are unmyelinated,  with a diameter between 0.4-1.2mm and conduction velocity  of 0.5- 
2.0m/s, whereas AS  fibres are myelinated,  more rapidly conducting  fibres, with a  conduction 
velocity  between  12-30m/s  and  diameter  range  from  2.0-6.0mm.  When  a  noxious  event  is
25detected, the primary afferents have different patterns of propagation.  There are two classes of 
A5  fibres,  which  propagate  modally  specific  information,  with  graded  intensity  and  short 
latency.  Both respond to intense mechanical stimuli but can be distinguished by their response 
to intense heat (Julius and Basbaum, 2001). They are responsible for the induction of the first 
acute pain sensation and trigger the reflex withdrawal response.  In contrast, the propagation of 
action potentials in C fibres is much slower.  The C fibres are responsible for the occurrence of 
the  longer lasting  dull  pain  sensation.  Other classes  of first order afferent  fibres,  known  as 
Aa and Ap fibres, which are large myelinated fibres with conduction velocities ranging between 
30- lOOm/s,  mainly propagate non-noxious stimuli.  In humans,  it has been suggested that the 
first cutaneous sensory receptors develop between 7.5-10.5 weeks gestation (Humphrey,  1978) 
and the first primary afferent fibres  synapse with neurones in the spinal  cord at  14 weeks.  C 
fibres, which terminate in the more superficial parts of the spinal dorsal horn, enter the spinal 
cord at 19 weeks gestation (Konstantinidou et al., 1995).
The primary afferents, which arrive at the spinal cord, are organised into bundles of dorsal roots 
that form synapses with second order neurones distributed along the dorsal hom of the spinal 
cord.  Intrinsic  neurones  of the  dorsal  hom  promote  the  interaction  of afferent  and  efferent 
nociceptive stimuli  and are responsible for the transfer to supraspinal  structures.  There are  a 
number of different types  of second order neurones  present  in the  spinal  cord;  these  include 
projection neurones, which directly transmit information to supraspinal centres; intersegmental 
propriospinal neurones, which integrate several spinal levels; and intemeurones, which can be 
further divided into interlaminar and intersegmental types.  For a full review of these pathways 
refer to  (Almeida  et  al.,  2004).  The  sensory  receptors  and  spinal  cord  synapses,  required  to 
experience  nociception,  develop  earlier  than  the  afferent  pathways  and  thalamocortical 
pathways, which are essential for the conscious perception of pain (see Table 1.1).
26Anatomical characteristic  Description Gestational age (weeks)
Peripheral cutaneous sensory 
receptors
Perioral cutaneous sensory receptors  7.5
Palmar cutaneous sensory receptors  10-10.5
Abdominal cutaneous sensory receptors  15
Spinal Cord Neurones for nociception in dorsal root  19 
ganglion
Thalamic afferents Thalamic afferents reach subplate zone  20-22
Thalamic afferents reach cortical plate  23-24
Table 1.1 Anatomical development of human nociceptive pathways in humans
Table adapted from Lee et al.  (2005).
Noxious  stimulation can evoke reflex movements at the  level  of the  spinal  cord or brainstem 
without  involving  higher  centres.  In  the  spinal  cord,  the  afferent  fibres  make  synaptic 
connections  with  spinal  cord  intemeurones  that  in  turn  synapse  onto  motor  neurones.  The 
classic  nociceptive  flexion  reflex  involves  activation  of flexor motomeurones  by  nociceptors 
afferents, which triggers muscle contractions, causing limb  flexion away from a stimulus.  At 
birth,  strong  spinal  nociceptive reflexes  can be  evoked by mechanical  stimulation,  which are 
exaggerated compared to the  adult  (Fitzgerald et al.,  1988),  with lower thresholds  and  larger 
prolonged muscle contractions.  The excitability of the mechanical neonatal withdrawal reflex is 
attributable to underlying changes in dorsal hom sensory processing and is likely to be due to 
absence  of fine-tuning  of sensory  and nociceptive  neuronal  circuitry  in  the  newborn.  In the 
human neonate,  as  in the  cat (Sherrington,  1910) and rat (Woolf and Swett,  1984), there  is a 
graded distribution of thresholds within the receptive field, with an area of maximum sensitivity 
on the plantar surface of the foot, and a decrease in sensitivity progressing up the leg towards the 
knee (Andrews and Fitzgerald, 1994).  A study of 50 neonates, with PCA between 27.5 and 42.5 
weeks, showed that infants exhibit a withdrawal reflex following innocuous stimulation.  The 
activation  threshold  is  lowest  in  the  youngest  infants  and  gradually  increases  with  PCA 
(Andrews and Fitzgerald, 1994). One suggestion is that the high level of excitability in the spinal 
cord of youngest infants may in part be due to the late development of intemeuronal pathways, 
including  those  involved  in  descending  inhibition  from  the  brainstem  (Fitzgerald  and 
Koltzenburg,  1986). Table  1.1  provides a brief overview of the anatomical development of the 
nociceptive pathways in humans.
27In contrast to nociception, which simply signals noxious stimuli to the central nervous system, 
pain  perception  requires  that  the  stimulus  be  recognised  as  unpleasant.  The  fundamental 
difference between physically processing a nociceptive  stimulus and perceiving a nociceptive 
stimulus  as  painful  depends  on  the  level  of the  nervous  system  at  which  the  response  is 
processed.  True pain experience requires that we consciously perceive the input at higher levels 
of the nervous system.  It is a prerequisite for the supraspinal processing of pain that peripheral 
sensory receptor afferents,  in the skin  or other organs,  form  synaptic  connections with  spinal 
cord neurones.  Following integration in the dorsal hom,  sensory and nociceptive information 
must be conducted to supraspinal centres, via ascending tracts, to targets in the brain stem, mid­
brain, hypothalamus, thalamus and amygdala.  Here, further central processing takes place and 
projections  are  established  with  the  somatosensory  cortex  and  other  structures.  Functional 
imaging studies in adults have provided a picture of a ‘pain matrix’ in the brain, subdivided into 
a  medial  and  lateral  system,  based  on the projection  sites  of the  lateral  and  medial  thalamic 
structures to the cortex.  The somatosensory cortices, SI and SII, in the lateral system are thought 
to have a discriminatory role  in detecting pain  localisation and intensity,  whereas the  medial 
system involving the anterior cingulate cortex and the insular cortex are thought to mediate the 
cognitive-evaluative component of pain (Apkarian et al., 2005; Brooks and Tracey, 2005).
The  thalamus  is  essential  for the  integration  of cortical  and  subcortical  information  for both 
motor  and  sensory  function.  It  represents  the  main  relay  structure  for  information  to  be 
transmitted  to  the  cortex  and  receives  descending  nerve  impulses  from  the  cortex.  The 
developmental  age  at  which  thalamic  fibres,  involved  in  the  transmission  of  noxious 
information,  reach  the  cortex  is  inferred  from  histological  studies  of  other  thalamocortical 
circuits.  Studies in human foetuses that report on the visual and auditory thalamic projections 
conclude that thalamic projections reach the visual cortex at 21-25 weeks developmental age and 
that  thalamic  afferents  reach  the  auditory  cortical  plate  at  24-26  weeks  developmental  age 
(Kostovic and Rakic,  1984; Krmpotic-Nemanic et al.,  1983).  Further studies have shown that 
afferents from the thalamic region reach the prefrontal cortex by 27 weeks, and conclude that 
thalamic fibres enter the cortex between 26-28 weeks developmental age (Mrzljak et al.,  1992). 
It has  also been  shown  that thalamocortical  fibres  are not present in the  cortical plate by  22 
weeks  (Kostovic and Rakic,  1990).  Thalamocortical fibres are thought to emerge somewhere 
between 21-28 weeks developmental age.  Once the critical thalamocortical connections are in 
place,  there is the potential  for noxious information to be transmitted to the cortex;  however, 
confirmation of the anatomical presence of these fibres does not mean that these pathways are 
functionally active or that the cortex can produce an organised response to noxious stimulation.
28A  more  detailed  discussion  of the  functional  responses  of these  pathways,  assessed  using 
somatosensory evoked potentials in neonates, is given in Section 1.2.12.
Nociceptive stimuli do not only activate sensory and motor pathways.  They will also stimulate 
the autonomic nervous system and endocrine responses.  It has been shown in both adults and 
premature infants that exposure to hostile conditions initiates a response, which alters behaviour, 
autonomic function and the secretion of multiple hormones (Carrasco and Van De Kar, 2003). 
Neuroendocrine responses,  such as increases in the concentration of cortisol, b-endorphin and 
noradrenaline have been used as indicators of stress following painful procedures in neonates. 
However, they are not specific responses to pain and cannot be used as surrogate measures of 
pain  perception  because  they  can  be  mediated  by  the  autonomic  nervous  system  and 
hypothalamic-pituitary-adrenal  axis,  which  does  not  require  conscious  cortical  processing 
(Carrasco and Van De Kar, 2003). As discussed in the previous section, vital signs, such as heart 
rate, respiration, transcutaneous oxygen and carbon dioxide levels have also been used to assess 
neonatal pain (Lindh et al., 1999; Johnston et al., 1995; Craig et al., 1993). As some studies have 
shown that using these measures infants respond to painful and non-painful procedures in the 
same way, care must be taken when interpreting results based on these measures alone (Craig et 
al., 1993).
1.2 Brain Imaging
1.2.1  Investigating the human brain
A  number  of different  approaches  have  been  used  to  investigate  the  function  and  regional 
anatomy of the human brain.  Some examples are summarised in Table 1.2.  Studies of the living 
brain  have  been  advanced  by  the  development  of  technology,  such  as  positron  emission 
topography  (PET),  functional  magnetic  resonance  imaging  (fMRI)  and  near-infrared 
spectroscopy (NIRS), which have enabled the brain to be examined in a manner that does not 
interfere with normal function.
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Technique
Energy Source Spatial
resolution
(mm)
Temporal
Resolution
(s)
Constraints Output
Measured
FMRI Radio waves 4-5 4-10 Immobilisation, 
Loud, cooperation
Relative cerebral 
blood flow
EEG/MEG Intrinsic electricity 10 0.001 Artifact, lack of 
unique localisation
Electrophysiology
Nuclear
(PET/SPECT)
Radiation 5-10 60-1000 Radiation limits, 
Immobilisation
Physiology, 
neurochemistry, 
absolute values
MR spectroscopy Radio waves 10 10-100 Immobilisation,
Loud
Relative chemical 
concentrations
Near-infrared
spectroscopy
Near-infrared light 5 0.05 Immobilisation, 
Surface>depth, 
limited field of view
Relative
Haemoglobin
concentrations
Transcranial
magnetic/electric
stimulation
Magnetic/electric
fields
10 0.01 Risk of seizures, 
Immobilisation, loud
Electrophysiology, 
conduction times
Structural MRI Radio waves 1 N/A Immobilisation, loud Structure, 
vasculature, white 
matter
Post mortem N/A 0.0001 N/A Post mortem Microarchitecture,
Chemoarchitecture
Single  or  multi-unit 
electrophysiology
Intrinsic electricity 0.01-1 0.01 Invasive, direct 
access to brain
Electrophysiology
Table 1.2 Summary of brain imaging techniques
Table adapted from Apkarian et al. (2005).
1.2.2  Brain imaging -  a haemodynamic approach
Numerous  studies,  in  particular those  using  PET  and  fMRI,  have  demonstrated  that  cortical 
activity is associated with an increase in cerebral blood flow (CBF) and cerebral blood volume. 
fMRI, using blood oxygen level-dependent (BOLD) contrast imaging, is the most widely used 
technique for generating images or maps of human brain activity.  It uses haemoglobin as  an 
endogenous contrast agent and relies on the fact that oxygenated and deoxygenated haemoglobin 
have different magnetic properties.  The physiological changes measured using these techniques 
arise from changes in cerebral blood flow, produced as a secondary consequence of increased 
neuronal activity (Logothesis et al., 2001).  Logothesis and colleagues simultaneously measured 
neuronal  electrical  activity  and  the  haemodynamic  response  following  visual  stimulation  in 
primates, to assess whether the fMRI signal occurred due to changes in neuronal activity or due 
to  a vascular change.  The  study  demonstrated that the  BOLD  response  in  primates  directly
30reflected  an  increase  in  neuronal  activity.  The  BOLD  response  correlated  with  local  field 
potentials  (LFP),  which  represent  the  synchronised  synaptic  inputs  of  a  given  neuronal 
population.  The study also reported that multi-unit spiking (MUA), which reflects the spiking 
activity of neurones situated very near to the electrode tip, did not correlate as well as the LFPs. 
Other studies have also reported a proportional relationship between average neuronal firing and 
the fMRI signal (Heeger et al., 2000).
When a region of the brain becomes functionally active, there is an increase in local neuronal 
activity.  This  drives  an increase  in regional CBF,  which increases  the  supply of oxygenated 
haemoglobin; this creates the increase in the BOLD signal.  The BOLD signal is also dependent 
on concomitant changes in the deoxygenated haemoglobin concentration, which occur because 
of oxygen  extraction.  As  the  signal  is  based  on  the  ratio  of oxygenated  to  deoxygenated 
haemoglobin, it is not possible to determine whether BOLD increases arise due to an increase in 
oxygenated  haemoglobin,  caused  by  an  increase  in  regional  CBF,  or  due  to  an  increase  in 
deoxygenated haemoglobin caused by increased oxygen metabolism.  This has implications for 
the interpretation of fMRI studies which only report BOLD increases, because other active areas 
of the brain may be ignored (Nair, 2005).
Although fMRI and PET are both based on the basic principle that images of blood flow change 
can be constructed based on a comparison with a baseline condition, there are key differences in 
the physiological mechanisms responsible for the detected changes.  Images obtained using PET 
rely on tissues absorbing a positron-emitting tracer, hence PET is dependent only on blood flow 
and is independent on the ratio of oxygenated to deoxygenated haemoglobin.  The PET scanner 
detects  gamma rays that are  emitted when a positron,  emitted by the tracer,  collides with an 
electron and is annihilated.  fMRI has a number of advantages over PET.  fMRI has a faster 
image acquisition time, hence  images can be acquired in a few seconds whereas PET scans are 
acquired  over  a  few  minutes.  fMRI  scans  also  have  much  higher  spatial  resolution  and, 
importantly,  in  fMRI  studies it is not necessary to  inject radioactive tracers into the  subjects. 
The use of PET and fMRI has increased our understanding of the function of the brain from a 
haemodynamic perspective.  These techniques have been used to study pain processing above 
the level of the spinal cord and have provided an insight into how cortical and sub-cortical areas 
are involved in different aspects of pain processing.
311.2.3  Pain processing above the level of the spinal cord
The  first  suggestion  that painful  stimulation  causes  increased blood  flow  in  specific  cortical 
areas  came  from  studies  conducted  in the  1970s.  Investigators  used  the  133Xenon  clearance 
technique  to  demonstrate  that  moderate  pain  gives  a  global  increase  in  CBF,  which  was 
predominantly observed in the frontal regions (Lassen et al., 1978). The observation that noxious 
stimulation can activate specific cortical and subcortical regions was later confirmed using PET. 
Functional activation following acute noxious heat stimulation was observed in human subjects 
in numerous brain regions.  Jones and colleagues (1991) showed activation in the contralateral 
anterior  cingulate  cortex  (ACC),  thalamus  and  lenticular  nucleus,  and  Talbot  et  al.  (1991) 
showed  activation  in  the  primary  and  secondary  somatosensory  cortices,  as  well  as  the 
contralateral  ACC.  More  recently,  studies have used  fMRI  to  confirm that multiple  cortical 
areas are activated following noxious stimulation.  A recent meta-analysis, which reviewed the 
brain  areas  activated  in  normal  subjects  following  a  noxious  stimulus,  identified  six  brain 
regions  as  being  consistently  activated across  different pain  studies  using variety  of imaging 
techniques (Apkarian et al., 2005). The areas consistently activated were the ACC, the primary 
and secondary somatosensory cortex (SI and SII), the insular cortex (IC), the thalamus (Th) and 
the prefrontal cortex (PFC).  More recently, the focus of pain-neuroimaging studies has moved 
away  from  simply  identifying  functionally  active  brain  regions.  Recent  studies  have 
concentrated on understanding the specific roles that the different cortical and sub-cortical areas 
perform  during  pain perception  and  the  analysis  of more  complex  drives  evoked by  painful 
stimuli, such as reward, fear, anxiety and decision-making.
32Figure 1.2 Cortical and subcortical regions involved in pain perception
Schematic of brain regions involved in pain perception taken from Apkarian et al., (2006), modified from Price (2000) to 
include additional areas and connections. S1, primary somatosensory cortex; S2, secondary somatosensory cortex; IC, 
insular  cortex;  ACC,  anterior  cinguiate;  PFC,  prefrontal  cortex;  BG,  basal  ganglia;  CB,  cerebellum;  PCC,  posterior 
cingulate; PMC, premotor cortex; BS, brainstem; Amyg, amygdala; Hippo, hippocampus; PAG, periaqueductal gray; VT, 
ventral tegmentum; M1, primary motor cortex; PPC, posterior parietal cortex; PMC, premotor cortex; PVG, periventricular 
gray; SMA, supplementary motor area; Hyp, hypothalamus.
Primary and secondary somatosensory cortices
SI and SII have been consistently identified as being involved in the sensory processing of pain.
Numerous studies have confirmed activity in SI contralateral to the stimulated site.  The sensory-
discriminative  features  of  pain  are  considered  to  include  detection,  stimulus  localisation,
intensity discrimination and quality discrimination (Treede et al., 1999). It is a key feature of the
nociceptive system, which enables subjects to locate the source of pain and have the capacity to
encode different intensities of noxious stimulation.  Within SI the somatotopic arrangement is
consistent with the tactile homunculus for hand and foot (Ploner et al., 1999; Tarkka and Treede,
1993). Pain intensity coding has been demonstrated for nociceptive neurones in SI using both
haemodynamic (Bomhovd et al., 2002) and electrophysiological (Iannetti et al., 2005b; Arendt-
Nielsen,  1994)  correlates  of pain.  Using  painful  laser  stimulation,  Iannetti  and  colleagues
showed that the amplitude of nociceptive specific components, driven by the operculoinsular and
33the primary somatosensory cortex, correlate with the perceived intensity of the pain (Iannetti et 
al., 2005b).
Anterior cingulate cortex (ACC)
The ACC is part of the medial nociceptive system.  Particular attention has been focused on the 
ACC as virtually all brain imaging studies that have used acute noxious stimuli provide evidence 
to suggest it is functionally activated.  94% of PET studies and 81% of fMRI studies have shown 
that  the  ACC  is  activated  during  acute  pain  processing  in  normal  subjects  (Apkarian  et  al., 
2005).  It has been identified as being involved in the strong affective-emotional components of 
pain processing, such as the motivation to avoid pain and associated unpleasantness and anxiety 
(Sawamoto  et  al.,  2000;  Apkarian  et  al.,  1999;  Rainville  et  al.,  1997;  Craig  et  al.,  1996). 
Rainville  et  al.  (1997)  showed  a  reduction  in  activity  in  the  ACC  following  hyponotic 
suggestion,  which  was  thought  to  have  selectively  diminished  unpleasantness,  despite  there 
being no change in the actual intensity of the noxious stimuli.  It is still unknown whether the 
ACC  has a nociceptive-specific area or whether activation is caused by a non-specific effect, 
possibly due to the affective processing and autonomic responses.  Many other imaging studies 
that  have  used  non-noxious  stimulation  also  show  activation  of the  ACC  (Raz  et  al.,  2005; 
Killgore and Yurgelun-Todd, 2005; Najib et al., 2004).  This suggests that the ACC may have a 
more general role in terms of affective-emotional processing, which is not specific to noxious 
stimulation.
Insular cortex (1C)
The insular cortex takes up an intermediate position between the lateral and medial system.  It 
receives its major input from the lateral system but projects to the limbic system.  The affective- 
emotional components of pain are also thought to be processed by the insular cortex.  In contrast 
to the ACC, the insular cortex has been shown to encode the intensity and laterality of painful 
stimuli (Brooks et al., 2002;  Coghill et al.,  1999).  Craig et al.  (2000) used PET to show that 
contralateral activity in the dorsal margin of the IC correlated with graded cooling stimuli.  The 
results suggest that the intensity of heat pain is encoded in the IC and that this site is involved in 
discriminating between noxious and innocuous temperature (Craig et al., 2000).
34Prefrontal cortex (PFC)
The PFC is the most anterior portion of the frontal lobes.  The PFC is thought to be related to the 
cognitive-evaluative processing of pain, such as the memory of pain and pain-related attention 
processing.  As activation does not increase with stimulus intensity, intensity coding is not a task 
of the prefrontal cortex (Coghill et al.,  1999). The prefrontal cortical regions are activated in a 
number of imaging studies but activation is not as common as the other cortical areas that have 
been described (Apkarian et al., 2005). The prefrontal cortex receives input from the ACC, but 
there is no evidence that it receives direct thalamocortical nociceptive input.
The studies that have been discussed outline a number of brain regions consistently activated 
following  noxious  stimulation.  There  are  also  considerable  differences  that  occur  across 
different experimental paradigms.  In  fact,  even when considering the  same  individual  in the 
same experimental conditions there is considerable variation in the subjective processing of pain. 
Many of the observed differences in pain imaging studies can be accounted for by the disparity 
between  technical  procedures.  It  is  also  likely  that  there  is  considerable  variation  in  pain 
processing when comparing responses between different individuals.
1.2.4  Brain imaging and the preterm infant
Our understanding of human pain processing in the adult brain has increased considerably over 
the last  15 years (Apkarian et al., 2005).  Studies of the haemodynamic correlates of pain have 
led to a better understanding of pain processing in adults at supraspinal levels, and analysis of 
pain-evoked potentials has provided an electrophysiological  representation of pain processing 
(Kakigi et al., 2005).  However, the imaging techniques and experimental paradigms adopted for 
the study of adult pain processing are not appropriate for the study of infants in intensive care. 
In  the  neonatal  population,  there  are  clear  technical  difficulties  associated  with  the  use  of 
imaging techniques such as fMRI and PET.  Although many successful fMRI studies have been 
conducted in neonates, it would be extremely difficult to perform a clinically required noxious 
procedure while an infant was in an fMRI scanner.  Many infants cannot easily be moved from 
the intensive care environment and, in this vulnerable population, it would be unethical to use 
the radioactive tracers required for PET studies.  Further experimental difficulties arise because 
studies can only be undertaken when there is a clinical requirement for a painful procedure to be 
carried out; it is not possible to use repetitive painful stimuli at predetermined intervals to assess 
the  development  of  pain  processing  throughout  early  development.  Hence,  many  of  the 
experimental paradigms used in adults cannot be applied to studies in infants.  For these reasons,
35alternative  brain  imaging  techniques  and  experimental  approaches  need  to  be  adopted  to 
investigate pain processing in the neonatal population.
The studies presented in the following chapters use near-infrared spectroscopy (NIRS) to assess 
the  haemodynamic  correlates  of  pain  and  electroencephalography  (EEG)  to  assess  the 
underlying cortical electrical activity.  NIRS and EEG are ideal for the study of neonates because 
the  equipment  is  portable  and  non-invasive.  NIRS  measures  regional  changes  in  the 
concentration of natural chromophores such as oxygenated and deoxygenated haemoglobin.  A 
further benefit of this technique over other optical imaging methods is that studies can be done at 
the  bedside,  while  the  infant  remains  in  intensive  care.  Many  studies  have  confirmed  the 
cerebral origin of such optical haemodynamic recordings from the surface of the head and the 
feasibility  of using  NIRS  to  detect  neural  activity  (Gratton  et  al.,  2005).  This  technique  is 
widely used in neonatal research and has been successfully applied in  infants to measure the 
haemodynamic  correlates  of neural activity during motor,  auditory,  olfactory and visual  tasks 
(Zaramella et al., 2001; Isobe et al., 2001; Bartocci et al., 2000; Sakatani et al.,  1999; Meek et 
al.,  1998).  It has  also  successfully been applied to  detect  evoked responses  in  infants,  from 
neonates to 12-month-olds during visual, memory, and language tasks (Taga et al., 2003; Pena et 
al.,  2003;  Baird et al.,  2002).  NIRS  and EEG  are  discussed  in  more  detail  in  the  following 
sections.
1.2.5  Near-infrared spectroscopy
NIRS is a technique used to measure blood and tissue oxygenation.  The method is based on 
spectroscopic measurements of oxygenated and deoxygenated haemoglobin concentration.  The 
technique depends on the transparency of biological tissue to near-infrared light and uses the fact 
that  the  absorption  of  near-infrared  light  is  dependent  on  the  amount  of  oxygenated  and 
deoxygenated haemoglobin present within the tissue (Owen-Reece et al.,  1999). A source and 
detector are placed on the surface of the head and the change in intensity between the emitted 
and absorbed light is used to measure changes in tissue oxygenation.  Furthermore, the absolute 
haemodynamic parameters such as blood flow (Edwards et al., 1988) and cerebral blood volume 
(Wyatt et al.,  1990a) can be calculated. In recent years, NIRS has been used to study functional 
activation  of various  areas  of the brain.  As  with other techniques  that use  a haemodynamic 
approach  to  assess  the  functional  activation  of the  brain,  it  is  based  on  the  assumption  that 
increased tissue oxygenation represents an increase in regional cerebral blood flow, which is in 
turn associated with an increase in underlying neural activity (Logothetis et al., 2001).
36Light in the visible region is strongly attenuated and cannot penetrate more than  1cm of tissue, 
whereas  near-infrared  light can  still  be  detected  after it has  traversed  through  8cm  of tissue 
(Elwell,  1995; Wyatt et al.,  1986). There are a number of compounds that absorb near-infrared 
light.  Of  particular  interest  are  oxygenated  and  deoxygenated  haemoglobin  because 
measurements  of these compounds  can provide  information  on the tissue  oxygenation  status. 
Changes in the amount of absorption or scattering will result in changes in the light reaching the 
detector.  The amount of light that a compound absorbs is dependent on two major features; the 
wavelength  of  light  and  the  properties  of the  tissue  being  penetrated.  This  wavelength- 
dependent absorption is known as the absorption spectrum of the compound.  The loss in light 
intensity  can  be  described  using  the  Beer-Lambert  Law,  which  states  that  for  an  absorbing 
compound in a non-absorbing medium, the attenuation {A) is proportional to the concentration of 
the compound in the solution (c), the specific extinction coefficient of the absorbing compound 
(a) and the optical path length (d), which is the distance between points where the light enters 
and leaves the medium.  The product of ac is known as the absorption coefficient (jua).  10 and I 
are  the  light  intensities  incident  on  the  medium  and  transmitted  through  the  medium 
respectively.
A = log
To
I
=  acd
Detector: Source:
Laser Diode Light In
Absorption and 
Scattering Photodiode Laser Out
Figure 1.3 Schematic diagram showing the effect of scattering
The total optical path length is greater than the geometrical displacement of the source and detector.
The  consequences  of  scattering  also  need  to  be  considered.  Scattering  has  the  effect  of 
increasing observed tissue attenuation at a given point.  The amount of scattering is dependent
37on the size of the scattering particle, the wavelength of light, and the refractive indices of the 
scattering medium (Elwell, 1995). In a highly scattering medium, the mean distance travelled by 
each photon  is  far greater than the geometrical  displacement (see Figure  1.3  for a  schematic 
representation).  In this case, the modified Beer-Lambert law can be used to describe the loss in 
light intensity.  The true path length, known as the differential path length (P) can be determined 
by  multiplying  the  geometrical  displacement by  a  scaling  factor,  which  is  dependent  on  the 
biological  tissue  being  penetrated and the relative proportion  of the  different  mediums.  For 
example, the scaling factor accounts for the proportion of soft tissue to muscle to bone.  The 
scaling  factor  (B),  known  as  the  differential  path  length  factor,  has  been  shown  to  be  age- 
dependent and in infants is estimated to be 4.39 +/- 0.28 (Wyatt et al., 1990b).
The modified Beer Lambert Law, as written below accounts for the losses due to scattering.  G is 
the additive term that accounts for scattering losses.
A —  log
To
y
= acd(B + G)
As  G  is  dependent  on  the  geometry  of the  medium  being  investigated  and  is  unknown,  the 
modified Beer-Lambert law does not calculate an absolute concentration of the compound, but 
instead  uses  the  change  in  attenuation  to  calculate  the  change  in  the  concentration  of the 
compound.  Since  absolute  concentrations  are  unknown,  all  measurements  are  expressed  as 
absolute concentration changes from an arbitrary zero, which is determined at the start of the 
measurement period.
AA = AcadB
1.2.6  Physiological interpretation of the near-infrared response
As described previously NIRS is a brain imaging method that relies on a vascular response to 
define  cerebral  activation.  Functional  studies  are  based  on  the  premise  that  changes  in 
haemoglobin content and oxygenation are related to regional cerebral blood flow (rCBF).  It is 
reasonable to  suppose that an increase  in haemodynamic activity correlates with an increased 
level  of  cortical  electrical  activity  (Logothetis  and  Wandell,  2004).  In  adults,  functional
38responses  typically  observed  in  activated cortical  areas  consist  of an  increase  in  oxygenated 
haemoglobin and a decrease in deoxygenated haemoglobin, resulting in an overall increase in 
total haemoglobin (Villinger et al., 2002).  This has been observed using NIRS, where increased 
blood  volume,  increased  oxygenated haemoglobin  and  decreased  deoxygenated  haemoglobin 
concentrations were observed in the visual cortex during visual stimulation (Meek et al.,  1995). 
These findings are supported by fMRI studies which have consistently shown an increase in the 
BOLD signal in the visual cortex during visual stimulation tasks (Ogawa et al.,  1993; Schneider 
et al., 1993).
Despite the apparent similarities in these findings, care must be taken when comparing results 
using NIRS to fMRI.  If NIRS studies only report increases in oxygenated haemoglobin, which 
is  most  often  the  parameter  of choice,  and the  increases  are  not coupled  with  a  decrease  in 
deoxygenated  haemoglobin,  then  had  these  studies  been  conducted  using  fMRI  the  reported 
activation  may  not  have  been  observed.  While  increases  in  oxygenated  haemoglobin  are 
consistent with our understanding of activation in terms of fMRI, the decrease in deoxygenated 
haemoglobin  also  corresponds  to  an  increase  in  BOLD  contrast  (Mehagnoul-Schipper  et  al., 
2002).  Areas of the brain that have a metabolic demand for oxygen  higher than the rate of 
supply may cause the BOLD signal to be negated or result in an overall decrease in the BOLD 
signal.
In contrast to  findings  in adults, there is evidence in neonates that an  increase  in oxygenated 
haemoglobin is not coupled to a decrease in deoxygenated haemoglobin.  This has been shown 
using NIRS and confirmed by observations using fMRI, which have shown that the BOLD effect 
is  inverted  in  this  population  (Sakatani  et  al.,  1999).  Using  NIRS  to  study  cerebral  blood 
oxygenation changes during auditory stimulation in newborn infants,  Sakatani (1999) reported 
parallel increases in the deoxygenated and oxygenated haemoglobin concentrations  in 60% of 
subjects.  In  fMRI  studies,  BOLD  decreases  have  also  been  reported  in  neonates  despite  an 
apparent  increase  in  blood  flow  to  the  activated  cortex  (Anderson  et  al.,  2001).  These 
observations are illustrated by two studies, which measured signal changes in the auditory cortex 
of unsedated  neonates  during  auditory  stimulation.  In  the  first  study  NIRS  was  used  to 
demonstrate  that  the  concentrations  of  both  oxygenated  and  deoxygenated  haemoglobin 
(measured with respect to the volume of cortex under the detectors) increased in two thirds of 
the  infants  (Zaramella  et  al.,  2001).  Notably,  if  fMRI  had  been  used  to  investigate  the 
haemodynamic response then an increase in the observed BOLD signal, caused by the rise in 
oxygenated  haemoglobin,  would  have  been  attenuated  by  the  increase  in  the  deoxygenated
39haemoglobin.  In  agreement  with  these  findings  the  study  using  fMRI  showed  that  BOLD 
decreases  were  recorded  in  the  auditory  cortex  in two-thirds  of the  infants  (Anderson  et al., 
2001).
During sensory stimulation in the neonate, an increase in both oxygenated and deoxygenated 
haemoglobin  has  been  observed  in  the  visual  cortex  during  visual  stimulation  (Meek  et  al., 
1998); in the motor cortex during passive motor movements of the arms or legs (Isobe et al., 
2001;  Hintz  et  al.,  2001;  Benaron  et  al.,  2000),  over  the  temporal  cortex  during  auditory 
stimulation (Zaramella et al., 2001), and over the anterior orbito-frontal gyri of the frontal lobes 
during the presentation of different smells (Bartocci et al., 2000). The findings indicate that in 
the human infant, the cerebral metabolic rate of oxygen consumption may exceed the increase in 
oxygen supply provided by the increase in regional CBF.  The metabolic ratio that appears to 
exist in adults may not hold for neonates.  It is probable that the inversion of the BOLD signal 
occurs  because  oxygen  metabolism  exceeds  the  supply.  Whether  the  vascular  response  in 
infants differs from adults and the age range at which this differs remains controversial (Martin 
and Marcar,  2001).  Due to the uncertainty in the  direction of the  deoxygenated haemoglobin 
response in neonates, when using functional NIRS it is particularly important to ensure that the 
detected changes occur as a direct response to the stimulation.  It is essential to ensure that the 
observed changes do not occur due to other factors such as movement artefacts.
1.2.7  Neurophysiological basis of the electroencephlogram (EEG)
EEG  can  be  used  to  assess  the  underlying  cortical  electrical  activity  in  infants.  An  EEG
recording measures the fluctuating field potentials as a function of time.  The deflections in an
EEG trace, measured against an inactive electrode, represent a change in voltage and polarity.
When multiple recording electrodes are used, it gives a representation of the spatial distribution
of the field over the scalp.  A normal adult EEG recording will consist of activity that occurs
over a range of frequencies.  The slow activity (0.3-7.0Hz) and fast activity (greater than 30Hz)
are sparsely represented with the majority of activity occurring in a frequency range between
8-30Hz.  The amplitude range for a cortical EEG signal most commonly lies between 10-50pV.
A nerve cell body has a resting potential of -60 to -70mV, which is subject to fluctuations chiefly
elicited by synaptic activity.  If an action potential travels along a nerve fibre that ends in an
excitatory synapse, an excitatory postsynaptic potential (EPSP) occurs in the following neuron.
Two action potentials travelling along the same fibre within a short time interval results in the
summation  of the  EPSP  in  the  postsynaptic  neurone.  If a threshold  membrane  potential  is
reached an action potential will be produced in the second order neurone.  If an action potential
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representing an inhibitory postsynaptic potential (IPSP).  The generation of an EPSP results in 
the  net  flow  of  cations  across  the  synaptic  membrane  and  consequently  gives  rise  to  a 
depolarisation.  The potential gradient causes cations to move along the nerve cell membrane 
through the extracellular space in the direction of the subsynaptic region.  These ion fluxes in the 
extracellular space are of paramount importance in the generation of field potentials and are the 
basis of an EEG recording.  The primary transmembranous currents generate secondary ionic 
currents along cell membranes in the intracellular and extracellular space.  The portion of these 
currents that flow through the extracellular space is directly responsible for the generation of the 
field  potentials.  Figure  1.4  shows  the  basic  mechanism  underlying  the  generation  of field 
potentials and the resultant EEG recording.
rest activity
magnetic
needs,
I
I
I
synapse I
I
I
t
[resistance of the 
[extracellular space
I
I
I
t
I
I
I
I
I
step 1
activation of a synapse: 
cation currents through 
the membrane
t>-
step 2
local change of 
membrane potential 
and potential gradient 
along the membrane
*
+  i 
+
step 3
currents along the membrane in the 
extra- (1) and intracellular (2) space:
(1) potentials at the resistance of 
the extracellular space (EEG)
(2) magnetic fields (MEG)
4
MEG
+  I 
+
I
g} EEG
Figure 1.4 Underlying mechanisms generating an EEG and MEG signal
Basic  mechanisms  underlying  the  generation  of  potentials  (electroencephalogram;  EEG)  and  magnetic  fields 
(magnetoencephlogram;  MEG) in  the extracellular space of the  CNS.  It is  based  on the  principle that an extended 
neuronal process is locally depolarised by the activation of an excitatory synapse.  Diagram from Niedermeyer and da 
Silva (2005).
1.2.8  Neonatal EEG
As EEG activity rapidly changes throughout early development, the correct interpretation of a 
neonatal EEG is dependent on knowledge of the post menstrual age (PMA).  The earliest EEG 
activity has been recorded in infants from 22-23 weeks PMA.  The characteristic feature of the 
neonatal EEG is that the activity is not continuous but consists of small bursts of activity against
41a  quiescent  background.  The  quiescent periods,  often  referred to  as  trace  discontinue,  vary 
enormously in duration.  In the youngest infants bursts of activity can be separated by up to 8 
minutes (Hughes,  1994).  The periods of quiescence decrease in time as the infants approach 
term  and are  thought to cease  from about  32  weeks.  If term  infants  demonstrate periods  of 
quiescence, this is considered to suggest neurophysiological immaturity and is indicative of poor 
outcome at 3 years old.  After the trace discontinue the earliest distinctive EEG pattern that can 
be observed is sharp theta activity on the occipitals of prematures (STOP).  The activity is 5- 
6Hz, is maximal in the occipital regions and can be either unilateral or bilateral.  STOP activity 
is most prominent in the youngest premature infants and has normally disappeared by term.  The 
next distinctive pattern, which is maximal between 29-31 weeks, is the premature temporal theta 
(PT0) activity Like STOP it is theta activity, but in contrast, it is maximal in the temporal areas 
and is normally bilateral.  Different sleep stages can be distinguished by 32 weeks.  The first 
organised  stage  is  active  sleep,  which  is  characterised  by  continuous  activity  of the  same 
frequency to that which occurs sporadically in younger infants.  Quiet sleep develops slightly 
later and shows discontinuous features that remain throughout life.  The final  state to become 
organised is the awake state.  This is characterised by low voltage theta activity.  Delta brushes, 
which are delta waves with fast activity superimposed,  are  also characteristic  of the neonatal 
EEG.  They can appear from 28 weeks, are prominent by 32 weeks and usually gone by term.  A 
great deal of work has been done characterising the neonatal EEG.  As this is not the main focus 
of this thesis, only a brief overview is given (see Table 1.3).
4227-27 weeks 28-31 weeks 32-35 weeks 36-41 weeks
Continuity Discontinuous, long 
flat stretches
Discontinuous Continuous in waking 
state and REM sleep. 
Discontinuous in non- 
REM sleep
Continuous except for 
trace alternant in non- 
REM sleep
Low voltage Long flat stretches Flat stretches, 
mainly
asynchronous
Low-voltage record 
suspect of serious 
cerebral pathology
Very low-voltage 
records are due to 
severe cerebral 
pathology, prognosis 
ominous
Interhemispheric
synchrony
Short bursts in 
synchrony
Mostly
asynchronous
activity
Partly synchronous Minor asynchronies 
present
Occipital theta 
(STOP)
Prominent Decreasing Decreasing Absent
Temporal theta 
(PT0)
Present and 
increasing
Prominent Decreasing and 
disappearing
Disappearing or 
absent
Alpha rhythm None None None None
Differentiation of 
awake and 
asleep state
Undifferentiated Undifferentiated Waking distinguished 
from sleep early in 
period, then 
differentiation of non- 
REM and REM sleep
Good
Slow activity 
(awake)
Slow bursts high 
voltage (state of 
vigilance 
undifferentiated)
Very slow activity 
predominant
Slow (delta) occipital 
maximum
Slow (delta), mostly of 
moderate voltage
Fast activity 
(awake)
Very little beta 
activity
Frequent ripples or 
brushes around 
16/sec
Frequent ripples or 
brushes (16-20 Hz)
Decreasing ripples, 
sparse fast activity
Trac6 alternant None None Present in non-REM 
(quiet sleep)
Present in non-REM 
(quiet sleep)
Spindles None None (ripples 
present)
None (ripples present) None (but scanty 
ripples)
REM sleep Undifferentiated Undifferentiated Continuous slow 
activity; REM present
Continuous slow 
activity (more REM 
than non-REM sleep
Table 1.3 Summary of EEG maturation
Table adapted from Niedermeyer and da Silva (2005).
431.2.9 Principles of event related potentials
EEG  is  a technique used to  investigate  human brain  function  in health and disease.  Further 
specialised techniques use EEG to assess underlying sensory and cognitive processing associated 
with specific types of stimulation.  Changes in EEG activity, associated with a specific sensory 
stimulation, are generally referred to as event related potentials (ERPs).  ERPs arise following 
the brain’s reception and response to an external  stimulus.  Characteristic peaks and troughs, 
caused  by  the  synchronised  bursting  of  neurones,  correspond  to  the  underlying  neuronal 
processing.  The  functional  significance of the ERP characteristics  involves the  simultaneous 
consideration of its components,  such as polarity (positive or negative),  timing (latency),  and 
scalp distribution (topography).  The amplitude and latency of successive peaks in the waveform 
can be used to determine the time course of information processing in the brain, whereas the 
distribution of voltage over the scalp can be used to estimate the neuroanatomical loci of these 
processes.  A subset of ERPs, known as sensory evoked potentials, includes those generated by 
visual,  auditory  and  somatosensory  stimuli.  Potentials  evoked  by  somatosensory  stimuli, 
referred to as somatosensory evoked potentials (SEPs), are discussed in the next section.
It is difficult to observe ERP activity in a raw EEG trace because few stimuli generate clear-cut 
changes in the EEG signal that can be observed above the background activity.  The difficulty in 
detecting ERPs is that the activity can be masked by the ongoing EEG activity.  Conventionally, 
ERPs  are  detected using  averaging techniques  so that  the  signal  of interest  is  amplified  and 
observed over and above background activity.  The basic assumption is that the signal of interest 
occurs  at  a  fixed  latency,  time-locked  to  the  stimulus,  which  means  that  the  ongoing  EEG 
activity can be treated as noise.  This simple model is an approximation as it does not take into 
account that sensory stimuli can cause a reorganisation of the EEG signal (Sayers et al.,  1974) 
or, for example, that some stimuli, such as visual stimulation, can reduce the amplitude of the 
ongoing EEG activity (Vijn et al., 1991).
1.2.10 Somatosensory evoked potentials
SEPs are routinely used to provide information for clinical assessment about the function of the 
somatosensory system and the integrity of somatosensory pathways.  The most common method 
used to generate SEPs is transcutaneous electrical stimulation.  Electrical stimuli depolarise the 
nerve  fibres  by  generating  a  potential  difference  across  the  nerve  fibre  membrane,  therefore 
bypassing  the  encoding  of natural  stimuli  by  the  receptors.  This  has  advantages  over  other 
physiological  stimuli  because  it  is  easy  to  control  and  produces  potentials  that  are  easily 
measured.  A comparison between electrical stimulation and mechanical stimulation (Ogawa et
44al., 2005) has shown that waveforms produced by the former are similar but of greater amplitude 
than  those  produced  by  the  latter  (Pratt  and  Starr,  1981).  The  difficulty  with  mechanical 
stimulation is that a reliable delivery method, essential to record time-locked neural events, is 
hard to achieve.  Designing a mechanical device that produces a quick and well-defined impact 
can be problematic.  Although some mechanical stimulation systems have been designed, such 
as the use of short-duration air puffs, these have not been routinely used clinically because only 
a  small  population  of  fibres  are  excited.  Electrical  stimulation  non-selectively  activates 
peripheral afferent fibres, and has the disadvantage that it produces a variety of sensations, such 
as buzzing and ringing.  It is also an unnatural stimulus that is not experienced in our normal 
environment.  Cortical  SEPs  generated  by  electrically  stimulating  the  median  nerve,  and 
recorded in the parietal region contralateral to the stimulation site, peak at around  18-35ms.  In 
adults, up to 500 averages are used to generate the SEPs.  Figure  1.5  shows an example SEP 
with the negative (N) and positive (P) components identified.  The EEG traces presented in this 
thesis have the negative potentials represented by a downward deflection.
Time (ms)
Amplitude 
N-P complex
Latency to N 
component
Latency to P 
component
Figure 1.5 Schematic of a somatosensory evoked potential
Schematic of an SEP with the latency and amplitude of the N-P complex labelled.
1.2.11  Background to pain-evoked somatosensory potentials
A particular challenge for clinical neurophysiologists has been to use EEG to record pain-related
somatosensory evoked potentials (SEPs).  The excellent temporal resolution provided by EEG
means that neural activity in the cerebral cortex can be recorded when afferent input reaches the
brain.  SEPs  have  conventionally  been  recorded  using  electrical  stimulation  applied  to  the
peripheral nerves.  It provides an excellent way of assessing the integrity of the nervous system
because activity can be recorded from the peripheral nerves to the spinal cord to the thalamus
and finally the cortex.  Its use is limited, however, in terms of assessing pain processing because
45electrical  stimulation  non-selectively  activates  a wide  range  of the  peripheral  afferent  fibres, 
which triggers a various sensations.
Evoked potentials following a painful  stimulus were first identified in the  1960s  (Spreng and 
Ichioka, 1964). Since then a wide range of stimulation protocols have been used in the attempt to 
measure pain-related SEPs.  Examples include, painful impact, where small solid bullets were 
fired  at  the  upper  arm  or  trunk  of participants  (Kohlloffel  et  al.,  1991)  and  dental  pulp 
stimulation (Hari et al.,  1983).  Each method has its advantages and disadvantages; however, the 
ideal  stimulus  would  be  one  that  generates  evoked  potentials  that  are  nociceptive-specific, 
reproducible, highly controllable and safe (Kakigi et al., 2005).  In addition, the stimulus must be 
short enough to cause a volley of afferent nerve fibre activity that is sufficiently synchronised to 
allow the recordings of time-locked brain responses.  In  1975 the first EEG signals following 
laser stimulation were recorded (Mor and Carmon,  1975).  These signals are now referred to as 
laser  evoked  potentials  (LEPs).  As  lasers  rapidly  heat  the  skin,  afferent  volleys  are  highly 
synchronised,  which allows time-locked events to  be  observed on a single  trial  basis.  Laser 
stimulators selectively activate thermosensitive A8 and C fibres, and as there is no contact with 
the  skin,  mechanosensitive  afferent  fibres  are  not  activated.  A  number  of  different  laser 
emission  sources  have  been  developed,  of which  the  C02  laser  is  most  often  used  (Arendt- 
Nielsen and Chen, 2003). Laser stimulation evokes a characteristic double pain sensation; which 
includes a sharp pricking sensation followed by a longer lasting dull pain.  Neurophysiological 
studies  have  shown  that  these  different  perceptual  responses  are  respectively  related  to  the 
activation  of A5 and  C primary afferents  (Plaghki  and Mouraux,  2003).  The earliest cortical 
potentials activated by laser stimulation of the hand have a dipolar distribution, which peaks at 
about 160ms.  The negative component is generated by the contralateral temporal region and the 
positive component is generated by the midfrontal region.  The latency of the N-P complex is 
compatible with input transmission occurring via A5 fibres (Kunde and Treede,  1993). A later 
potential, which peaks between 200-350ms, is maximum at the vertex (Cz).  This N-P vertex 
potential represents the largest amplitude response following laser stimulation and is the easiest 
to  record.  This  vertex  potential  is  thought to reflect a late  cognitive  response  driven by the 
cortical processing of the noxious stimulation.
1.2.12  Somatosensory processing in the preterm infant brain
Somatosensory evoked potentials  (SEPs)  have been used in neonates to  assess  the  functional 
integrity  and  maturity  of the  neonatal  central  nervous  system.  Studies  have  shown  that  the
46immature  brain  is  able  to  respond  to  external  stimuli,  and  careful  characterisation  of these 
responses  provides  an  excellent way  of looking  at  age-dependent changes  in  the  developing 
neonate.  In most studies an electrical  stimulus has been used to activate the median or tibial 
nerve (Pike et al., 1997; Taylor et al., 1996) but other methods, such as tactile stimulation of the 
fingers, have also been used (Pihko et al., 2004). Cortical SEPs have been reported to occur from 
the 25th week of gestation (Taylor et al.,  1996). Such reports confirm that at this early stage of 
development  the  somatosensory pathways are  able  to  conduct peripheral  impulses  to cortical 
structures.  These  studies  have  consistently  shown a decrease  in peak latency with  increased 
gestational age (Smit et al.,  1999; Taylor et al., 1996; Klimach and Cooke,  1988). This decrease 
in  latency  is  attributed  to  the  immature  myelination  of the  sensory  pathways,  the  immature 
functioning of the synapses and the smaller diameter of the axons in the younger infants (Pihko 
and Lauronen, 2004). The latency to response is dominated by two developmental features that 
have  the  opposite  consequences.  Increased  myelination  causes  a  progressive  increase  in  the 
conduction velocity and synchronisation of the potentials, whereas increased body length causes 
a decrease in latency and a decrease in synchronisation.
While there is good evidence to suggest that SEPs can be reliably recorded from 30 weeks PCA, 
the  evidence  is  less  good  in  infants  below  28  weeks.  A  handful  of studies  have  looked  at 
responses in extremely premature infants and to date the results have been variable.  One study, 
which  looked  at  SEPs  in  infants  below  32  weeks,  found  that  they  were  only  able  to  record 
reliable  SEPs  in  24  out  of  59  infants  (Smit  et  al.,  2000).  In  contrast,  by  term  the  same 
investigators  could get reliable EP recordings in 58  out of 65  studies performed (Smit et al., 
2000). The first study to record EPs in infants below 28 weeks was conducted by Klimach and 
Cooke in 1988.  They recorded EPs from 3 infants below 28 weeks and although they reported 
an overall success rate of 90% across the whole population (26-41 weeks PCA) they stated that 
most unsuccessful studies were conducted in infants below 28 weeks PCA (Klimach and Cooke, 
1988).
It  is  possible  that  the  poor  success  rate  in  this  population  is  due  to  the  extreme  technical 
difficulty in undertaking these studies.  It is equally plausible that while sensory pathways may 
be anatomically intact at this age, they may not have formed mature synaptic connections and 
therefore cannot be functionally activated.  Findings by Pike and colleagues dispute this (Pike et 
al.,  1997).  They  looked  at posterior tibial  SEPs  in  67  preterm  infants,  aged between  27-37 
weeks gestation, and were able to obtain reliable recordings from all the infants in their study. 
They argue that poor success rates in recordings is not due to variable rates of myelination and
47neurogenesis  but  a  consequence  of  the  practical  and  technical  difficulties  involved  in 
undertaking these studies in the challenging NICU environment.  In a recent review, Vanhatalo 
et al. suggest that methods for recording and analysing SEPs in preterm babies are suboptimal 
and that the unique properties of the preterm SEP call for novel analytical methods (Vanhatalo 
and Lauronen, 2006).  The review highlights the point that previous studies have empirically 
shown  that  less  averaging  gives  more  clearly  defined  waveforms.  This  reflects  the  natural 
variability  in the waveforms between trials, and challenges the validity of using conventional 
grand averaging approaches.
48CHAPTER 2: GENERAL METHODS
2.1 Neonatal Research
2.1.1  General overview
This thesis describes a set of studies where the question of cortical pain processing in very young 
infants is addressed by directly measuring cortical responses to noxious stimulation using near- 
infrared  spectroscopy  (NIRS)  and electroencephalography  (EEG).  To  date,  neither EEG  nor 
NIRS have been used to investigate the onset or development of the cortical response to pain in 
infants.  By combining these techniques, we hypothesised that  it might be possible to  assess 
whether  the  nociceptive  pathways  conduct  impulses  to  the  cortex  and  at  what  stage  during 
development the cortex is able to produce a response.  Because the exact relationship between 
the haemodynamic response and underlying electrical activity in neonates is both unclear and 
conceivably different from that in adults,  it is advantageous to measure responses  using both 
recording modalities  simultaneously.  In addition, behavioural  and physiological responses to 
pain are monitored and scored using a clinical pain assessment tool.  A series of experiments are 
described which set out to test whether the immature cortex is functionally active in response to 
noxious  stimulation;  how  the  cortical  responses  change  throughout  early  development;  and 
whether other factors modulate the cortical processing of pain.  The overall aim of these studies 
is to develop a systematic approach to measure pain in the neonatal population.
2.1.2 Neonatal intensive care
The  site  of the  current  study, University College London Hospital  (UCLH)  is  a level  3  unit, 
which  means  it  provides  intensive  care  for  babies  needing  respiratory  support;  for  babies 
weighing less than  1,000 grams and/or less than 28 weeks gestation receiving nasal continuous 
airway  pressure;  for  babies  with  severe  respiratory  disease  or  for  those  who  require  major 
surgery.  UCLH is attached to a foetal medicine department, which means a high number of the 
infants  are  identified  antenatally  as  having  problems.  UCLH  has  approximately  3000-4000 
deliveries per annum of which up to 400-500 are admitted to the intensive care unit.  In specialist 
London units, babies bom at less than 23 weeks have a 42 per cent chance of survival.  Those 
bom at 25 weeks have an 80 per cent chance of survival and those bom at 28 weeks have a 90 
per cent chance of survival (Green, 2005).
492.1.3  Research challenges in a neonatal unit
A number of specific challenges need to be addressed when research is undertaken on infants 
receiving intensive care.  As with all studies involving humans, the first requirement is to obtain 
ethical approval from the institutional ethics board.  The aim of the board is to review research 
proposals to ensure that the research complies with recognised ethical standards.  The purpose is 
to  protect  the  dignity,  rights,  safety  and  well-being  of  all  research  participants.  This  is 
particularly  important when  studying neonates because they  cannot personally give  informed 
consent.  Consent is given on their behalf by their parents or legal guardians.
Research studies should ideally be conducted without having to move the infant, which means 
studies are conducted at the bedside.  The equipment needs to be designed such that it is suitable 
for use in an intensive care environment.  Medical and nursing staff must have access to the 
infants at all times, so it needs to be compact and portable.  It is essential that equipment and 
research  personnel  are  kept  to  the  absolute  minimum  so  as  not  to  hinder  the  medical  care 
provided for the infants.  It is also important that the equipment is compatible with the medical 
equipment  in  use.  This  has  the  advantage  that the  ongoing physiological  monitoring  of the 
infants  can  be  recorded  and  downloaded  for  research  purposes.  To  prevent  the  spread  of 
infection it must be possible to clean the equipment completely and to dispose of parts that come 
into contact with the infants.  Cross infection can be reduced if infants colonised with bacteria 
are identified.  Although all infants are handled using universal precautions, it may be safer to 
avoid  studying  infants  colonised with known bacteria,  such  as  MRSA.  This  is  of particular 
importance  when  doing  research  involving premature  infants  because  the  immune  system  is 
immature and they have a high risk of developing infections.
A good relationship needs to be established with the nursing and medical staff.  Even if ethical 
approval  has been obtained,  it is  still  essential  to gain approval  from the  staff caring  for the 
infant at the time of the study.  If clinical staff are concerned about how a research study is being 
conducted then they are within their rights to prevent the study from taking place.  Staff are 
working in a stressful and difficult environment so every attempt should be made not to interfere 
with medical or nursing practices.  The priority of a neonatal unit is to provide clinical care to 
the infants and research undertaken on this population should in no way compromise the infants’ 
well-being.
Written informed consent is obtained from parents before any study commences.  A sensitive 
approach needs to be adopted when requesting consent from parents.  It is not appropriate to
50approach a parent if they have recently received bad news about the wellbeing of their child. 
Parents need to be kept informed about the research and, where possible, should be invited to 
keep copies of video footage, photographs or other research data that has been recorded from 
their children.  If photographs or video footage  is to be used for any other purposes,  such as 
publication, further consent needs to be sought.  It is a requirement of the ethics board that the 
informed consent is maintained but it is important to remember that parents have the option to 
withdraw their infants  from the study at any time.  Studies will  only be  successful  if a good 
relationship is maintained with parents.  This is particularly important in the case of longitudinal 
studies.  Patient and parent confidentiality must be protected.  Data is anonymised by allocating 
a unique study number for each infant and test occasion.  Data files are password protected and 
paper records are stored in a locked filing cabinet.
Studies presented in this thesis involve research undertaken when a blood sample is clinically 
required.  As the needs of the infants are constantly reviewed based on clinical assessment it is 
essential  to  check  infants  medical  records  regularly  for  changes  in  their  condition  and  the 
intended treatment.  When considering the optimum time to do a study numerous factors need to 
be considered, such as the working hours of the pathology laboratory, whether parents wish to be 
present, and why the blood samples are required.  It is also important to establish whether other 
clinical procedures are also being performed at the same time.  If an infant is undergoing other 
procedures, such as an eye examination for retinopathy of prematurity (ROP), then it may not be 
appropriate to study the child on that occasion.  Infants are  limited in their ability to tolerate 
excessive  handling  and  the  well-being  of the  child needs  to  be  considered  at  all  times.  By 
liaising with the clinical  staff,  it is possible to ascertain whether an infant is stable enough to 
tolerate the extra handling.  It is important to be prepared to abort a study at any time when these 
conditions are not met.  As all the blood samples are clinically required, it may still be necessary 
to perform the medical procedure even if the research cannot be undertaken.
2.1.4  Single event recordings
One of the major challenges of this study is that the stimulus cannot be administered unless a
heel lance is required for clinical purposes.  This means that once the equipment has been set up
there is only one opportunity to record the evoked activity.  On some occasions, it is necessary to
perform two heel lances in order to get the required quantity of blood; however, it is optimal for
the  infant  if only  one  heel  lance  is  performed.  Any  methodological  or  technical  problems
resulting  in  a  failed  recording  attempt  means  all  the  preparatory  work  is  redundant.  The
preparatory work for this type of study includes recruitment, clinical assessment of the infant,
51preparation  of equipment,  application  of electrodes,  optodes  and  other  recording  equipment, 
liaising  with  parents  and  doctors  to  find  out  when  studies  can  be  conducted,  recording 
demographic details and other data required by the ethics board.  It is estimated that each study 
takes in excess of six hours to set up so it is crucial that the number of aborted attempts are 
minimised.  By checking that all the equipment is working correctly before starting each study 
the number of technical difficulties that arise can be limited.  Due to the clinical instability of the 
infants, there are many reasons why studies may be aborted on clinical grounds.  By ensuring the 
infants are handled in the best possible way when preparing for a study means they will be more 
settled and less likely to become unstable as a result of the extra handling.
2.1.5 Study design and ethical permission
Studies were undertaken on inpatients in the neonatal intensive care unit (NICU) and the special 
care baby unit (SCBU) at the Elizabeth Garrett Anderson and Obstetric Hospital, which is part of 
University College London Hospital (UCLH).  Ethical approval was obtained from the UCLH 
ethics committee and informed written parental consent was obtained for each infant prior to the 
commencement of each study.
2.1.6 Infant recruitment
Infants were recruited between March 2004 and June 2006.  A copy of the parent information 
sheet and the parental consent form are provided in the appendix (Appendices 1.1  and 1.2).  138 
parents  were  approached  and  invited  to  enrol  their baby  or babies  into  the  study.  Of these 
parents, 21  did not give an answer as their babies were either transferred to another hospital or 
discharged before a decision was made.  Parents were given at least 24 hours before they were 
asked if they had made a decision.  71  babies were successfully recruited to the study, which 
gave  a recruitment success rate  of 61%.  Overall,  infants were  studied on 204  test occasions 
using either NIRS, EEG, video recording or a combination of these techniques.  The stimulus in 
each study was either a clinically required heel lance or non-noxious tactile stimulation.
2.1.7 Selection criteria
Medical charts were reviewed for pertinent medical history and, unless specifically stated, all 
infants included in the study had normal appearances on cranial ultrasound scans.  At the time of 
the study,  infants were assessed as clinically stable.  Infants were not receiving analgesics  or 
sedatives  at  the  time  of the  study  unless  specifically  stated.  Infant  handling  was  kept  to  a
52minimum; hence, infants were studied in a variety of positions and sleep states.  Postmenstrual 
age  (PMA)  was  determined  from cranial ultrasound  scans taken at  19-20  weeks  gestation  or 
from the maternal report of the last menstrual period.
2.1.8 Heel lance protocol
The heel lance was performed when the heart rate and oxygen saturation were stable.  Following 
heel lance the foot was not squeezed for a period of at least 30 seconds to ensure that the evoked 
response occurred only as a result of the initial stimulus and can be timed from a single discrete 
event.  When  the blood was  free-flowing  the  foot was  not  squeezed,  however,  as  the  blood 
samples are needed for clinical purposes, if blood flow was poor and it was necessary to squeeze 
the  foot the study was excluded from further analysis.  It was often possible to  collect blood 
samples without squeezing the foot.
2.1.9 Collaborators
A number of collaborators were involved in aspects of the work presented in this thesis.  Anne 
Cantarella (BNurs) is a neonatal research nurse who was employed by UCLH to assist with the 
study.  She was involved in obtaining parental consent prior to each study and performed the 
heel  lances  when  required.  She  was  present  when  each  study  was  undertaken  and  was 
responsible  for ensuring the  infants wellbeing.  In addition,  she  did  some  of the behavioural 
scoring presented in Chapter 4.  Alan Worley (MSc, MIEEE) is a clinical scientist employed by 
Great Ormond  Street  Children’s  Hospital.  He was  involved  in the  design,  development and 
integration of the  multi-modality physiological  monitoring  systems.  In  addition,  he built the 
trigger system described in Chapter 5.  Dr Martin King (PhD) provided statistical assistance with 
the mixed-model regression.
53CHAPTER 3: RESULTS PART 1
Cortical haemodynamic responses to noxious stimulation in preterm 
infants 
3.1 Introduction
3.1.1  Chapter overview
In this chapter, we attempted to measure cortical pain activity in very young infants by direct 
measurement  of  the  haemodynamic  response  to  noxious  stimulation  using  near-infrared 
spectroscopy (NIRS).  Although previous studies have shown that painful procedures in preterm 
and term infants evoke a range of behavioural and physiological responses,  such as change in 
facial  expression,  crying,  and  change  in heart rate  and oxygen saturation,  the purpose  of the 
studies  presented  in  this  chapter  was  to  establish  whether  noxious  stimulation  also  evokes 
cortical activity.  The intention was to establish whether a fully integrated pain response may be 
achievable in the immature infant brain.  When this research began, NIRS had not been used to 
investigate  the  onset  or  development  of the  cortical  responses  to  noxious  stimulation.  We 
hypothesised that using this technique, it would be possible to establish whether the immature 
cortex is functionally activated in response to noxious stimulation; the developmental profile of 
the response; and whether the response can be modulated depending on the physiological state of 
the infant.
543.2  Materials and Methods
3.2.1  Participating infants
Eighteen infants aged between 25  and 45 weeks postmenstrual age (PMA) were tested on 31 
occasions  during  clinically  required  routine  heel  lancing.  Table  3.1  provides  details  of the 
individual clinical characteristics of each infant and gives the PMA at the time of each study. 
Infants included in the study were tested on one or more occasions (see Table 3.1).  Two infants 
were receiving morphine at the time of heel lance.  In a separate study, the cortical response to 
non-painful mechanical stimulation of the foot using von Frey hairs was studied in  11  infants, 
aged 26 to 35 weeks PMA.
Neonatal characteristics of each infant included in the study
Baby no. PMA at birth
(completed
weeks)
Birth weight
(g)
Days on
mechanical
ventilator
PMA at time of 
study (completed 
weeks)
Diagnosis
1 24 560 8 25 extreme prematurity
2 24 547 36 25,27 extreme prematurity, RDS
3 24 639 15 26,32,34,39,42 extreme prematurity, CLD, GOR
4 24 613 42 28,32,35,43 extreme prematurity, CLD, GOR
5 24 768 54 34,36 extreme prematurity, PDA CLD, GOR
6 27 1108 1 29,30 Preterm
7 27 1014 1 36 Preterm
8 28 858 3 35,45 preterm, RDS, CLD, PDA
9 29 1482 1 29 Preterm
10 29 1106 1 34 Preterm
11 30 683 1 37 preterm, hyperbilirubinemia, IUGR, CLD
12 32 1324 0 34 Preterm
13 33 1408 1 38 Preterm
14 33 2118 0 34 preterm, RDS
15 32 1798 0 33 preterm, RDS
16 34 2350 3 35,40 preterm, NEC
17 34 1340 0 37,37 Preterm
18 37 2100 0 39 IUGR
Table 3.1 Neonatal characteristics for each infant included in the study
PMA: postmenstrual age, NEC: necrotising enterocolitis, IUGR: intra-uterine growth restriction, RDS: respiratory distress 
syndrome, CLD: chronic lung disease, GOR: gastro-oesophageal reflux, PDA: patent ductus arteriosus (ligated).
553.2.2  Infant demographics
Table 3.2 details the demographic characteristics of the infants.
Demographic characterisation of the neonatal population
Mean gestational age at birth (weeks), n=18 28.2 (4.3); range, 24.0-37.3
Mean PMA at time of study (weeks), n=31 35.0 (5.2); range, 25.7-45.6
Mean postnatal age at time of study (days), n=31 7.8 (38.5); range, 5-34
Mean birth weight (g), n*18 1212.0 (574.3); range, 547-2350
Mean weight at time of study (g), n=31 1914.9 (952.9); range, 520-4184
No. of multiple gestation infants, n=18 7
No. of infants with chronic lung disease, n=31 7
Mean no. of days on mechanical ventilator, n=18 9.4 (16.7); range, 0-54
Mean no. of test occasions, n*18 1.7 (1.1); range, 1-5
Mean no. of days between consecutive studies, n*13 27.3 (20.7); range, 1-69
Table 3.2 Demographic characterisation of the neonatal population
Standard deviations are in parentheses.
3.2.3 Assessment of sleep state
Sleep state was assessed using the behavioural state indicator in the premature infant pain profile 
(Stevens et al.,  1996). Behavioural state was determined by observing the infant for 15 seconds 
prior to the heel lance and selecting one of four categories from the PIPP that best describe the 
infant’s  state.  The  four behavioural  state  categories  are  active/awake  (eyes  open with  facial 
movements), quiet/awake (eyes open with no facial movements), active/sleep (eyes closed with 
facial movements) or quiet/sleep (eyes closed with no facial movements).  Infants in the first two 
categories were classified as awake and those in the second two categories were classified as 
asleep.
3.2.4 Near-infrared spectroscopy
Cortical  activity  is  associated with  increased  localised  cerebral  blood  flow.  In  this  study,  a 
double channel near-infrared spectrophotometer (NIRO-200, Hamamatsu Photonics) was used to 
measure regional changes in oxygenated and deoxygenated haemoglobin concentration.  This is 
a non-invasive technique which has been widely used in neonatal research to measure functional 
activation  of the  cortex  (Kusaka  et  al.,  2004;  Sakatani  et  al.,  1999).  The  light  emitters  and
56detectors  (optodes)  were  positioned  symmetrically  on  either  side  of  the  head  over  the 
somatosensory  cortex,  using  the  international  10-20  EEG  placement  system  to  identify  key 
landmarks (Jasper,  1958). The optodes were attached to the head using double-sided adhesive 
tape.  To help prevent displacement of the optodes, and to prevent ambient light from affecting 
the  recording,  the  optodes  were  positioned  under  a  snugly  fitted  hat.  Figure  3.1  shows  a 
photograph of an infant with the optodes placed over the somatosensory cortex.  Optodes were 
placed  on  the  head  at  least  15  minutes  prior to  recording  and real-time  changes  in  cerebral 
haemodynamic activity were monitored.  The measured absorption changes at each wavelength 
were converted to the relative concentration changes.  The changes were expressed in pmol/L, 
and  the  optical  path  length was  calculated  by  multiplying  the  inter-optode  distance  by  the 
neonatal differential path length factor (DPF).  DPF has been calculated to be 4.39 for neonates 
(Wyatt et al.,  1990b).  A  sampling frequency of either 2Hz or 6Hz was selected.  Changes in 
oxyhaemoglobin  [Hb02]  and  deoxyhaemoglobin  [HHb]  were  measured.  Total  haemoglobin 
[HbT] concentration change was calculated [HbT] = [Hb02] + [HHb].
Figure 3.1 Optode placement
Photograph of premature infant (33+4 weeks PMA) with optodes positioned over the somatosensory cortex.
3.2.5  Analysis of NIRS data
Baseline activity was recorded for 20 seconds prior to the heel lance.  The maximum change in 
[HbT] was defined as the maximum change from the mean pre-stimulus recording in the 20- 
second period post heel lance.  Calculating the maximum change in haemoglobin concentration 
from a prestimulus baseline has been used in other NIRS studies (Kusaka et al., 2004; Isobe et
57al., 2001). In five studies, only unilateral data was obtained due to loss of contact of an optode 
on one side while the other optode remained in good contact.  Data analysis was undertaken by a 
blinded observer using a prewritten MATLAB script (MATLAB version 7.0).  If more than one 
heel lance was required on a given test occasion only the response to the first heel lance was 
included in the analysis.
3.2.6 Tactile stimulation
In  a  second  series  of measurements,  the  selectivity of the  cortical  response  was  investigated 
using non-noxious stimulation,  von Frey hairs were used to apply a known calibrated force to 
the plantar surface of the foot using techniques described by Andrews and Fitzgerald (1994). 
The force applied to the foot was increased using graded von Frey hairs.  Each von Frey hair was 
applied to the plantar surface of the foot five times in each infant at intervals greater than 60 
seconds.  The  reflex  withdrawal  threshold  was  defined  as  the  stimulus  at  which  a  distinct 
movement of the foot away from the same von Frey hair occurred in at least three out of five 
occasions.  The  maximum  force  applied  was  one  von  Frey  hair  above  reflex  withdrawal 
threshold.  The range of force applied by the von Frey hairs (0.096-25.8lg) was similar to that 
previously reported (Andrews and Fitzgerald,  1999). For each hair, a haemodynamic response 
was  defined  as  more  than  10%  of the  post-stimulus  response  lying  two  standard  deviations 
outside the pre-stimulus baseline in three out of five responses.
3.2.7 Statistical analyses
The maximum change in [HbT], defined as the maximum change from the mean pre-stimulus 
recording in the 20 second period post stimulus,  is referred to as the stimulus response and is 
used in all the statistical analyses.  To assess whether the stimulus response was significantly 
different  from  the  pre-stimulus  baseline  within  an  individual  subject,  the  maximum  post­
stimulus  value  was  compared  with  the  pre-stimulus  sample  mean  (two-sample  t-test).  To 
establish whether there was a significant difference between the cortical response in the awake 
and asleep infants restricted maximum likelihood mixed-model regression was used (Hand and 
Crowder,  1996). The regression analysis provides an estimate of the mean stimulus response in 
the  awake  and  asleep  states  as  a  function  of  age;  it  takes  into  consideration  the  non­
independence  among  observations  made  in  infants  where  more  than  one  measurement  was 
acquired.  The analysis was performed using SAS proc mixed (SAS Version 9.1).
58A  linear  dependence  on  age  was  adopted,  and  an  (age*state)  interaction  term  allowed  for  a 
potential  difference  in  age dependence between the  awake  and asleep  states.  The  likelihood 
ratio test was used to test whether the response to heel lance was different in the ipsilateral and 
contralateral  cortices.  A number of calculations,  including  sensitivity  analysis  and the usual 
regression  diagnostics  were  performed  to  ensure  that  the  regression  results  are  robust.  The 
results  were  satisfactory.  The  inclusion  of infants  receiving  morphine  did  not  substantially 
change the statistical assessment; however, these infants were excluded from all the statistical 
analysis used to calculate regression coefficients.
593.3  Results
3.3.1  Noxious stimulation  produces a cortical  response  in  preterm  infants from 25 
weeks
Figure 3.2 shows a typical somatosensory haemodynamic response to noxious stimulation of the 
heel during routine blood sampling in a preterm infant.  An increase in the total haemoglobin 
concentration over the contralateral somatosensory cortex following heel lance was observed in 
all  but  one  infant.  The  mean  increase  in  [HbT]  in  the  contralateral  somatosensory  cortex, 
calculated from the whole sample of infants, was 7.74|imol/L (SE:  1.10, N=30), while a mean 
decrease in [HbT] of -O.lOpmol/L (SE:  1.10, N=26) was recorded on the ipsilateral side.  While 
the magnitude  of the ipsilateral response was variable and sometimes positive,  it was  always 
smaller than the contralateral response (see Figure 3.3).
10 ,
5
0
-5
Time (s)
    [H bT] contra  _  [HbT] ipsi
Figure 3.2 Haemodynamic response
Sample trace  in  a  single  infant (29+5 weeks  PMA)  demonstrating  the  evoked  change  in  [HbT]  in  the  contralateral  and 
ipsilateral somatosensory cortex following a painful stimuli given at t=20 seconds.  Sampling frequency: 2Hz.
60The  likelihood  ratio  test,  used  to  compare  the  responses  in  the  ipsilateral  and  contralateral 
cortices,  showed a highly significant difference between the two sides.  (The likelihood ratio: 
34.6 with 4 degrees of freedom; where 0.05 level chi-sq critical value = 9.49).  This confirms 
that the cortical response to heel lance was a localised effect that did not occur due to a global 
haemodynamic change.
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Figure 3.3 Group results for awake infants
Bar  chart  showing  individual  ipsilateral  and  contralateral  maximum  A[HbT]  following  heel  lance  in  each  awake  infant. 
The age of each infant in completed postmenstrual weeks is shown.
3.3.2  The magnitude of the cortical response increases with postmenstrual age
Figure  3.4  illustrates  that  the  cortical  response  to  noxious  heel  lance  increases  with 
postmenstrual age (PMA).  Mixed-model regression was used to estimate the mean response in 
the waking and  sleeping states,  as  a  function of postmenstrual  age  and allowed  for the non­
independence  among  repeated  observations  made  in  the  infants  where  more  than  one 
measurement was acquired.  Analysis shows that this age dependence in the magnitude of the 
response only occurs in awake infants (PMA regression coefficient: 0.698pmol/L/week, 95% Cl 
limits:  0.132,  1.265pmol/L/week).  Age  dependence  was  not  observed  in  the  sleeping  state 
(PMA  regression coefficient  in  the  asleep  state:  -0.291pmol/L/week,  95%  Cl  limits:  -1.004, 
0.423pmol/L/week).  Furthermore, as illustrated in Figure 3.3 there was no age dependence in 
the ipsilateral responses.  It should be noted that although the youngest infants displayed the 
smallest responses, even the very youngest infant (25+5 weeks PMA) demonstrated a clear and
61statistically  significant response above the pre-stimulus baseline (p<0.005,  two-sample t-test). 
Figure 3.5 shows the cortical response to heel lance in the youngest infant in the sample.
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Figure 3.4 Effect of age on haemodynamic response
Developmental  profile  of  maximum  A[HbT]  in  contralateral  somatosensory  cortex  following  heel  lance  in  infants  at 
different  PMA  (regression  coefficient  for  awake  infants  (red  squares):  0.698pmol/L/week,  95%  Cl  limits:  0.132, 
1.265pmol/L/week;  asleep  infants  (blue  triangles):  -0.291  pmol/L/week,  95%  Cl  limits:  -1.004,  0.423pmol/L/week). 
Connected  points  represent  repeated  measures  in  individual  infants.  Unfilled  points  represent  infants  receiving 
morphine; these infants are excluded from the regression analysis.
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Figure 3.5 Haemodynamic response in the youngest infant
Sample trace in the youngest infant in our sample (25+5 weeks PMA) demonstrating the evoked  change in  [HbT]  in the 
contralateral and ipsilateral somatosensory cortex following a painful stimuli given at t=20 seconds.  Sampling frequency: 
6Hz.
623.3.3  Awake infants have larger cortical responses than sleeping infants
The magnitude of the response was dependent upon sleep state (Figure 3.6).  At the mean PMA 
(35.2  weeks)  the  least-squares  mean  stimulus response  estimates  in  the  waking and  sleeping 
states  are  10.20pmol/L  and  3.57pmol/L  (95%  Cl  limits:  7.31,  13.09  and  0.31,  6.83|imol/L, 
respectively).  The mean difference between these two estimates is 6.63pmol/L, which achieves 
statistical significance (95% Cl limits: 2.35,10.91pmol/L).
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Figure 3.6 Mean cortical responses in awake and asleep infants
Comparison  between  the  stimulus  response  estimate  (A[HbT]  in  the contralateral  somatosensory cortex) following  heel 
lance in the awake and asleep state at mean PMA, 35.2 weeks.  Error bars represent the 95% confidence interval limits.
3.3.4  Latency to peak response is greater in younger infants
The latency of the maximum response in the contralateral somatosensory cortex from the time of 
the heel lance stimulus is dependent upon age, but the relationship is nonlinear over the whole 
age range (25-45 weeks PMA), with a greater dependence in the younger subjects (see Figure 
3.7).  Individual latencies range from 2-19 seconds (mean 8.02+4.74 seconds), with the longest 
latencies recorded in the youngest infants.  In the age range from 25-38 weeks PMA, regression 
analysis, used to estimate the time to peak response as a function of PMA, demonstrates a clear 
increase in latency with age (regression coefficient = -0.99(imol/L/week, 95% Cl limits:
1.54, -0.44pmol/L/week).
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Figure 3.7 Latency to peak response
Latency  to  maximum  A[HbT]  in  contralateral  somatosensory  cortex  following  heel  lance  in  infants  at  different  PMA 
(regression coefficient = -0.99|imol/L/week,  95% Cl  limits: -1.54, -0.44pmol/L/week).  Regression  line represents infants 
aged 25-38 weeks PMA where there is a linear dependency on PMA.
3.3.5  Non-noxious tactile stimulation does not evoke detectable cortical responses
Non-noxious mechanical stimulation of the plantar surface of the foot did not elicit a measurable 
change  in  the  haemodynamic  activity  in  either the  contralateral  or  ipsilateral  somatosensory 
cortex (N=l 1, 26-35 weeks PMA).  In each case, a stimulus intensity was used that produced a 
visible foot withdrawal, demonstrating that the sensory input was sufficient to produce a reflex 
motor response.  Despite this, no measurable cortical haemodynamic response was recorded.  It 
is probable that the non-noxious von Frey hair stimulation evokes activity in the somatosensory 
cortex that NIRS is not sensitive enough to detect.  Hence, these results do not mean that non- 
noxious sensory input cannot activate the somatosensory cortex, but rather a single non-noxious 
stimulus,  strong  enough  to  evoke  reflex  movement  of the  foot,  does  not  evoke  a  cortical 
response  equivalent to  that recorded  following  noxious  stimulation.  Furthermore,  the  reflex 
withdrawal is not responsible for the activation of the somatosensory cortex observed following 
noxious stimulation.
643.4 Discussion
3.4.1  Interpreting cortical haemodynamic pain responses
The results illustrate that noxious stimulation can evoke specific haemodynamic changes in the 
cortex of the youngest infants recorded at 25 weeks PMA.  These changes were measured using 
near-infrared spectroscopy (NIRS), which allowed continuous and non-invasive monitoring of 
blood oxygenation of the brain to be performed at the bedside, following a clinically required 
heel lance.  The cortical response is significantly attenuated during sleep, which in adults has 
been interpreted as evidence of cognitive pain processing (Wang et al., 2004; Wang et al., 2003) 
but  could be  due  to  a  general  reduced  firing  ability  of cortical  neurones  during  sleep  and  a 
widespread  impairment  of sensory  processing  (Rosanova  and  Timofeev,  2005).  Behavioural 
states are less differentiated in preterm infants and a large proportion of their sleep is classified 
as  indeterminate,  that  is  neither  active  nor  quiet  sleep  (Lehtonen  and  Martin,  2004),  which 
complicates interpretation of the data on the basis of cognitive processing.  The smaller cortical 
responses  to  noxious  stimulation  in  younger  infants  are  likely  to  reflect  lower  energy 
requirements due to less neuronal activity (Kostovic and Judas, 2002).  The linear relationship 
between  subjective  pain  intensity  and  regional  cerebral  blood  flow  in  the  contralateral 
somatosensory  cortex  observed  in  adults  (Bomhovd  et  al.,  2002)  may  also  be  reflected  in 
neonates. Our results suggest that infants undergoing intensive care process painful experiences 
at  the  cortical  level  and  that  the  activity  associated  with  this  process  increases  with 
postmenstrual age.  A true confirmation of this requires electrophysiological measures such as 
recording of somatosensory evoked potentials (see Chapter 5).
3.4.2 The development of spinal and supraspinal pain processing in human infants
In contrast to the cortical responses reported here, spinally mediated reflex limb withdrawal from 
a  noxious  stimulus  is  greater  both  in  magnitude  and  duration  in  the  youngest  infants  and 
decreases with age (Andrews and Fitzgerald,  1999; Andrews and Fitzgerald,  1994; Fitzgerald et 
al.,  1988).  The  data  highlight  the  dissociation  between  spinal  reflex  responses  and  cortical 
nociceptive processing in human infants, and illustrate that the strong reflex responses in preterm 
neonates do not necessarily mean more perceived pain.  Reflexes may have a protective function 
for an organism that is less able, through cortical immaturity, to perceive and organise a more 
directed response.  Reflex thresholds are also lower in infants than in adults and can be evoked 
by  von  Frey  hair  mechanical  stimulation,  as  observed  here.  The  postnatal  development  of 
cutaneous  flexion  reflexes  in  rat  pups  and preterm  human  infants  show  remarkable  parallels
65(Fitzgerald  and  Jennings,  1999;  Fitzgerald  et  al.,  1988),  and  it  is  likely  that  this  reflex 
excitability  is  due  to  an  altered  balance  of local  and  descending  excitatory  and  inhibitory 
processing in the developing dorsal horn (Fitzgerald, 2005). Here it is shown that von Frey hair 
mechanical  stimulation  of  the  foot,  sufficient  to  evoke  a  flexion  reflex,  did  not  elicit  a 
measurable  haemodynamic  response  in  the  somatosensory  cortex,  again  highlighting  the 
differences between spinal and cortical pain pathways at this stage.
3.4.3  The onset and maturation of cortical pain processing
Much  has  been  written  about  when  exactly  a human preterm  infant  or  foetus  may  begin  to 
process pain (Lee et al., 2005).  In principle, with more data it would be possible to  establish 
whether there is a well-defined age of onset in the cortical pain response.  The age of onset, 
however, may precede the limits of viability (23-24 weeks PMA).  Even if it were possible to 
look at the neonatal responses to noxious stimulation in this age group, it cannot be assumed that 
cortical  responses  seen  in  neonates  are  directly  translatable  to  the  foetus  in utero  due  to  the 
unique features of the uterine environment (Mellor et al., 2005).
The long latencies of the cortical responses in the youngest infants is likely to be due to the low 
conduction  velocities  and  slow  synaptic  responses  in  the  nociceptive  circuitry,  which  is 
consistent  with  the  long  latency  reflex  responses  observed  at  the  same  age  (Andrews  and 
Fitzgerald,  1999).  The  long  latencies  observed  in  the  youngest  infants  reflect  the  lack  of 
myelination and decreased synaptic strength, which means the immature nervous system is slow 
to  mount  a  directed  coordinated  response  following  external  stimulation.  Other  studies  in 
neonates  that  have  measured  haemoglobin  oxygen  saturation  in  the  somatosensory  area 
following passive knee movement, have also reported latencies consistent with these findings 
(Isobe et al., 2001). Isobe and colleagues reported the mean time corresponding to the maximum 
changes in [Hb02] and [HHb] to be 11.9±3.3s and 19.1+6.7s respectively (gestational age, 24-35 
weeks).  The mean latency to the maximum response has also been reported following visual 
stimulation and is a similar duration (Kusaka et al., 2004). Despite the long latencies, the cortical 
responses following noxious stimulation were well defined with a clear onset.  The responses 
were even evident in the two extremely premature infants that were receiving morphine at the 
time of study.  This is interesting in light of recent reports that show that morphine has no effect 
on behavioural  and physiological  pain  scores  in  infants  following heel  lance  (Carbajal  et al., 
2005), and requires further investigation.
663.4.4  Cortical pain processing in human infants
The results from this chapter were published in 2006 in the Journal of Neuroscience providing, 
for the first time, a direct measure of cortical activation in response to noxious stimulation in the 
preterm  infant  (Slater  et  al.,  2006b).  Since  this  study  was  completed,  further  evidence  has 
confirmed  that  the  somatosensory  cortex  in  premature  infants  is  activated  during  noxious 
stimulation  (Bartocci  et  al.,  2006b).  In  agreement  with  the  results  presented  in  this  chapter, 
Bartocci  et  al.  conclude  that  noxious  stimulation  causes  functional  activation  of  the 
somatosensory  cortex  and  that  premature  infants  are  able  to  process  pain  selectively  in  the 
cerebral  cortex.  In their paper, they present a study where one optode is positioned over the 
somatosensory cortex and one optode is positioned over the occipital cortex.  Following noxious 
stimulation,  they  found  an  increase  in  the  oxyhaemoglobin  concentration  [Hb]  in  the 
somatosensory region but detected no change in the occipital region.
There are, however, a number of differences in the findings in the Bartocci study and the results 
presented  in  this  chapter.  While  here  we  show  an  increase  in  [HbT]  in  the  contralateral 
somatosensory  cortex  and  a mean  decrease  in  [HbT]  in the  ipsilateral  somatosensory  cortex, 
Bartocci  et  al.,  (2006)  report  bilateral  increases  in  [Hb]  in  both  cortices.  The  apparent 
discrepancies may be accounted for by the different methodological approaches adopted in each 
study.  The noxious stimulus described in this chapter was a brief discrete event that occurred 
when the heel was lanced.  The foot was not squeezed for a period of 30 seconds following the 
heel lance, which ensured that the measured cortical response was a direct result of the acute 
stimulus.  By contrast, the stimulus used in the Bartocci study was considerably more variable. 
It lasted between 35 and 60 seconds, while a needle was being inserted into a vein (Bartocci et 
al.,  2006b).  The  long  duration  of  this  stimulus  may  lead  to  bilateral  activation  of  the 
somatosensory cortex, whereas the acute noxious event used here causes selective activation of 
the contralateral somatosensory cortex.  Furthermore, while the output measure in our study was 
the  peak  haemodynamic  response  that  occurred  within  20  seconds  of the  stimulus,  in  the 
Bartocci  study  they  report  the  average  response  that  occurred  over  a  60-second  period.  It 
remains  plausible  that  early  contralateral  activation  is  followed  by  a  bilateral  or  ipsilateral 
response.  This  is supported by evidence in adults, where transient suppression of the BOLD 
response  has  been  reported  to  occur  in  the  ipsilateral  somatosensory  cortex  during  tactile 
stimulation (Hlushchuk and Hari, 2006). The peak negative BOLD response occurs within  10 
seconds and the average duration of the deactivation is 18 seconds.
67The response to tactile stimulation was reported in both studies (Slater et al., 2006b; Bartocci et 
al., 2006b). In this chapter, it has been shown that carefully controlled tactile stimulation using 
graded von Frey hairs does not produce a measurable cortical response.  By contrast, Bartocci et 
al.  report  bilateral  activation  in  response  to  the  infant  having  their  skin  disinfected  with  an 
alcohol-soaked pad.  This variable, long-duration stimulus, which also has a cooling effect, may 
activate specific cortical areas that are not activated when a more selective approach is adopted 
using von Frey hairs.  The importance of the tactile stimulation study presented in this chapter 
was that a cortical response was not detected by near-infrared spectroscopy, despite the presence 
of a spinal reflex withdrawal of the foot.  This confirmed that movement of the foot was not 
responsible for the haemodynamic activity recorded following the heel  lance.  Bartocci  et al. 
conclude  that  both  tactile  and  painful  stimulation  activate  somatosensory  cortical  areas. 
Progress  in  pain  research  is  dependent  upon  precise  definitions  and  characterisations  of the 
conditions of the stimuli used, and in this respect term and preterm infants are no different from 
adults (Slater et al., 2006a). It is important that reported cortical activations are a direct response 
to the noxious stimulation and are distinguished from a diffuse barrage of sensory stimulation. 
The  poorly  defined  stimulus  used  in  the  Bartocci  study  could  potentially  lead  to 
misinterpretations of the precise cause of the evoked activity.  To be confident that the response 
is due to the noxious element of the stimulus it is required that the stimulus is well defined.  In 
this way, a defined activation time can be determined from the stimulus-locked event.
Anand et al. argue that because the postnatal age of the infants in our study range from 5 to 134 
days the results may be confounded by the fact that infants have experienced variable degrees of 
previous pain exposure (Anand et al., 2006). Many studies have shown that neonatal responses 
to acute pain are dependent on exposure to previous painful events (Grunau et al., 2005; Grunau 
et  al.,  2001b;  Johnston  et  al.,  1995).  It  is  plausible  that the  larger haemodynamic  responses 
observed in infants who have a greater PMA may represent maturational changes as well as a 
degree  of previous pain experience.  Since  there  is  likely to be  a correlation between age  in 
postnatal days and number of painful experiences, it follows that if previous pain exposure were 
the most significant factor, than the  magnitude of the haemodynamic response would show a 
better degree of correlation with postnatal age than postmenstrual age.  In this study, however, 
the correlation between postnatal age and the maximum change in contralateral [HbT] was much 
weaker than the correlation with PMA, which is not consistent with suggestions made by Anand 
et al. (see Appendix 5 for details).  Hence, it is more likely that the varying degree of exposure to 
painful procedures, which has not been accounted for in this model, may partly explain the large 
scatter observed in the results.  Another reason why the scatter is wide may be due the difficulty
68in locating the key landmarks on the skull.  Premature infants, and in particular those who were 
bom extremely prematurely, often have unusual shaped heads due to positional moulding, which 
can make it more difficult to ensure that the optodes are located in the correct position.  This 
means that identifying the somatosensory region can be more difficult.
In conclusion, neonates are able to mount a specific and lateralised cortical response to noxious 
stimuli from 25 weeks PMA.  The results highlight the clinical need for a systematic approach to 
reduce the occurrence of acute pain and to improve the analgesic treatment of repetitive pain in 
neonates.  Analysis  of the underlying neural activity will  elucidate the extent of this  cortical 
processing,  but this  study clearly  demonstrates that noxious  information is  transmitted to  the 
immature  preterm  cortex  and  therefore  has  the  potential  to  influence  higher  levels  of the 
developing central nervous system.
69CHAPTER 4: RESULTS PART 2
Clinical Pain Assessment
4.1  Introduction
4.1.1  Understanding the infant response to noxious procedures
It is accepted that pain assessment in non-verbal populations is a challenging clinical problem 
(Stevens, 2006).  As we do not have a direct measure of pain, it is difficult to assess its existence 
and severity.  In the previous chapter it was shown that noxious stimulation does activate cortical 
areas in the premature infant brain (Slater et al., 2006b; Bartocci et al., 2000). From 25 weeks 
PMA  infants  are  able  to  mount  a  localised  haemodynamic  response  in  the  contralateral 
somatosensory cortex following noxious heel lance (Slater et al., 2006b). These results suggest 
that infants do have the required neuronal connections to experience the affective components of 
pain and are not simply displaying reflex responses to nociception.  Despite these findings, it 
remains unclear whether pain scores, calculated using current pain assessment tools, are a true 
reflection  of higher-level  pain processing.  As  infants  cannot report  subjective  pain  intensity 
verbally, it is useful to establish whether clinical pain scores, calculated on the infant’s behalf, 
correlate with the magnitude of cortical  activation that occurs  following a noxious procedure 
(Slater et al., 2006b).
The rationale for undertaking this study is partly based on the fact that we cannot know whether 
noxious stimulation is actually causing pain in the neonatal population (Bowsher, 2006).  It is 
only  possible  to  measure  responses  to  nociception,  which  in  some  cases,  are  assumed to  be 
surrogate  measures  of pain  processing  (Bartocci  et  al.,  2006a).  True  pain  experience  must 
involve  supraspinal  processing,  so  it  is possible  that measures  of the  cortical  haemodynamic 
response may provide a better measure of central nervous system pain processing as compared 
with either behavioural or physiological measures.  Although pain scores used in neonatal pain 
assessment  cannot  provide  an  objective  measure  of the  intensity  of perceived  pain,  they  do 
provide  a  reliable  measure  of  the  behavioural  and  physiological  responses  that  manifest 
following  a noxious procedure  (Stevens  et al.,  1996).  In  adults,  it has  been  shown  that the 
magnitude  of the  regional  haemodynamic  response  in  the  contralateral  somatosensory  cortex 
correlates with perceived pain intensity (Bomhovd et al., 2002). If this holds true in the neonatal 
period, then it would be beneficial to know whether current neonatal pain assessment measures
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nociceptive processing in preterm infants (Slater et al., 2006b; Bartocci et al., 2006b).
The behavioural, physiological and cortical responses to noxious stimulation in a neonate can be 
measured directly (Slater et al., 2006b; Stevens et al.,  1996). In this study the measures include 
change in heart rate and oxygen saturation, driven by the autonomic nervous system; change in 
facial expression, driven by motor neurone activity which results in a coordinated set of facial 
muscle  contractions;  and  cortical  haemodynamic  activity  in  the  contralateral  somatosensory 
cortex.  As these responses are driven by a common noxious stimulus in the periphery, albeit 
activating multiple ascending pathways, it is possible that there will be a degree of correlation 
between  these  measures.  However,  it  is  also  possible  that  cortical  activation  can  occur 
independently  of  autonomic  and  motor  responses  or  vice  versa.  The  behavioural  and 
physiological responses to noxious stimulation will be assessed using the validated PIPP scoring 
system (Stevens et al.,  1996) and the haemodynamic response will be assessed using NIRS, as 
described  in  Chapter  3.  The  study  provides  the  first  objective  evidence  of whether  cortical 
processing following acute noxious stimulation correlates with the observed responses that are 
used clinically to assess neonatal pain.
In addition, the  latency to  change  in  facial  expression following a noxious procedure will  be 
investigated.  It was shown in Chapter 3 that the latency between the noxious stimulation and 
peak haemodynamic response  in the  contralateral  somatosensory cortex  is greater in younger 
infants.  It is possible that the latency to  change  in facial  activity will  mirror this trend.  By 
carefully  analysing an  infant’s  facial  response,  it is possible  to measure the  time  to  onset of 
change in facial activity after a well-defined noxious stimulus.  Studies presented in this chapter 
are designed to establish whether latency to change in facial expression is a function of maturity. 
It is hypothesised that latency to facial expression change will be longer in younger infants.
714.2  Materials and Methods
4.2.1  Participating infants
36  infants aged between 25  and 43  weeks postmenstrual  age (PMA) were  studied on 94 test 
occasions.  Clinical pain assessment  scores  were  calculated using the PIPP when heel  lances 
were performed to provide blood samples for routine clinical assessment.  Within this group, a 
subset of 12 infants was studied on 33 test occasions using near-infrared spectroscopy to assess 
the haemodynamic response to the noxious stimulus simultaneously (PMA range: 25-43 weeks). 
Table  4.1  details  the  demographic  characteristics  of  the  infant  population.  Infants  with 
congenital abnormalities were excluded from the study.  One infant included in the study had an 
intraventricular  haemorrhage  (IVH).  The  results  from  this  infant  have  been  highlighted 
throughout. Table 4.2 details the demographic characteristics of the subset of infants also studied 
using NIRS.
Demographic characterisation of the neonatal population
Mean gestational age at birth (weeks), n=36 30.5 (4.3); range, 22.8-37.4
Mean PMA at time of study (weeks), n=94 34.5 (3.3); range, 25.7-43.3
Mean postnatal age at time of study (days), n=94 36.9 (30.2); range, 2-134
Mean birth weight (g), n*36 1440.7 (696.9); range, 533-3330
Mean weight at time of study (g), n*94 1777.6 (691.2); range, 532-4184
No. of multiple gestation infants, n=36 12
No. of infants with chronic lung disease, n-36 7
Mean no. of days on mechanical ventilator, n*36 7.2 (13.3); range, 0-54
Mean no. of test occasions, n=36 3.0 (2.5); range, 1-11
Mean no. of days between consecutive studies, n=94 6.2 (11.6); range, 1-69
Table 4.1 Demographic characterisation of the neonatal population
Standard deviations are given in parentheses.
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Mean gestational age at birth (weeks), n=12 28.6 (4.4); range, 24.0.8-34.6
Mean PMA at time of study (weeks), n=33 34.7 (3.7); range, 25.7-43.3
Mean postnatal age at time of study (days), n=33 45.1 (34.2); range, 5-134
Mean birth weight (g), n=12 1079.1 (750.8); range, 547-2350
Mean weight at time of study (g), n=33 1702.7 (747.9); range, 532-4184
No. of multiple gestation infants, n=12 6
No. of infants with chronic lung disease, n=12 1
Mean no. of days on mechanical ventilator, n=12 10.6 (17.6); range, 0-54
Mean no. of test occasions, n*12 2.8 (1.9); range, 1-7
Mean no. of days between consecutive studies, n*33 8.6 (14.2); range, 0-57
Table 4.2 Demographic characterisation (combined NIRS studies)
Standard deviations are given in parentheses.
4.2.2 Near-infrared spectroscopy
The NIRS techniques have been described in detail in chapter 3 (Section 3.2.4).  As with all the 
NIRS studies the haemodynamic response is defined as the maximum change in [HbT] from a 
prestimulus baseline, in the 20-second period following the heel lance.
4.2.3 Heel lance protocol
The heel lance was performed as described in the general methods in Chapter 2 (Section 2.1.4). 
If the  foot  was  squeezed  before  a  change  in  facial  expression  was  observed,  the  study  was 
excluded from subsequent analysis.
4.2.4 Premature infant pain profile
Infant pain  was  measured  using  the  PIPP.  The  Infants  were  video-recorded  for  at  least  15 
seconds prior to  the heel  lance  and  for at least  30  seconds  after the  heel  lance  (Sony  DCR- 
DVD201E camcorder).  This is the minimum requirement to calculate the PIPP score.  In most 
cases,  infants were videoed for at least  5  minutes.  The time  of the heel  lance  stimulus was 
marked on the video footage by an LED that flashed when the spring-loaded blade was released
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physiological data was downloaded to a computerised data collection system.  Postmenstrual age 
(PMA) was determined as described in the general methods in Section 2.1.6.
The video footage was analysed after the heel lance procedure to establish the behavioural state 
score and facial expression score.  Behavioural state was assessed by observing the  15-second 
period prior to the heel lance and categorising the infant into one of four groups.  Categorisation 
depended on whether facial movement could be observed in the video footage and on whether 
the infant’s eyes were open or closed (refer to  Section 3.2.3  for a description of the different 
behavioural categories in the PIPP).  The facial expression component of the PIPP was analysed 
by  watching  the  video  footage  for  30  seconds  immediately  following  the  heel  lance.  The 
presence of each facial  expression indicator (nasolabial  furrow, eye squeeze and brow bulge) 
was assessed individually.  The observer focused on one facial expression and used a stopwatch 
to calculate the duration over which the facial expression could be observed in the 30-second 
time window.  This was repeated for each indicator.  The video footage was repeatedly watched 
until the coder was satisfied that the duration of each expression had been correctly recorded.  A 
score between 0 and 3, assigned for each of the three facial expressions, was dependent on the 
percentage of time that the facial expression was observed in the 30 second period after the heel 
lance (see Figure  1.1  for a copy of the score sheet).  10% of the sessions were randomly scored 
by an independent assessor.  The intrarater reliability and interrater reliability were determined. 
The second coder was blinded to whether or not the infant was undergoing a heel lance.  In  12 
cases it was not possible to video record the infants.  In these studies, the infants were scored in 
real-time at the bedside.  A full description of the PIPP score can be found in the paper that 
describes its initial development and validation (Stevens et al., 1996).
Infants were monitored for changes in heart rate and oxygen saturation on a beat-to-beat basis 
using a Nellcor 200 transcutaneous monitor.  The physiological readings of heart rate and blood 
saturation, required for the PIPP assessment, were downloaded to an external PC.  Data analysis 
software was used to calculate the mean heart rate and oxygen saturation in the 15 seconds prior 
to the heel lance.  This was recorded on the PIPP record sheet (see Figure  1.1).  The software 
also determined the maximum heart rate and the minimum oxygen saturation in the 30 second 
period immediately following the heel lance.  These values were used to calculate the percentage 
increase  or  decrease  from  the  prestimulus  baseline  for  heart  rate  and  oxygen  saturation 
respectively.  A score between 0 and 3  was also assigned based on the gestational age of the 
infant (refer to Figure 1.1 for the exact categories).  For each heel lance, all the different aspects
74of the PIPP were recorded and a total composite score was calculated.  The total score ranged 
between 0 and 21.
4.2.5 Comparison between pain scores and haemodynamic activity
The  degree  of correlation  between  the  PIPP  score  and  the  magnitude  of the  haemodynamic 
response was assessed.  As the magnitude of the haemodynamic response is dependent on PMA 
and sleep state (Slater et al., 2006b) the relationship between the unweighted PIPP score (i.e. the 
total  PIPP  score  excluding  weighting  factors  for  gestational  age  and  sleep  state)  and  the 
haemodynamic response was also established.  In addition, the relationship between the  facial 
expression score and the magnitude of the cortical activity was assessed.  The sum of the three 
PIPP facial expression indicators (i.e. eye squeeze, brow bulge and nasolabial furrow) is referred 
to throughout this chapter as the facial expression score.  The percentage of infants who had a 
facial  expression  score  of zero  was  calculated.  The  individual  cortical  responses  (i.e.  the 
maximum  A[HbT]  in  the  contralateral  somatosensory  cortex)  for  each  of  these  infants  is 
presented.  The relationship between the physiological responses in the PIPP score (i.e. the score 
from the change in heart rate and oxygen saturation categories) and magnitude of the cortical 
response was assessed.
4.2.6 Latency to facial response
The latency to facial response was defined as the time between the heel lance stimulus and the 
first occasion when any of the three PIPP facial indicators were observed.  The latency to facial 
response  was  plotted  against  PMA  and  regression  analysis  was  used  to  estimate  the  facial 
expression  score  as  a  function  of PMA.  Infants  classified  as  ‘facial  non-responders’  were 
excluded  from  the  latency  analysis,  as  they  did  not  show  any  observable  change  in  facial 
expression.
4.2.7 Statistical Analysis
The NIRS data was analysed in the same way as described in chapter 1   (see Section 3.2.7).  To 
establish the  degree  of correlation between the  PIPP  facial  expression  score  and the  cortical 
response restricted maximum likelihood mixed-model regression was used (Hand and Crowder, 
1996).  The  model  effectively treats  the problem as  a  simple regression problem because  the 
effect of the repeated measures in the same infant was not significant.
754.3  Results
4.3.1  Facial expression change
Figure 4.1a and 4.1b shows a photograph of an infant before and after a heel lance.  After the 
heel  lance the  infant’s eyes are forcefully closed, the brow  is  lowered and  furrowed, and the 
nasal roots are broadened and bulged with a deepened nasolabial furrow.  It is these changes in 
facial expression that are observed by health care professionals when attempting to assess or 
treat pain and it is these facial expressions that are assessed by the PIPP.
Figure 4.1a  Figure 4.1b
Figure 4.1  Photograph of infant before and after a heel lance
Photograph of infant (27+3 weeks PMA) showing characteristics features before (Figure 4.1a) and after a heel lance 
(Figure 4.1b).  NIRS optodes are placed over somatosensory cortex during the heel lance procedure.  Brow bulge, eye 
squeeze and nasolabial furrow can be seen in Figure 4.1b.
4.3.2  Assessment of the components of the premature infant pain profile
The  PIPP  score,  the  unweighted  PIPP  score  (which  is  the  complete  PIPP  excluding  the 
weighting factors for age and sleep state), and the facial expression score alone was calculated 
for each infant.  For clarity, Figure 4.2 shows a breakdown of how the different scores were 
calculated for the infant in the photograph in Figure 4.1.
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Figure 4.2 Example calculation of the PIPP, unweighted PIPP and facial expression score
Individual components that make up the PIPP score, unweighted PIPP score, and facial expression score for the infant in 
Figure 4.1.
The mean PIPP score, the unweighted PIPP score, and the facial expression score for the whole 
population are given in Table 4.3.  By analysing the facial expression components of the PIPP 
score (i.e. brow bulge, eye squeeze and nasolabial furrow), it was established that 43% of studies 
were classified as  ‘facial non-responders’.  On each test occasion an infant was defined as a 
‘facial non-responder’ if they received a score of zero in all of the facial expression categories 
following the heel lance procedure.  This occurred in 41 out of 94 test occasions.  This group of 
infants is of particular clinical interest as they are at risk of having their pain under-treated, and 
are therefore considered as a subset in more detail in Section 4.3.6.
Analysis of behavioural and physiological responses using the PIPP score
Mean PIPP score, n= 88 7.35 (0.46)
Mean unweighted PIPP score, n=88 4.34 (0.52)
Mean facial expression score, n=94 2.42 (0.37)
Table 4.3 Group analysis - behavioural and physiological responses to heel lance
SEMs are given in parentheses.
774.3.3  The facial expression score and cortical response are well correlated
A subset of infants, whose demographic characteristics are described in described in Table 4.2, 
had their responses  to heel  lance  simultaneously  assessed using NIRS  and the PIPP  (N=33). 
Similar  NIRS  results  were  found  to  those  presented  in  Chapter  2;  an  increase  in  the  total 
haemoglobin concentration in the contralateral somatosensory cortex was observed following a 
heel lance in 30 out of the 33 studies.  As the PIPP score and the haemodynamic activity were 
assessed  simultaneously,  it  was  possible  to  establish  the  degree  of correlation  between  the 
magnitude of the haemodynamic response and the components that make up the PIPP.
Following a heel  lance the relationship between the facial expression score and the maximum 
change in the haemodynamic response in the contralateral somatosensory cortex was established. 
This  is  illustrated  in  Figure  4.3.  The  highest  facial  expression  scores  were  observed  in  the 
infants with the highest level of cortical activity.  Regression analysis, used to estimate the facial 
expression  score  as  a  function  of  the  cortical  response  gives  a  regression  coefficient  = 
0.773pmol/L, 95% Cl limits: 0.45482,  1.091pmol/L, demonstrating a high degree of correlation 
between the cortical response and the facial expression score.
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Figure 4.3 Relationship between facial expression score and haemodynamic response
Relationship between the facial expression score and the maximum A [HbT] in the contralateral somatosensory cortex. 
The open diamonds represent an infant with intraventricular haemorrhage (IVH).
784.3.4  The haemodynamic and autonomic responses are weakly correlated
The maximum increase in heart rate and the maximum decrease in oxygen saturation are the two 
indicators  in  the  PIPP  score  that  assess  the  physiological  response  to  noxious  stimulation. 
Figure 4.4 shows that the maximum change in [HbT] in the contralateral somatosensory cortex, 
weakly correlates with the physiological score calculated from the sum of the two physiological 
indicators  (regression  coefficient  =  0.45pmol/L,  95%  Cl  limits:  0.05,  1.92pmol/L).  This 
demonstrates that the physiological and autonomic changes do not always parallel the cortical 
response following noxious stimulation.
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Figure 4.4 Relationship between the physiological and haemodynamic activity
Relationship  between  maximum  A[HbT]  and  the  physiological  response  following  noxious  stimulation.  The  open 
diamonds represent an infant with intraventricular haemorrhage (IVH).
4.3.5  PIPP  weighting  factors  do  not  improve  the  correlation  with  the  cortical 
response
Figure 4.5  shows  the  relationship between the total  PIPP  score  and the  maximum change  in 
[HbT] in the contralateral somatosensory cortex.  Although the haemodynamic response results 
from  the  functional  activation  of  the  somatosensory  cortex,  and  the  PIPP  score  uses 
physiological and behavioural indicators to assess the pain response, there is a strong correlation 
between the measures (r = 0.716pmol/L, 95% Cl limits: 0.318, 1.114pmol/L).
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Figure 4.5 Assessment of the components which contribute towards the PIPP score
Relationship  between  maximum  A[HbT]  and  individual  components  of  the  PIPP  score.  The  lines  represent  the 
regression lines for different components of the PIPP score.  The filled areas represent the various contributions of the 
different components of the PIPP score.
In addition, Figure 4.5 also shows the correlation between the haemodynamic response and the 
facial  expression  score,  and  the  correlation  between  the  haemodynamic  response  and  the 
unweighted PIPP score.  Figure 4.5 demonstrates how the addition of the different components 
of the  PIPP  influences  the  degree  of correlation  with  the  haemodynamic  cortical  response. 
Regression analysis shows that the regression values for the total PIPP score (r = 0.716pmol/L, 
95% Cl limits: 0.318,  1.114pmol/L) and total facial expression score (r = 0.773pmol/L, 95% Cl 
limits: 0.454,  1.091pmol/L) are similar, which implies that the weighting factors, for sleep state 
and gestational age, combined with the physiological score does not improve the correlation with 
the cortical response.  When the physiological components are added to the facial expression 
score,  the  degree  of  correlation  is  improved  (r  =  0.870p.mol/L,  95%  Cl  limits:  0.149, 
1.888pmol/L), however, when the weighting factors  are  also  added this  improvement is  lost. 
This  arises  because  the  youngest  sleeping  infants  tend  to  have  the  smallest  haemodynamic 
responses and it is these infants whose scores are weighted most heavily.
4.3.6  ‘Facial non-responders’ still mount a cortical response to noxious stimulation
On  33  test  occasions,  12  infants  had  their  PIPP  score  and  haemodynamic  response 
simultaneously measured in response to a heel lance.  According to the PIPP score, infants did
80not  display  a  change  in  facial  expression  on  13  test  occasions  and  therefore  had  a  facial 
expression score of zero; however, most of these infants demonstrated a robust haemodynamic 
response.  Figure 4.6 shows the maximum change in [HbT] in the contralateral somatosensory 
cortex  in  the  13  individual  infants  who  were  classified  as  ‘facial  non-responders’.  The 
maximum change from the pre-stimulus baseline ranged from -1.68 to 7.00|imol/L (see Figure 
4.6).  Although there is a good overall correlation between the cortical activity and the facial 
expression (see Figure 4.5), it cannot be assumed that if an individual infant does not display a 
facial response that there is no underlying cortical activity.  It is possible to mount a cortical 
response to a noxious event without displaying a change in facial activity, therefore an infant 
classified as  a ‘facial non-responder’  may still process the noxious information at the cortical 
level.  The infants who did not display a change in facial expression were not different in terms 
of their clinical assessment.  In fact, as infants were studied on a number of test occasions some 
of the  infants  included  in  Figure  4.6  displayed  changes  in  facial  expression  on  other  test 
occasions; therefore the lack of facial response observed in these infants does not arise because 
the infants are intrinsically unable to mount a coordinated facial response.
Figure 4.6 Cortical responses for infants classified as ‘facial non-responders’
Bar  chart  showing  contralateral  maximum  A [HbT]  in  the  somatosensory  cortex  following  heel  lance  in  individuals 
classified as facial non-responders.  The infant with intraventricular haemorrhage (IVH) is identified in black.
4.3.7  Latency to first facial response
The latency to the first facial expression response following a heel lance is plotted as a function 
of PMA in Figure 4.7.  In the age range, from 25-43 weeks PMA, regression analysis used to 
estimate the latency to change in facial expression as a function of PMA, demonstrates that the 
younger infants have a longer latency to response than the older infants (regression coefficient =
-2
Study number
81-0.70 fimol/L/week, 95% Cl limits:  -1.08, -0.31pmol/L/week).  The latency ranged from  1-21 
seconds;  however,  all  five  infants  under  the  age  of 31  weeks  PMA  had  a  latency  to  facial 
expression response greater than  10 seconds (see Figure 4.7).  This range is a similar order of 
magnitude to the results presented in chapter 3, where the latency to the peak haemodynamic 
response was also observed to be longer in the younger infants (see Section 3.3.4).
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Figure 4.7 Latency to facial expression change
Latency to change in facial expression plotted against PMA.  (Regression coefficients = -0.70pmol/L/week, 95% Cl limits: 
-1.08,  -0.31|imol/Uweek).  Regression  line  represents  infants  aged  25-38  weeks  PMA  where  there  is  a  linear 
dependency on PMA.
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4.4.1  A comparison of cortical responses and clinical behavioural assessment
The PIPP is the most commonly used quantitative method for assessing neonatal pain.  In the 
present study, heel lancing produced PIPP scores similar to those previously reported (Stevens et 
al.,  1996).  Concurrent  measures  of the  behavioural,  physiological  and  cortical  responses  to 
noxious  stimulation  allowed  us  to  break  down  the  PIPP  score  and  examine  the  relationship 
between the cortical haemodynamic response and the individual components that contribute to 
the PIPP.  This provided the opportunity to see how various neonatal pain assessment measures, 
which include change in facial expression and physiological activity, correlate with the cortical 
haemodynamic activity.
Regression analysis demonstrates that following a noxious event, change in facial expression is 
the  component  of  the  PIPP  that  correlates  best  with  the  level  of  cortical  activity  in  the 
contralateral  somatosensory  cortex.  A  weaker  correlation  was  observed  between  the 
physiological  response  and the  cortical  haemodynamic  response.  Previous  studies  have  also 
shown that following noxious stimulation change in facial expression is the most specific and 
consistent response (Grunau et al.,  1998; Grunau and Craig, 1987) and it has also been reported 
that  the  behavioural  and  physiological  indicators  of pain  are  not  highly  correlated  with  one 
another (Johnston et al., 1995). The correlations that have been observed are likely to have arisen 
partly because of the shared underlying neural mechanisms.  For example, nociceptive pathways 
originating  from  the  spinal  cord  dorsal  horn  directly  activate  brain  structures,  such  as  the 
medullary and midbrain reticular formation, and deep layers of the superior colliculus that are 
involved in motor organisation, as well as activation of the autonomic nervous system.  Multiple 
ascending pathways project to  several brainstem and cortical  regions and individual neurones 
often project in more than  one  of these pathways  (Price,  2000).  The  spinothalamic  pathway, 
which relays nociceptive information to the  somatosensory region via nuclei  of the thalamus, 
converges  on  the  same  limbic  and  subcortical  structures  accessed  by  other  ascending  spinal 
pathways  involved  in  the  behavioural  and  autonomic  responses.  This  suggests  that  the 
physiological responses controlled by the sympathetic nervous system, which functions for the 
most part at a subconscious level and involves a limited amount of cognition, may not be the 
most suitable surrogate measure of higher-level pain processing.
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represents perceived pain intensity.  The weighting factors result in an increased pain score for 
the younger infants and those who are asleep.  If, as has been shown in adults, activity in the 
somatosensory cortex in infants correlates with perceived pain intensity then it is possible that 
the reduced level of cortical activation observed in these infants arises because the level of pain 
perception is in fact lower.  The fact that infants also demonstrate an attenuated facial response 
when they are asleep, may occur because they actually perceive less pain.  Weighting factors 
were  initially  introduced to  ensure  that pain  in  the youngest  infants  was  not underestimated. 
While this may be useful in a clinical setting, arbitrarily increasing the pain score in these infants 
does not tell us anything about how these infants actually respond to noxious stimulation nor 
does it provide a better measure of pain processing.
4.4.2  Infants classified as ‘facial non-responders’ display cortical activity
The premature infant pain profile results in a high percentage of preterm infants being classified 
as  ‘facial non-responders’ but it is not clear that these infants are truly pain free.  Clear facial 
grimacing, universally recognised as an expression of pain (Craig et al.,  1993), was observed 
following  heel  lancing;  however,  in  43%  of studies  a  change  in  facial  expression  was  not 
observed.  ‘Facial non-responders’  refer to infants who achieved a zero facial expression score 
according to the PIPP.  Infants who do not mount a behavioural or physiological response to 
noxious stimulation are of particular clinical interest as these infants are at risk of having their 
pain  underestimated.  While  noxious  stimulation  generally  evokes  parallel  cortical  and 
behavioural responses in infants, pain may be processed at the cortical level without producing 
detectable behavioural or physiological changes.  The ability for an infant to display a change in 
facial  expression  in  response  to  a  noxious  stimulus  requires  that  motor  neurone  activity  is 
sufficiently coordinated to produce a visible set of facial muscle contractions.  This relies on a 
complex set of interactions at the spinal or brainstem level.  Our study has demonstrated that if 
an  infant does  not  demonstrate  a change  in  facial  expression,  it cannot be  assumed  that  the 
stimulus does not reach the neonatal cortex.  It is possible that while the noxious information is 
being transmitted to the higher-levels of the central nervous system, behavioural observations do 
not reflect this process.  As a result, pain assessment based on behavioural tools alone should be 
interpreted with caution.  Infants who  do not display a change  in  facial  expression may  still 
process pain at higher levels of the cortex.
The physiological and behavioural measures assessed using the PIPP rely on spinal, brainstem
and  autonomic  responses.  Responses  that  rely  on  sensorimotor  reflex  circuitry,  which  is
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transmitted noxious sensory information.  Furthermore, this input-output relationship may alter 
with age, further distorting the true nociceptive processing that is being assessed.  For example, 
it  has  been  shown  that  non-noxious  stimulation  in  preterm  infants  can  produce  reflex  limb 
withdrawal,  while  the  same  stimulus  fails  to  produce  any  haemodynamic  cortical  response 
(Slater et al., 2006b). It has also been suggested that the facial activity evoked by heel lance is 
blunted in the youngest infants (Johnston et al.,  1993) while the magnitude and spread of motor 
activity in the limbs is greater than that in older infants (Andrews and Fitzgerald, 2000; Andrews 
and  Fitzgerald,  1999).  These  factors  explain  the  complex  relationship  between  the  different 
measures  in  the  PIPP  and  the  haemodynamic  response.  The  relationship  between  spinal, 
brainstem and cortical responses to noxious stimulation could be tested by measuring the flexion 
reflex electromyography (EMG), changes in facial expression and cortical responses, in response 
to  both  noxious  and  non-noxious  events.  It  would  be  of interest  to  test  whether the  EMG 
summary-parameters  change  with  age  and  stimulus  type  along  the  same  trajectories  as  the 
summary-parameters  used  to  characterise  the  cortically  evoked  response.  It  would  also  be 
beneficial  to  establish  whether reflex  EMG  responses  can  occur  independently  of a  cortical 
response and vice versa.  Results from studies like these could inform us about the relationship 
between  spinal  reflexes  and facial  action coding relative to the  cortical  responses to noxious 
stimulation.
The percentage of infants classified as  ‘facial non-responders’  in this  study is high compared 
with previous reports.  Another study that used the PIPP to assess pain responses following heel 
lancing  found  that  20%  of infants  did  not  demonstrate  a  facial  or  physiological  response 
(Johnston et al., 1999). A more detailed study of change in facial expression, which used the full 
neonatal facial  coding system (NFCS),  found that during a heel lance 22% of infants had no 
change  in  eye  squeeze,  27%  had  no  change  in  brow  bulge,  and  35%  did  not  demonstrate 
nasolabial furrow (Grunau et al.,  1998). The high percentage of ‘facial non responders’ in this 
study  can  also  be  explained  by  a  number  of factors.  Previous  studies  have  reported  that 
squeezing the foot is more stressful (Lindh et al.,  1999) and painful (Grunau et al.,  1998) than 
the actual heel lance. In these studies, the foot was not squeezed during the recording period so it 
is possible that the  overall  heel  lance procedure was  less painful.  In  addition,  to reduce  the 
number of studies affected by movement artefact a number of steps were taken to ensure that the 
babies were settled.  Positioning techniques, which included side lying and swaddling were used 
and particular care was taken to expose only the foot that was to be lanced.  As a result, this 
allowed the babies to maintain a stable state; often an asleep infant would not wake up as a result
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to  the  heel  lance  may  have  arisen due  to  the  developmentally-sensitive  approach used when 
handling the infants (Als, 1998).  80% of infants in this study were classified as asleep.  Previous 
work has shown that infants who are asleep have a smaller cortical response following a noxious 
procedure  (Slater  et  al.,  2006b).  Lower  pain  responses  have  also  been  observed  using 
behavioural  indicators  (Johnston  et  al.,  1999).  It  was  to  account  for  this  observation  that  a 
weighting  factor  was  included  in  the  PIPP  to  increase  the  score  for  sleeping  infants.  The 
intention was to prevent sleeping infants from having their pain underestimated.
4.4.3  Latency to change in facial expression is greater in younger infants
The youngest infants have the longest latency to change in facial expression.  In this study the 
youngest infant  did not display a facial  expression response until 21  seconds  after the  initial 
stimulus.  According to the PIPP the infant would not have shown a response for at least 60% of 
the observation period.  As a result, there is a risk that pain in extremely preterm infants is being 
underestimated and under treated.  Previous studies, which have used a limited post-stimulus 
response period, may have come to the erroneous conclusion that the youngest infants display 
little  or no  response  following  noxious  stimulation.  These  findings  were predicted  from the 
NIRS results, where latency to peak response was also longest in the youngest infants (Slater et 
al., 2006b).  The long latencies are attributed to low conduction velocities and slow synaptic 
responses in the nociceptive circuitry.  As described in Section 4.4.1, shared ascending pathways 
transmit information to the cortex and to nuclei that initiate the motor response.  It is therefore 
not surprising that if responses are observed to be slower in one system then they are also likely 
to be slower in others.  This study has shown that it takes longer for the youngest infants to 
produce a coordinated facial response to nociception.  These data provide further evidence to 
suggest that pain scores calculated for the most premature infants should be used cautiously.
86CHAPTER 5: RESULTS PART 3
Nociceptive-Specific Event Related Potentials in the Preterm Infant 
5.1 Introduction
5.1.1  Chapter overview
In  Chapter  3  it  was  shown,  using  near-infrared  spectroscopy,  that  cortical  haemodynamic 
responses to heel lance can be observed in infants from 25 weeks PMA (Slater et al., 2006b). 
The rationale for measuring the haemodynamic response was based on the assumption that the 
haemodynamic activity is driven by underlying cortical electrical events that result in an increase 
in energy demand and subsequent  increase in blood flow (Logothetis and Wandell,  2004).  A 
more  direct  measure  of neuronal  activity  can  be  achieved  from  the  study  of somatosensory 
evoked potentials.  The aim of this chapter is to establish whether noxious stimulation can evoke 
electrical activity in somatosensory cortical neurones that can be measured and characterised.  In 
this study, we recorded electroencephalography (EEG) activity following noxious stimulation in 
premature infants, and analysed the traces for nociceptive-specific responses.  It was postulated 
that  the  neonatal  EEG  would  be  characterised  by  periods  of quiescence  and  that  because  a 
noxious event would have a large impact on the nervous system it may be possible, on a single 
trial basis, to observe activity evoked by a noxious event over and above the background EEG. 
As the hypothesis is based on findings from a single noxious event, it is essential to establish 
whether repeated stimulation in the same infant generates reproducible responses and whether 
comparable responses can be observed between infants.  In addition, careful consideration needs 
to be given to how the heel lance will be time-locked to the EEG recording.  The aim was to 
produce the first ever, direct recordings of cortical electrical activity in human preterm infants 
following noxious sensory input.
875.2  Materials and Methods
5.2.1  Participating infants
Studies  were  successfully  performed  on  33  occasions  in  21  infants  aged  28-42  weeks 
postmenstrual  age  (PMA)  when heel  lances  were performed  for routine blood tests.  Eleven 
studies  were  rejected  due  to  movement  artefact.  Table  5.1  details  the  demographic 
characteristics of the infants in this study.
Demographic characterisation of the neonatal population (EEG study)
Mean gestational age at birth (weeks), n=21 30.9 (4.3); range, 24.1-40.1
Mean PMA at time of study (weeks), n=33 35.4 (3.3); range, 28.0-42.9
Mean postnatal age at time of study (days), n=33 33.9 (32.6); range, 2-128
Mean birth weight (g), n=21 1580.0 (783.2); range, 533-3330
Mean weight at time of study (g), n=21 2041.4 (787.2); range, 899-4184
No.  of multiple gestation infants, n-33 4
No.  of infants with chronic lung disease, n=21 3
Mean no.  of days on mechanical ventilator, n=21 6.43 (13.59); range, 0-51
Mean no.  of test occasions, n=21 1.6 (0.81); range, 1-4
Mean no.  of days between consecutive studies, n=21 4.2 (10.0); range, 0-34
Table 5.1  Demographic characterisation of the neonatal population (EEG study)
Standard deviations are given  in parentheses.
5.2.2  Design and development of time-locked trigger system
To undertake these studies, it was necessary to use a novel approach to time lock the heel lance 
to the EEG recording.  Only by time locking the stimulus to the recording would it be possible to 
observe activity associated with the noxious event.  The equipment had to be designed in such a 
manner that it did not interfere with the clinical requirements of the infant and it complied with 
the protocols currently in use on the unit.  The heel lance device normally used for obtaining 
blood  samples  is  a  sterile  disposable  automatic  incision  device  (Tenderfoot,  International 
Technidyne Corporation).  The lancet houses a spring-loaded surgical steel blade that is released 
when a small switch on the surface of the device is depressed.  When the device is activated, the 
blade swings in an arc motion so that for a short time the blade protrudes from the device such 
that  it can  make  an  incision  in the  superficial  layers  of skin.  After the blade  is  released,  it 
automatically and permanently retracts.  The smallest lancet (Tenderfoot Preemie) produces a 
standardised wound with a depth of 0.85mm and a length of 1.75mm.
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considered.  One example was to attach a small microphone to the surface of the lancet.  The 
release of the spring-loaded blade is accompanied by an auditory cue that could be detected by a 
microphone.  Due to the noisy nature of the neonatal environment, the likelihood that the system 
would not detect the auditory cue or would trigger in response to other sounds was too high; this 
design was not pursued.  An alternative approach was to attach an accelerometer (K-shear accel., 
Kistler  Instruments  Ltd)  to  the  superior  surface  of  the  heel  lancet  using  Blu-Tack.  An 
accelerometer can detect the vibration generated by the release of the blade and the output can be 
sent to a recording device.  The  system could be designed such that  it only triggered once a 
certain  threshold  of activity  was  detected.  If the  received  signal  does  not  match  a  stored 
electrical template then the system will not trigger the EEG recording to start.  This design was 
eventually used and an engineer at Great Ormond Street Children’s Hospital built an in-house 
system suitable for clinical use (Worley et al., 2006).  A block diagram of the trigger circuit is 
given in Appendix 6 (Figure 5.16).
5.2.3  Electrodes and skin preparation
Surface electrodes (Ambu Neuroline disposable cup electrodes) were placed on the scalp using 
the  international  10-20  EEG  electrode  placement  system  (Jasper,  1958).  Four  recording 
electrodes were positioned over the somatosensory cortex; recording electrodes were located at 
Cz,  CPz,  CP3  and  CP4.  Reference  and  ground  were  placed  at  Fz  and  on  the  forehead 
respectively.  If access  was  difficult,  the  reference  electrode  was  placed  at  POz.  Electrode 
positions are shown in Figure 5.1.  To reduce the electrode/skin impedance each electrode site 
was prepared by rubbing the skin with an abrasive EEG prepping gel (NuPrep gel D.O.Weaver 
and Co).  'Nu-prep' is the skin preparation gel in use at Great Ormond Street Hospital and has 
been shown to be safe for use with neonates.  The gel was applied with a cotton wool bud in 
order to abrade the smallest area possible.  Conductive EEG paste (Elefix Nihon Kohden, Corp) 
was used to optimise contact with the electrodes and improve conductance.  The electrodes were 
secured to the scalp using adhesive tape (mefix Molnlycke Health Care AB).  Once the recording 
electrodes were in place, leads were coiled and tied together to minimise electrical interference. 
Electrode impedance was assessed to be acceptable by visually inspecting the EEG traces.  High 
impedances  were  corrected  by  re-abrasing  the  skin  and  re-applying  the  electrode  or  by 
completely  replacing  the  electrode.  Electrode  application  took  approximately  30  minutes. 
Electrodes were disposed of after each study.
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Figure 5.1 Electrode positions
Schematic diagram  of electrode  positions.  Recording  electrodes are  placed  at Cz,  CPz,  CP3  and  CP4.  They are 
referenced to either Fz or POz depending on access to the infant.
5.2.4  EEG recording
EEG  activity  was  recorded  using  a  4-channel  data  acquisition  unit  (Cambridge  Electronic 
Design,  micro 1401) and an isolated pre-amplifier (Cambridge Electronic Design,  1902).  The 
bandwidth  was  0.5-30Hz  and  the  sampling  frequency  was  set  at  2  KHz.  Data  acquisition 
software  (Signal,  version  1.82,  Cambridge  Electronic  Design  Ltd)  was  used  to  record  the 
activity.  The release of the blade  from the heel  lancet (Tenderfoot) electrically triggered the 
EEG recording and evoked activity was recorded for a  10 second period.  A calibration signal 
was applied at the start of each recording to ensure that the amplitude of the signal was correctly 
scaled.  All equipment conformed to the electrical safety standard for medical devices, IEC-601- 
1.
In a subset of studies,  a tri-axial  accelerometer (K-shear accel.,  Kistler Instruments Ltd) was 
placed on the infant’s head in order to detect movement artefact.  In these studies, the recording 
electrode at position CPz was not used as it was necessary to use one of the recording channels 
to record the accelerometer output.
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The heel  lance was performed using the methods described in Chapter 2  (Section 2.2.6).  In 
addition, an accelerometer, connected to a trigger circuit, was attached to the superior surface of 
the heel lancet using Blu-Tack (K-shear accel., Kistler Instruments Ltd).  Prior to the heel lance, 
the lancet was placed on the heel and the system was manually triggered to create a control EEG 
trace.  The aim of the control procedure was to deliver a stimulus where the tactile component 
was identical to the heel lance but the noxious component not received.  Results from all heel 
lances were included in the analysis.  If more than one heel lance was required on the same test 
occasion both heel lances were included in the analysis.
5.2.6 Combined haemodynamic and electrical monitoring
In two studies, EEG recordings were combined with simultaneous NIRS recordings.  The NIRS 
measurements were performed as described in chapter 3 (Section 3.2.4).
5.2.7 Premature infant pain profile
Infants were videoed throughout the study in order to examine behavioural responses.  The PIPP 
was used to assess infant pain as described in Chapter 4 (Section 4.2.4).
5.2.8 Data analysis
The EEG data was imported into a data analysis package (Clampfit 8.1, Axon Instruments, Inc.).
The data was filtered using a 50Hz notch filter to reduce electrical interference and then baseline
corrected.  The  traces  were  visually  inspected  and  clearly  identifiable  waveforms  above  the
background EEG were manually characterised.  The latency to the negative (N) and positive (P)
components were identified independently by two observers.  As this was part of an exploratory
study,  the observers were not blinded to the nature  of the recordings.  Traces  from different
infants were compared to see if similar features between the trials could have arisen as a direct
result of the noxious event.  When waveforms of interest were identified, analysis software was
used to determine the latency and amplitude of each of the components of interest (Clampfit 8.1,
Axon Instruments, Inc.).  Results from each observer were compared.  Trials were placed in one
of five  categories.  Classification  was  dependent  on  the  quality  of the  EEG  recording  and
whether a waveform of interest could be identified (see Table 5.2).  Trials in Categories 3, 4 and
5  were excluded from further analysis.  Through an iterative process a set of parameters was
established  which  characterised  the  components  of interest.  All  the  analysis  was  initially
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waveform of interest was identified in the contralateral  somatosensory cortex, further analysis 
was then undertaken on the other three channels.  The additional channels were analysed using 
normal averaging techniques.
Classification of EEG traces following heel lance
Good EEG trace with identifiable waveform 
Good EEG trace with no identifiable waveform e.g.  waveforms cannot be visually identified
Movement artefact e.g.  identified using the accelerometer
Quality of EEG  too poor to analyse e.g.  due to electrical interference
Technical failure e.g.  due to trigger failure
Table 5.2 Classification of EEG traces following heel lance 
5.2.9 Characterisation of waveforms
The mean response across the cohort of infants was found using normal averaging techniques 
and a time-shifted averaging approach (Purves and Boyd, 1993). Individual trials following heel 
lance  stimulation were  manually  assessed  and  the  observed  activity was  time-shifted  so  that 
peaks  were  aligned  to  correct  for  latency jitter.  The  heel  lance  and  control  responses  were 
analysed using the same methods.  The latency to the peak N and P response was determined and 
the amplitude of the components was calculated for each trial.
925.3  Results
5.3.1  Integrated time-locked physiological monitoring
A trigger system was successfully designed to enable a number of physiological responses to be 
time locked to a noxious event.  Each time the system was triggered, an event marker was sent to 
the pulse oximeter data file, an LED flashed, which was recorded on the video footage and the 
EEG recording was initiated. The system was also capable of sending an event marker to the 
NIRS data file. A block diagram of the system is given in Figure 5.2.  The main advantage of 
this trigger system is that the heel lance protocols used in the neonatal unit were not changed 
when  a  study  was  undertaken.  Nursing  staff  can  perform  heel  lances  following  routine 
procedures.
Heel lancet with
accelerometer
attached
/ \
Video recorder 
time-Jocked via 
LED controlled by 
trigger box
d
Trigger circuit Von Frey hair 
stimulus
EEG I Accelerometer trace
A/D converter
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Figure 5.2 System Diagram
Block diagram of recording system.
The  system  was  successfully  designed  to  prevent  the  trigger  from  firing  following  spurious 
signals, for example, when the heel lancet is handled or when the security tag is released.  To 
date the trigger system has been 100% successful.  During all the recording sessions, it has never 
falsely fired following a spurious event and on the few occasions where the heel lance has not 
triggered, it was identified that the accelerometer was incorrectly attached to the lancet.  Care 
has to be taken to ensure that the Blu-Tack remains adhesive until the time when the heel lance
93is performed.  Adhesion can be impaired if the lancet becomes too warm, i.e. when left in an 
incubator for a long time, or if it is contaminated by solvents used to clean the apparatus.
5.3.2 Variability in trigger timing
The  heel  lancets  used  in  this  study  are routinely used on the Neonatal  Unit to  enable blood 
samples  to  be  collected  for  clinical  assessment  (Tenderfoot,  International  Technidyne 
Corporation).  Using an infrared optical measuring device, the stimulus duration, which is the 
duration in which the blade protrudes  from the heel  lancet,  was  determined to be  124+4.8 ps 
(N=10).  In addition,  the time taken from the midpoint of the stimulus duration to  the event 
trigger was calculated to be 104+113ps (N=10) (Worley et al., 2006).  These measurements were 
established to verify that the latency variation between the observed waveforms was not caused 
by the timing jitter in the trigger circuit.  The variation in the latency to trigger was insignificant 
compared to the latency differences in the physiological measurements (Worley et al., 2006).
5.3.3 Identification of pain-specific evoked potentials
Figure 5.3 and 5.4 are epochs of EEG activity recorded from the first infant in the study.  Figure
5.3 shows a 1000ms epoch in one infant following a heel lance at t=0 (PMA: 42+6 weeks).  The 
four  recording  electrodes  were  placed  over  the  somatosensory  cortex.  The  top  trace  is  the 
recording from the contralateral somatosensory cortex.  Traces were visually inspected to see 
whether activity  could be  observed  over and  above the  ongoing EEG  activity that may have 
arisen as a direct consequence of the noxious stimulus.  A waveform of interest is identified in 
the  trace  (see  Figure  5.3).  To  investigate  whether this  activity  was  evoked  by  the  noxious 
stimulation  further  studies  were  conducted  in  a  larger  cohort  of infants  to  see  whether  the 
observed  waveforms  were  reproducible.  The  demographic  characteristics  of  the  neonatal 
population are given in Table 5.1.  The responses evoked following a heel lance were compared 
to  responses  following  a  control  procedure.  In  total,  61  attempts  were  made  to  record  the 
resultant  EEG  activity  following  a  clinically  required  heel  lance.  After  accounting  for 
exclusions  due  to  technical  failure  and movement artifact,  there were  33  successful  trials.  A 
summary of the trials that were undertaken is given in Table 5.3.
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Figure 5.3 Example EEG trace
Four recording electrodes positioned at CP1, CP2, CPz and Cz in a single infant (PMA = 42+6 weeks).  Heel lance given 
at t=0ms.  The  top trace  represents the  activity  in  the  contralateral  somatosensory cortex  (CP1).  The activity that has 
been circled identifies the waveform of interest.
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Figure 5.4 Example EEG trace - control response
Four recording electrodes positioned at CP1, CP2, CPz and Cz in a single infant (PMA = 42+6 weeks).  The response is 
recorded when the heel lancet is placed against the surface of the foot but not triggered.
5.3.4  Reproducibility of the evoked response
In 27 out of the 33 studies comparable negative/positive waveforms were observed in response 
to a single acute noxious event in the contralateral somatosensory cortex (CP3 or CP4 depending 
on which foot was heel lanced).  The N-P complex was visible in 82% of the studies (see Table 
5.3).  The  latency  and  amplitude  of the  N  and  P  components  for  each  individual  trial  are 
presented in Appendix 7 (Table 5.4) and each of the raw traces is shown in Appendix 8 (Figure 
5.17).
Classification of single-trial EEG traces
Technical failure 20% (12/61)
Quality of EEG  too poor to analyse 8% (4/49)
Movement artefact 27% (12/45)
Good EEG trace no identifiable waveform 18% (6/33)
Good EEG trace with identifiable waveform 82% (27/33)
Table 5.3 Classification of single-trial EEG traces
96The  responses  to  five  different heel  lance trials  are  shown in Figure  5.5a and the  associated 
responses in the control studies are shown in Figure 5.5b.  The heel lance and sham responses in 
the same  infant on the same test occasion are represented in the same colour.  The infants in 
these studies are between 33 and 36 weeks PMA.  The shams show the electrical activity when 
the lancet is placed against the foot but the heel lance is not performed.  To aid identification, the 
peak responses have been aligned in Figure 5.5a.  X marks the time point when the heel lance 
occurred.  The  scale bar on the x-axis gives an indication of the degree of time  shifting and 
therefore the variability in the latency of the response.  It is clear from Figure 5.5a that the peak 
latency is variable; however, the patterns of activity are similar between the different trials.  The 
variation in the latency and amplitude of the N and P components are presented in more detail in 
Section 5.3.7.
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Figure 5.5b Response to control study
Figure 5.5 EEG response following heel lance in five studies
Response to heel lance (Figure 5.5a) and associated control response (Figure 5.5b) in five individual heel lance trials. 
The matching colours in each figure represent trials undertaken in the same infant on the same test occasion.  In Figure 
5.5a the peak responses are aligned to aid identification.  X marks the point where the heel lance occurs.  (Bandwidth 
0.5-30Hz.  Sampling rate 2000Hz).
5.3.5  Repeated stimulation in the same infant generates reproducible waveforms
Further evidence to  support  the  hypothesis  that these potentials  are  specifically  generated  in
response to the noxious stimulation comes from repeated studies conducted in the same infant.
In four cases, in order to get sufficient blood for the required blood sample, two heel lances were
98performed  in the same  infant on the same test occasion.  The morphology of the waveforms 
following the  first and  second heel  lance was compared.  Repeated heel  lancing in the same 
infant on the same test occasion evoked similar patterns of activity as similar waveforms were 
observed following the first and second heel lance.  The examples in Figure 5.6 show the evoked 
potentials  in  the  contralateral  somatosensory  cortex  following  repeated  heel  lancing  in  two 
infants.  The  two  traces  in  each  figure  represent  the  responses  to  two  separate  heel  lances 
undertaken in the same infant within 5 minutes of each other.  The figures show that repeated 
noxious stimulation in the same infant produces reproducible waveforms.  In the first infant the 
amplitudes  of the negative/positive components are 25.4pV and 31.0pV and the latencies are 
291.0ms and 412.5ms.  In the second infant, the amplitudes are  18.4pV and  18.5jnV and the 
latencies are 439ms and 554ms.  The traces in the contralateral somatosensory cortex (CP3 or 
CP4) in each of the individual heel lance trials where a waveform was visually identified are 
given  in  Appendix  8.  Traces  from  the  same  infants  on  the  same  test  occasion  have  been 
highlighted.  The  fact  that  very  similar  patterns  of activity  can  be  observed  in  single  trials 
provides  convincing evidence that  specific  activity  associated with  the  noxious  input  can  be 
measured and characterised.
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Figure 5.6 Responses to heel lance in the same infant
Evoked  potentials in the contralateral somatosensory cortex following  heel lance  in two infants.  The two traces in each 
figure represent the responses to two separate heel lances undertaken in the same infant within 5 minutes of each other 
(heel  lance  1  is  black,  heel  lance  2  is  red).  The  figure  shows  that  repeated  noxious  stimulation  in  the  same  infant 
produces reproducible waveforms.  (Bandwidth of 0.5-30Hz.  Sampling rate 2000Hz.)
5.3.6  Classification of waveforms
Figure 5.7 shows the mean response following a heel lance in the contralateral somatosensory
cortex from the 27 single trials where a waveform was visually identified (age range:  31— 42
99weeks  PMA).  The  activity seen in Figure  5.7  is a direct average and time-shifted averaging 
techniques have not been used in this analysis.  Figure 5.8  shows the mean control response, 
calculated  using  the  same  standard  averaging  techniques,  when  the  heel  lancet  was  placed 
against the foot but not triggered.  It is clear from Figure 5.7 that following the heel lance there 
is activity in the EEG trace that occurs as a direct result of the noxious stimulus, which is not 
present in the control data presented in Figure 5.8.
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Figure 5.7 Average response to heel lance using standard averaging
Average evoked  response in the contralateral somatosensory cortex following  heel lance at t=0ms (N=27) (mean  PMA= 
35+3  weeks).  Traces  included  in  the  average  are  those  where  a  waveform  was  manually  identified  (27  out  of  33 
studies).
The mean response from the same population using the time-shifted averaging approach is given 
in Figure 5.9.  Using this averaging approach the waveform is more clearly defined, however the 
overall morphology is still similar to that observed in Figure 5.7.  As this approach accounts for 
the  latency  variation  between  trials,  it  produces  an  average  waveform  that  is  a  better 
representation of the waveforms in the individual trials.
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Figure 5.8 Average response in the control study using standard averaging techniques
The response when the heel lancet was placed against the foot but the blade was not released (Bandwidth of 0.5-50Hz. 
Sampling rate 2000Hz).
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Figure 5.9 Average response using time-shifted averaging
Average evoked response in the contralateral somatosensory cortex following heel lance at t=0ms (N=27) (mean PMA= 
35+3 weeks).  The trace is averaged around the peak negative component in each single trial.  The discontinuities in the 
trace between 0-200ms arise when time-shifted traces are appended to the average (Bandwidth of 0.5-50Hz.  Sampling 
rate 2000Hz).
5.3.7  Variability in pain-specific evoked potentials
There is considerable variation in the latency to response in the individual trials.  The latency of 
the N component ranges from 279-625ms and the latency of the P component ranges from 306-
101646ms  (N=27,  PMA  range  31-42  weeks).  The  degree  of latency  scatter  between  trials  is 
represented in Figure 5.10.  The latency to the N component (red triangles) and P component 
(black diamonds) are plotted for each trial.  The trials are ranked in terms of increasing PMA. 
For both the N and P components, the variation around the mean response is shown.  Although 
there may well be a developmental profile, the number of trials at the extreme ages is small and 
the scatter is wide.  The latency to peak response has therefore not been plotted as a function of 
PMA and this will be investigated in the future.
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Figure 5.10 Latency to N and P components in individual trials following heel lance
Latency to N and P component for each individual study.  The black diamonds represent the first N component and the 
red triangles represent the P component.  The black and red lines represent the mean latency to response to the N and 
P components respectively.
Figure  5.11  shows  the  amplitude  of the N-P  complex  plotted  for each  individual  trial.  The 
amplitude of the N-P complex ranges from 10-48pV, with a mean amplitude of 24.4pV.  In this 
figure, the trials have also been ranked in terms of PMA; however, a more detailed analysis of 
the relationship between amplitude and PMA has not yet been undertaken.  Further analysis of 
this data may enable the factors that contribute to the variation in the size of response, such as 
sleep state, PMA and previous exposure to painful procedures to be determined.
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Figure 5.11 Amplitude of N-P complex in individual trails following heel lance
Amplitude of the N-P complex for each individual study ranked in order of PMA.
The analysis presented in this chapter so far has focused on a late N-P component that occurs at 
around 300-600ms in the contralateral somatosensory cortex.  Other activity in the traces needs 
to be analysed using a similar approach.  Figure 5.12 shows the average trace from each of the 
recording electrodes from the 27 trials.  In each channel, the mean response has been calculated 
using normal averaging techniques.  Figure 5.12 provides strong evidence that there is also an 
earlier component that can be  identified at the vertex (Cz).  This may reflect earlier afferent 
input and needs to be investigated further.
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Figure 5.12 Average response from four recording electrodes following a heel lance
Average evoked  response  in four recording electrodes placed over the somatosensory cortex following  heel  lance at 
t=0ms (N=27) (mean  PMA= 35+3 weeks).  Trials included in the average are those where a waveform was manually 
identified in the contralateral somatosensory cortex (CP3 or CP4).
5.3.8  Combined NIRS and EEG recordings
Figure 5.13 shows the haemodynamic and electrical response to a heel lance in a single infant on 
one test occasion when both NIRS and EEG activity were simultaneously measured.  To date 
combined  NIRS  and  EEG  recordings  have  been  successfully  recorded  in  two  infants.  The 
preliminary  data  demonstrates  that  it  is  technically  feasible  to  record  the  time-locked 
haemodynamic and electrical  activity  following a heel  lance  in preterm infants  (Slater et al., 
2006c).
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Figure 5.13 Simultaneous NIRS and EEG recordings following a heel lance
Example NIRS and EEG trace in the contralateral somatosensory cortex in a single infant (PMA = 42+3 weeks).  The 
source and detector optodes were positioned either side of the recording electrode (CP1) so that both recordings were 
made from the same area of the brain.  Figure 5.13a shows the NIRS recording (heel lance occurred at t=20 s) and 
Figure 5.13b shows the evoked EEG activity (heel lance occurs at t=0ms).  The waveform of interest has been circled in 
Figure 5.13b.
5.3.9  Control for movement artefact
To ensure that the observed activity did not occur because of movement artefact, a subset of 
studies was undertaken where an accelerometer was placed on the forehead of each infant.  The 
accelerometer trace could be compared to the recorded EEG activity.  When movement artefact 
was visible in the accelerometer trace the study was excluded from further analysis.  An example 
trace  is  given  in  Figure  5.14.  The  top  trace  shows  the  movement  artefact  recorded  by  the 
accelerometer.  Movement can clearly be observed in the trace between  100 and 300ms.  The 
resultant activity in the other channels can also be observed.
105i 2000
1000
-1000
-40
2 0
0
i
2 o
Tim* {msi
Figure 5.14 The effect of movement artefact
An accelerometer trace and the EEG traces from three recording electrodes positioned at Cz, CP3 and CP4 in a single 
infant.  Heel lance given at t=0ms.  The top trace represents the head movement recorded by an accelerometer.
5.3.10  Correlation of EEG responses and behavioural responses
The average PIPP score across all trials was 7.6 + 4.6 (see chapter 4 for further details regarding 
how this was calculated).  The range of the PIPP score in individual trials was 1-17.  Although 
the data is preliminary, it is of interest to note that of the 6 infants where a waveform was not 
identified in the contralateral  somatosensory cortex,  5  also did not display a change  in facial 
expression.  By comparison, of the  19 studies where a waveform was identified, only 5 infants 
did not demonstrate a change in facial expression.  This is represented in the tree diagram in 
Figure 5.15. The number of infants in this analysis is lower than the number of infants in the 
total population because the facial expression score was not determined for every infant when an 
EEG study was performed.
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Figure 5.15  Facial expression change and the presence of an observable waveform
Tree diagram to show the relationship between change in facial expression and the presence of an observable waveform 
in the contralateral somatosensory cortex.
1075.4 Discussion
5.4.1  Nociceptive-specific  event  related  potentials  can  be  observed  in  preterm 
infants
EEG  was  used  to  measure  time  locked changes  in the  evoked activity  following  a clinically 
required heel lance.  It was possible to observe nociceptive-specific event related potentials in 
infants  from  31-42  weeks  PMA.  The  N-P  complex  was  visible  in  the  contralateral 
somatosensory cortex (CP3  or CP4) in 82% of the studies.  This is consistent with single-trial 
analysis  following  laser stimulation in adults where the N-P complex was  identified at Cz  in 
79% of trials (Iannetti et al., 2005b).  Noxious stimulation can evoke specific patterns of neural 
activity within the cortex of preterm and term infants.  Individual traces from different infants 
show similar patterns of activity, and when the stimulus is repeated in the same infant on the 
same  test  occasion,  identical  waveforms  were  produced  in  some  cases.  The  study  provides 
further evidence that infants undergoing intensive care process painful experiences at the cortical 
level.  The study suggests that from 31 weeks the sensory pathways are sufficiently developed to 
transmit noxious information to the preterm infant cortex.
The  observed  activity  has  striking  similarities  to  that  observed  in  adults  following  laser 
stimulation (Iannetti et al., 2005b).  In the infants where a waveform was identified the latency 
of the N component ranges from 279-625ms and the latency of the P component ranges from 
306-646ms.  Although there  is considerable variability in the latency  of the response  it is  in 
keeping with that seen in adults following laser stimulation (Iannetti et al., 2005b).  In a single 
adult subject, Iannetti and his co-authors showed that the variability in the latency to the peak 
response was 214-250ms.  In an earlier study by Purves and Boyd (1993), a latency variation of 
+/-60ms  was  observed  in  LEP  trials  performed  in  different  adults.  The  latency  variation 
between trials observed in these studies is greater in infants than it is in adults.  Given that the 
heel  lance  stimulus  is  less  easily  controlled than LEPs,  is  undertaken  on  infants  of different 
developmental ages and in different behavioural states, and that the stimulus cannot be repeated 
in the same infant for the purpose of the study, it seems acceptable that there is more variation 
between trials.  In addition, as the neuroanatomical pathways are less developed in the neonatal 
population it is likely that this will also result in more latency variation between individual trials.
The latency of these components is longer in infants compared to adults.  This is consistent with 
other  studies  in premature  infants  where  electrical  stimulation  has  been used to  evoke  SEPs
108(Smit et al.,  1999; Taylor et al.,  1996; Klimach and Cooke,  1988). As described in the previous 
chapters, the long latency is thought to reflect the immaturity of the nervous system (Andrews 
and Fitzgerald,  1999). Infants in the neonatal unit range from 22 to 45 weeks PMA.  Based on 
the SEP studies in infants (Smit et al., 1999; Taylor et al.,  1996; Klimach and Cooke,  1988) and 
the work presented in Chapter 3 (Section 3.3.4) and Chapter 4 (Section 4.3.6) of this thesis, it is 
hypothesised that the latency to response will be age dependent over this age range.  To confirm 
whether the developmental trends are similar to those observed in the haemodynamic activity it 
would be necessary to study more infants at the extreme ages.  This  is particularly important 
because of the large latency variation between trials.  The developmental profile could easily be 
masked by the latency jitter if too few infants were included in the analysis.
5.4.2  Identification and analysis of evoked potentials
The  standard  technique  used  to  observe  stimulus-evoked  activity  is  to  average  the  response 
across  multiple  trials.  For  example,  the  SEP  studies  that  have  been  conducted  in  neonates, 
described in detail in Section 1.2.12, use repeated electrical stimulation to increase the signal to 
noise ratio.  Using this method the signal of interest can be observed over and above the ongoing 
background EEG  activity.  This type of analysis is based on the assumption that the  evoked 
activity is time-locked to the stimulus and that the ongoing EEG activity can be treated as noise. 
There are a number of reasons why using this approach alone was not ideal in this study.  For 
ethical reasons the noxious stimuli cannot be repeated in the same subject to improve the signal 
to noise ratio.  Therefore, an average response would have to be taken from a single infant at 
various  stages  during  development  or from  a cohort  of different  infants  who  were  the  same 
developmental  age.  Both  these  approaches  are  potentially problematic  because  of the  wide 
latency jitter that has been observed between trials.  Even if the stimulus is repeated on the same 
infant on  the  same  test occasion,  long-latency  evoked potentials,  generated by  a nociceptive 
input, will exhibit marked latency jitter between trials (Iannetti et al., 2005b). This is attributed 
to the slow conduction velocity of the primary sensory neurones and the intrinsic variation in 
latency that is associated with cognitive processing.
Despite the latency variation between trials, it was still possible to use these normal averaging
techniques  to  see  evidence  of the  time-locked activity.  The  waveforms  of interest  were  not
completely masked by the averaging process even if some aliasing does occur.  As the latency to
response  varies  considerably between trials,  it  is  possible that  standard  averaging techniques
could  distort  the  waveform  and  cause  a  significant  reduction  in  peak  amplitude.  An
approximation of average  latency may also be misleading.  In this  study comparable  activity
109could be observed between trials,  hence it was possible to characterise the responses using a 
time-shifted averaging approach, similar to that used for the analysis of LEPs (Iannetti  et al., 
2005b; Purves and Boyd,  1993). Time-shifted averaging was first used to analyse LEPs in 1993. 
Individual trials following laser stimulation were manually assessed and the observed activity 
was time-shifted so that peaks were aligned to correct for latency jitter (Purves and Boyd, 1993). 
This  method  enabled  the  maximum  amount  of biological  information  to  be  disclosed  from 
single-trial  responses.  Using  this  technique,  it was possible  to  compare  directly  the  evoked 
response in each trial and produce an average response that was a better representation of the 
individual  waveforms.  In  February  2006  a  paper  published  in  Clinical  Neurophysiology 
outlined an automated method to identify the amplitude and latency of LEPs on a single-trial 
basis using a time-shifted averaging approach (Mayhew et al., 2006).  The paper described a 
method that used multiple linear regression to determine the amplitude and latency of N2 and P2 
components  following  laser stimulation.  The  authors  demonstrated  that  estimates  calculated 
using the automated approach correlated with corresponding estimates determined manually by a 
human  expert.  The  automated  technique  can  be  used  to  determine  latency  and  amplitude 
components from evoked potentials generated from a range of sensory stimuli (Mayhew et al., 
2006).  The authors suggest that it may be possible to implement this technique to measure the 
latency and amplitude of evoked potentials generated by a range of other sensory modalities.  If 
the algorithms used in the automated analysis could be used to assess the neonatal response to a 
heel lance, it would strengthen the case that nociceptive-specific activity is being observed and 
remove some of bias created when traces are manually analysed.
The range in amplitude of the N-P complex was also wide (10-48pV).  In the Iannetti study the 
variation in amplitude, in a single adult was reported to be 22.9-49.5pV (Iannetti et al., 2005b). 
Although  the  amplitude  range  is  similar  in  both  studies,  the  underlying  reasons  for  these 
observations may be different.  In the neonatal study, the variation in amplitude may be due to 
factors such as, sleep state, age at time of study or previous pain exposure.  The influence of 
each of these factors can be considered when a larger data set is available.  The lower amplitude 
calculated using standard averaging techniques is explained by the wide latency jitter between 
trials.  As the time-shifted averaging approach is less affected by latency variation, it produces a 
response that better represents the waveforms produced in the single trials.  It is possible that the 
amplitude of the observed response correlates with perceived pain intensity.  If the total number 
of activated neurones is critical for encoding noxious events and stronger inputs activate more 
neurones synchronously, then this is likely to result in an increase in the observed amplitude, 
which  could  potentially  reflect  the  level  of perceived  pain.  It  is  also  possible  that  pain
110perception may correlate with the latency to the response, but given the intrinsic wide variation 
in the  latency of these  components,  it is probable that a subtle  latency distribution would be 
masked.  In addition, it is important to note that pain perception cannot be directly measured in 
this population.  It would, however, be possible to compare the outcome measures discussed in 
this chapter with other surrogate measures of nociception, such as change in facial expression 
and autonomic responses.
Evoked activity observed following noxious stimulation in the neonates might be analogous to 
LEPs  in adults.  Despite the  salient differences  in the  latency and topography of the  evoked 
responses, there are clear similarities.  It will be beneficial to look at the power spectrum of the 
neonatal evoked potentials to establish whether it is similar to that reported in LEP studies.  In 
addition,  it  would  also  be  useful  to  compare  the  power  spectrum  of the  neonatal  evoked 
potentials  to  that  of the  long  slow  transient  potentials  that  have  also  been  observed  in  the 
neonatal  period  (Vanhatalo  et  al.,  2005).  These  spontaneous  slow  activity  transients  are 
characterised by a large voltage deflection, with an amplitude of up to 800pV and a maximum 
rate of 8/min.  This would provide further evidence to suggest that the potentials, which arise 
following nociceptive input in the neonate, do not represent spontaneous transient responses that 
only  occurs  during  this  developmental  period.  Vanahtalo  et  al.,  (2005)  suggest  that  the 
spontaneous slow activity transients, confined to the neonatal period, terminate in parallel with 
the maturation of functional GABAergic inhibition.  In this thesis, the small number of studies 
conducted in infants that are post term suggest that the activity is still present at this age.  This 
provides further evidence that the potentials are specific responses to the noxious stimulation, 
which do not represent transient developmental activity.
Numerous LEP studies in adults have confirmed that the largest scalp signal is a late negative- 
positive complex (N2-P2) with maximal amplitude at Cz.  The bilateral operculoinsular and the 
contralateral somatosensory  areas has been shown to generate the N2 component (Ohara et al., 
2004; Frot et al.,  1999; Tarkka and Treede,  1993) and the cingulate gyrus has been shown to 
generate the P2 component (Iannetti et al., 2003; Tarkka and Treede, 1993).  An earlier negative 
component has also been characterised in the adult studies, as a lateralised response originating 
from the operculoinsular cortex (Vogel et al., 2003; Tarkka and Treede,  1993).  In the neonatal 
studies,  two  distinct  responses  have  also  been  observed.  The  first  occurs  at  approximately 
150ms and is maximum at the vertex (Cz) and the second occurs at approximately 450ms and is 
maximum  in  the  contralateral  somatosensory  cortex.  The  difference  in  the  location  of the 
maximum cortical responses may be due to differences in the type of stimulation, or perhaps,
111due  to  differences  in  how  the  immature  nervous  system processes pain  at  the  cortical  level. 
Most studies that have used LEP have activated the dorsal surface of the hand.  It is plausible 
that activation of the heel may have a different topographic representation.  In order to establish 
the  source  generators  of the potentials  in the  neonatal  studies,  and to  compare  these  studies 
directly with LEP studies, more electrodes need to be placed on the surface of the head.  Even if 
technical difficulties means that it is not possible to achieve full head coverage, it is particularly 
important to have additional electrodes placed over the temporal regions.
The majority of the analysis conducted so far has focused on the late cortical component that is 
most well  defined  in  the  contralateral  somatosensory  cortex.  In the  initial  analysis,  the  late 
negative component was the most easily identified potential.  This may be due to the separate 
source generators that are thought to drive the N and P components.  The earlier activity may 
represent the initial afferent input.  It is expected that latency jitter between trials will not be as 
wide in the earlier components; however, the amplitude of these components may be smaller and 
more difficult to observe in the single trial analysis.  It would be particularly useful to analyse 
results  in  subsets  of  infants  who  are  the  same  gestational  age  in  order  to  control  for 
developmental  changes  in  the  observed  waveform.  Studies  of this  type  will  enable  us  to 
establish whether a developmental profile can be observed.  In addition, further work needs to be 
done to assess the relationship between changes in facial expression and the presence or absence 
of the described waveforms.
5.4.3  Limitations of the study
One of the major limitations of this study is that the EEG activity was assessed using only four 
recording  electrodes.  As  this  was  an  exploratory  study,  it  was  decided  that  the  available 
electrodes would be placed over the somatosensory region of the cortex to give the best possible 
chance of recording the  evoked activity.  This  meant that  full  coverage  of the head was not 
possible and prevented activity in other areas of the brain from being investigated.  The limited 
topography meant that  no  electrodes  were placed over indifferent  areas  of the  skull.  Future 
studies  need  to  be  performed  using  a  high-resolution  EEG/EP  recording  system  with  more 
recording electrodes.  It would then be possible to look at the voltage distribution over the scalp 
and  confirm  whether  the  observed  waveforms  are  specifically  located  in  the  somatosensory 
region of the cortex.  With the appropriate computational analysis, the neuroanatomical loci of 
these processes  could be  identified.  More  recording channels would also  facilitate the  time- 
locked recording of other measures.  For example,  an accelerometer could be  included in  all
studies to detect movement artefact without the disadvantage of losing a recording electrode.
112These studies provide pilot data on which further work can be based.  The studies were designed 
to establish whether it is possible to record EEG activity in neonates that occurs as a direct result 
of a noxious event.  Based on the  findings,  future experiments can be hypothesis driven and 
designed  to  answer  specific  questions  about  the  cortical  processing  of pain  during  early 
development.  Further studies and other stimulation paradigms are discussed in more detail in 
Chapter 6.  The data strongly suggest that it may be possible to observe nociceptive-specific 
event related potentials in premature infants following a single noxious event.  These responses 
need to be carefully characterised to  optimise  the recording parameters  and to  determine the 
underlying neurological processes that are driving this activity.
5.4.4  Simultaneous recording of haemodynamic and electrical cortical processing
It is technically feasible to use EEG and NIRS to measure pain-related activity in the cortex of 
premature infants.  Simultaneous collection of EEG and NIRS data on a single-trial basis allows 
paired comparisons to be made between the two measures.  By using both these techniques on 
the same test occasion, a further insight into how the premature infant brain processes pain at the 
higher cortical levels can be achieved.  It is valuable to undertake these measures simultaneously 
because the techniques measure different aspects of cortical processing.  While it is clear that 
both EEG and NIRS are measures of stimulus-evoked activity, it is important to remember that 
the  aspect  of the  neural  activity  being  captured  by  each  technique  is  completely  different 
(Villringer,  1997).  EEG measures time-locked activity over a short time-interval whereas NIRS 
integrates both time-locked and non-time-locked activity and detects longer lasting changes in 
haemoglobin concentration.  It appears that the latencies and amplitudes of waveforms are not 
affected by the combined recordings; although more combined studies need to be undertaken to 
confirm this.  In adults studies, it has been shown that simultaneous use of fMRI and EEG does 
not affect the quality of the recordings (Iannetti et al., 2005a).
The  experimental  set-up  enables  a  number  of different  recording  modalities  to  be  used  to 
investigate the response to noxious stimulation in premature and term infants.  Measuring the 
time-locked haemodynamic,  electrical,  physiological  and behavioural  responses  to  an  acutely 
painful procedure provides an excellent experimental paradigm to further our understanding of 
the evoked activity that occurs during this early stage of development.  This integrative approach 
provides an opportunity to assess the effect of pain on the  immature nervous  system.  Using 
EEG to measure the electrically evoked activity has demonstrated that reproducible waveforms 
can be observed as  a specific  consequence of activation of nociceptors  (Slater et al.,  2006d). 
Further work will establish how the electrical evoked activity is related to the haemodynamic
113activity  and  confirm  whether  there  is  an  observable  change  in  amplitude  or  latency  with 
increasing PMA.
114CHAPTER 6: CONCLUSION
6.1.1  Do premature and term infants process noxious stimuli at the cortical level?
One  of the aims  of this thesis  was to  address the question of whether premature  infants  can 
mount a cortical response following noxious stimulation.  The studies presented in this thesis 
demonstrate that infants, from 25 weeks PMA, can mount a cortical haemodynamic response in 
the contralateral somatosensory cortex following a heel lance, which can be recorded using near- 
infrared spectroscopy (Slater et al., 2006b).  By comparing the responses to non-noxious tactile 
stimulation,  the  specificity  of the  response  to  the  noxious  event  has  been  confirmed.  The 
magnitude of the response increases with postmenstrual  age and is modulated by sleep state. 
Infants who are awake display a greater cortical response  than those who are  asleep.  These 
studies confirm that noxious procedures performed in infants can activate cortical structures.
The premature infant pain profile (PIPP) scoring system was used to assess how the behavioural 
and physiological responses correlated with cortical response to noxious stimulation.  There is a 
strong correlation between the magnitude of the haemodynamic response and change in facial 
expression,  whereas,  there  is  a  weaker  correlation  with  change  in  heart  rate  and  oxygen 
saturation.  Despite the strong correlation observed between the facial expression change and the 
haemodynamic  activity,  care  needs  to  be  taken  when  interpreting  these  findings.  In  some 
studies, infants demonstrated a clear cortical response following a heel lance but did not display 
any change in facial expression.  Although these infants did not display a behavioural response 
that could be  observed by  an onlooker,  they were  still processing the  noxious  stimuli  at the 
cortical level.  As behavioural responses to noxious stimulation are routinely used to assess pain 
in premature infants, it is useful that the limitations of using facial expression as the sole pain 
scoring system have been identified.
The underlying cortical electrical activity has also been considered.  EEG recordings following a 
heel  lance  were  analysed  and  the  existence  of clearly  identifiable  nociceptive-specific  event 
related potentials was recognised.  Noxious stimulation can  evoke  specific patterns  of neural 
activity within the cortex of preterm and term infants.  While the EEG data demonstrates that it 
is possible to record nociceptive-specific brain responses following a single noxious event, these 
responses need to be carefully characterised.
1156.1.2  Further work
The  summary  measures  used  to  characterise  the  haemodynamic  and  electrical  activity  are 
latency  to  peak  response,  onset  latency,  response  duration  and peak  amplitude.  In  order to 
characterise the responses more carefully, further analysis of this data should include the within- 
subject and between-subject variability for each of these measures.  Careful characterisation of 
the cortical electrical responses, which have been observed following noxious events, is essential 
if  these  measures  are  to  be  used  as  a  measure  of higher-level  pain  processing.  This  is 
particularly  important  for  the  evoked  potential  data  because  it  may  be  possible  to  use  this 
measure to test whether cortical responses to noxious and non-noxious stimuli are affected by a 
variety  of analgesic  regimes.  Simultaneous  studies  using NIRS  and  EEG  could  assess  the 
relationship between the haemodynamic and electrical activity evoked by both noxious and non- 
noxious  somatosensory  stimuli.  It  may  be  possible  to  consider  the  temporal  relationship 
between  the  two  responses  using  appropriate  modelling  methods  (King  et  al.,  2003). 
Characterisation of the responses would be aided if procedures other than a clinically required 
heel  lance  could  be  performed  to  activate  AS  and  C  fibres.  One  possibility  is  that  a 
transcutaneous electrical stimulator, referred to as a prickle stimulator, could be used to give a 
time-locked  prickle  sensation,  which  is  known  to  activate  these  fibres  (Gamsworthy  et  al., 
1988).  If a stimulator of this type  could be used,  it would be easier to perform longitudinal 
studies, because the experimental protocol would not be dependent on the clinical needs of the 
infants.
Further  work  also  needs  to  be  carried  out  using  non-noxious  mechanical  stimulation  to 
distinguish between the tactile and the noxious component of the response.  In principle, this 
could be tested using standard von Frey hair stimulation; however, in pilot studies and in studies 
presented in Chapter 2,  it was not possible to record a measurable response to von Frey hair 
stimulation using either EEG or NIRS.  This may be because the required number of stimuli, 
essential to increase the signal to noise ratio, may be unrealistic in this population.  This requires 
further investigation; however, other non-noxious stimulation could also be used.  One possible 
method to activate Ap fibres would be to place a small vibrating disc in contact with the dorsal 
surface of the foot.  The advantage of studies using non-noxious stimulation is that it may be 
possible to measure a graded response to varying stimulus strengths.  Experiments of this kind 
would confirm that patterns of neural activity in the human infant somatosensory cortex can be 
measured  using  neurophysiological  methods,  and  would  provide  a  clearer  picture  of  the 
specificity, repeatability and reliability of the responses.
116The cortical haemodynamic response to heel lancing increases with increasing postmenstrual age 
(Slater et al., 2006b).  There was no doubt, however, that the two youngest participants in the 
study,  aged  25  weeks  PMA,  showed  a  clear  cortical  haemodynamic  response.  It would  be 
beneficial  to  use  EEG  to  measure  the  nociceptive  evoked  neural  activity  in  infants  of this 
gestational age because it is in this population that there is least data.  To date, the youngest 
infant in the EEG study was 28 weeks; a recognisable waveform was not observed in this infant 
but it is not known at this stage whether this is representative of the whole population of this age. 
Characterising  these  responses  during  this  early  stage  of  development  would  further  our 
understanding of the neurobiology of nociceptive processing at this age.
Several  studies  have  shown that  reflex responses  and biobehavioural  markers  of nociception 
increase  with  repeated  heel  lancing  and  other  invasive  procedures.  This  suggests  that 
hyperalgesia  may  be  occurring  in  these  infants.  It  would  be  of  interest  to  test  whether 
sensitisation from repeated heel lances leads to an increase in evoked cortical responses to both 
noxious and non-noxious procedures.  One method that could be used would be to compare the 
responses of newborn infants, bom between 36-40 weeks gestation, with age-matched premature 
infants who have already undergone weeks of intensive care.  It would be possible to establish 
whether the mean responses, using each outcome measure, differ between the two groups.  The 
results would  confirm whether cortical  responses  in young  infants  are  sensitised by repeated 
noxious stimulation, as suggested by other studies (Grunau et al., 2005).
Numerous  clinical  trials  have  been undertaken  in the neonatal population to  investigate  how 
analgesic strategies and nursing interventions can alter ‘pain responses’ (Boyle et al., 2006; Hall 
et al., 2005; Gal et al., 2005; Anand et al., 2004).  The trials involving the effect of analgesics 
tend to  have  complex  designs  and  rely heavily  on pain  scores  as  the  sole  outcome  measure 
(Carbajal  et  al.,  2005).  While  such  trials  face  substantial  challenges  in  terms  of  ethical 
considerations  and confounding  comorbid conditions,  the real  problem  lies  in the  inadequate 
measures of the pain itself.  It is not certain whether the outcome measures used in these studies 
are  reliable  measures  of nociceptive  processing.  One  of the  goals  in  establishing  a  reliable 
measure of the cortical  response to nociception is to test whether cortical responses,  to both 
noxious  and  non-noxious  stimuli,  are  significantly  affected  by  current  analgesic  regimes. 
Numerous trials that have investigated the effectiveness of sucrose, show statistical differences 
in pain measures between infants randomised to receive or not to receive sucrose (Boyle et al., 
2006; Gal et al., 2005).  As a result, sucrose is increasingly being used in neonatal intensive care 
units (NICU) to treat procedural pain.  Despite behavioural evidence that sucrose relieves pain in
117young infants (Stevens et al., 2004), it remains controversial, particularly among clinicians who 
are unsure of its effectiveness, and reluctant to link a sweet taste with a noxious procedure.  It 
would be possible to test the effects of sucrose on the cortical response to noxious stimulation by 
undertaking a clinical trial, where the endpoint could be the summary measures of the observed 
nociceptive-evoked potential.  Infants could be randomised to receive either water or sucrose, 
and it could be established whether there is a significant difference in the response in the sucrose 
and non-sucrose groups.
It may also be possible to measure directly the effect of morphine on the cortical response to 
nociception.  Morphine  is the most commonly used analgesic and  sedative  medication in the 
NICU.  Many ventilated babies are routinely prescribed morphine infusions and, as they become 
tolerant, the dose often needs to be increased.  Morphine infusions are prescribed after surgery or 
after having suffered a pathological fracture or an extravasation injury.  In addition, bolus doses 
of morphine may be prescribed prior to single painful procedures.  The effects of morphine on 
cortical evoked potentials and haemodynamic activity in response to a heel lance could be tested. 
It would be possible to analyse whether there is a significant difference between the magnitude 
of response in infants receiving morphine compared to those who are not.  It is important to bear 
in  mind  that  in  the  early  stages  it  would  not  be  possible  to  assign  infants  at  random  to  a 
morphine and non-morphine group so we could not definitively attribute differences in the group 
mean  outcome  to  an  analgesic  effect.  Nevertheless,  after taking account of treatment  group 
allocation, studies of this type could provide essential pilot data for future trials where it may be 
possible to randomised babies to higher or lower doses of morphine.
Most avenues that have been discussed regarding the  future  areas  of research have  involved 
using the nociceptive-specific evoked potential as a quantifiable outcome measure to assess the 
different aspects of the neurobiology of pain processing.  It has not been suggested that NIRS is 
used,  for  example,  to  assess  the  efficacy  of  sucrose  or  morphine.  This  is  because  the 
reproducibility  between  trials  appears  to  be  less  consistent.  The  morphology  of  the 
haemodynamic  responses  is  more  variable  and  it  is  more  difficult  to  establish  the  area  of 
maximum response.  Ensuring that optodes are located in the same place between trials is more 
difficult as compared with locating the correct EEG positions.  For these reasons, an analysis of 
the summary measures of the evoked potential would be more appropriate to answer this kind of 
question.  It would be possible to refine the NIRS measurements if the responses were measured 
with better anatomical precision.  This could be achieved using 2-dimensional mapping systems
118(Isobe et al., 2001).  The peak response in the somatosensory cortex could be measured directly, 
which would greatly reduce the between-trial variability.
6.1.3  Concluding remarks
In  conclusion,  this  study  describes  a  number  of methods  that  can  be  used  to  further  our 
understanding  of pain processing  in  the  neonatal population.  By  measuring  cortical  activity 
following noxious events in preterm infants, it may be possible to further our understanding of 
pain processing during early development.  A better understanding of infant pain processing will 
pave  the  way  for  the  development  of a  systematic  approach  to  reduce  pain  and  improve 
analgesic strategies in this vulnerable population.
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Appendix 1   Information sheet for parents
University College London Hospitals
NHS Foundation Trust
Neonatal Unit
Information Sheet for Parents
Version  3 April 2005
Babies  in  hospital  are regularly exposed to painful stimuli as part of their routine medical treatment. 
However,  infants are unable to say whether or not it hurts. Therefore other ways need to be used to 
assess  the  amount  of  pain  being  felt  by  newborn  babies.  It  is  useful  to  know  how  pain  is  being 
processed because the long term  effect of being  exposed to pain when you are young is not known. 
It  is  possible  that  babies  who  experience  pain  during  early  development  may  have  an  altered 
response to pain when they are older.  This study may offer an  insight into the best way to manage 
pain relief in very young infants.
In this study we would like to use three techniques to assess the way in which babies respond to pain 
and  other sensations.  We will  only  study your  baby’s  response to  pain  while they  are  having  their 
routine  blood  tests.  We will  not  do  any  extra  blood  tests for the  purpose  of the  study.  Non  painful 
sensations, such as light touch with nylon hairs, vibration or very low level electrical nerve stimulation 
may also be used.
The first technique will look at the baby’s behaviour and will assess how facial  expression  changes 
when infants are exposed to pain. Sometimes it would be useful for us to video your baby’s face and 
calculate a pain score after the study is over. We do not plan to keep these video recordings.
The other techniques will monitor brain activity. This will be done using EEG, whereby electrodes are 
gently  placed  on  the  infant’s  scalp  to  measure  brain  waves.  EEG  is  routinely  used  in  the  intensive 
care  unit.  The third  technique  is  called  near-infrared  spectroscopy.  It  has  been  developed  so  that 
sensors placed on the head can detect changes in blood flow and  oxygen  levels resulting from  brain 
activity.
UCL  H ospitals is  an NHS  Trust incorporating the Eastm an  Dental  Hospital,  Elizabeth  G arrett A nderson 
gjgggggg.  Hospital,  Hospital for Tropical D iseases, The  M iddlesex Hospital,  National  Hospital for Neurology &
h o s p ita ls   N eurosurgery and  University College  Hospital.
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NHS Trust
All the imaging systems are portable and studies can be performed at the cotside. We have used 
these techniques at the neonatal unit for almost 20 years without any adverse effects.
These tests will be carried out in the neonatal unit while your baby is comfortable in their cot or while 
being  held.  If your baby starts to cry we will  stop the study.  The study will  not  interfere with the 
routine clinical care. As we are interested in how your baby’s response to pain changes as they grow, 
we may study your baby on a number of occasions during their stay in hospital.
All proposals for research involving newborn babies are reviewed by an ethics committee before they 
can proceed. This proposal was reviewed by the joint University College London and UCL Hospitals 
committees on the ethics of human research. There is no pressure to agree to the study and you are 
free to withdraw at any time without giving a reason.
Thank you for taking the time to read this sheet.
 
Consultant Neonatologist
Rebeccah Slater 
Research Fellow
 
Research NurseAppendix 2 Parent consent form
University College London Hospitals
NHS Foundation Trust
Neonatal Unit
m ia
Pain Processing in Neonates
Consent Form 
Version 2 March 2004
1.  Have you read the information sheet about this study?  YES/NO
2.  Have you had an opportunity to ask questions about and discuss this study?  YES/NO
3.  Have you received satisfactory answers to all your questions?  YES/NO
4.  Have you received enough information about this study?  YES/NO
5.  Who have you spoken to about this study?
6. Do you understand that you are free to withdraw from this study
at any time?  YES/NO
without giving a reason for withdrawing?  YES/NO
without affecting your future medical care?  YES/NO
7. Do you agree to take part in this study?
YES/NO
Signed.................................................  Date.
Name (block letters)
Consent obtained by
UCL  H ospitals is an NHS Trust incorporating the Eastm an  Dental  Hospital,  Elizabeth G arrett A nderson
    Hospital,  Hospital for Tropical  D iseases, The  M iddlesex Hospital, National  Hospital for Neurology &
h o s p ita ls   N eurosurgery and  University College  Hospital.
122Appendix 3 Record of infant data
DATA SHEET
THE DEVELOPMENT OF PAIN PROCESSING IN NEWBRON INFANTS
Study Number
Date of Birth
Gestation at Birth
Type of Delivery
Sex
Ethnicity
Significant Medical/Surgical History
Cranial Ultrasound Results 
MRI  Yes/No
Additional Information
Antenatal Steroids
Number of days on ventilator 
Date:
Date Recruited to Study
Version 3 / October 2005
123Appendix 4 Test occasion record sheet
TEST OCCASION RECORD
THE DEVELOPMENT OF PAIN PROCESSING IN NEWBORN INFANTS
Study Number
Test Occasion Number
Date of Study
Nursery
Age in Days
Postmenstrual Age
Current Weight
Current Mode of Ventilation
Number of days on ventilator
Medication
Position
Last Feed
Significant Prior Handling
Time commenced: Time finished:
Version 3 / October 2005
124Study Number:
Cranial Ultrasound Results 
MRI  Yes/No
Baseline  observations  before 
commencing study
Heart Rate 
Respiratory Rate
Oxygen
Saturation
Sleep State 
Blood pressure
Imaging Study Spectroscopy EEG Video
Stimulus
Von Frey Electrical
Heel
lance Vibration
Stimulus application site Foot Arm
Right Left
Name  of  person  who  did  heel 
lance
Spectroscopy NIRO TOPOGRAPHY
Optode position -  channel 1 Right Left Area of cortex
Optode position -  channel 2 Right Left Area of cortex
EEG Lead Placement 
Electrode Position
2 3 4 Ground Reference
Frame no.
125Appendix 5 Relationship between postnatal age and haemodynamic response
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Figure 3.8 Effect of age on haemodynamic response
Developmental  profile  of  maximum  A[HbT]  in  contralateral  somatosensory  cortex  following  heel  lance  in  infants  at 
different postnatal  ages  (regression coefficient:  0.073|imol/L/week,  95%  Cl  limits:  0.018,  0.128pmol/L/week).  Infants 
receiving morphine were excluded from the regression analysis.
126Appendix 6 Block diagram of trigger circuit
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Figure 5.16 Block diagram of trigger circuitAppendix 7 Analysis of waveform in individual trial
Detailed analysis of N-P complex
Study Sex PMA Latency to Latency  to Amplitude Duration
Number (weeks) Foot lanced N1 (ms) P1 (ms) (pV) (ms)
1 Female 42+6 Right 430.5 451.0 23.8 20.5
2 Female 42+3 Left 450.5 475.5 12.5 25.0
3 Male 35+4 Left 416.0 517.0 36.9 101
4 Male 35+4 Left 320.5 351.0 17.4 30.5
5 Male 33+3 Right 409.0 440.5 32.4 31.5
6 Male 33+3 Left 579.5 609.5 17.2 30.0
7 Female 35+4 Left 346.5 379.0 47.6 32.5
8 Female 36+2 Right 439.5 496.5 18,5 57.0
9 Female 36+2 Right 554.5 598.0 18.4 43.5
10 Female 36+2 Right 412.5 446.0 31.0 33.5
11 Female 36+2 Right 291.0 327.0 25.4 36.0
12 Male 35+4 Left 416.0 440.5 17.3 24.5
13 Female 37+5 Left 353.5 371.0 12.3 17.5
14 Female 31+1 Left 413.0 460.5 46.0 47.5
15 Female 36+0 Left 501.0 522.0 10.1 21.0
16 Male 31+1 Left 573.5 630.5 22.7 57.0
17 Male 35+4 Left 542.0 652.0 48.6 110
18 Female 31+3 Right 279.0 306.0 13.6 27.0
19 Female 31+6 Left 436.5 489.0 36.5 52.5
20 Female 41+1 Right 455.5 505.0 34.5 49.5
21 Female 35+2 Left 470.5 521.5 16.5 51.0
22 Male 35+4 right 625.0 646.0 30.0 21.0
23 Female 35+2 Left 397.5 444.5 21.3 47.0
24 Female 33+2 Right 379.0 411.5 10.9 32.5
25 Female 34+6 Right 500.5 530.5 25.1 30.0
26 Female 34+6 Right 398.5 427.5 17.9 29.0
27 Male 35+2 right 400.0 430.5 10.8 30.5
28 Female 42+6 Right - - - -
29 Male 37+6 Right - - - -
30 Female 34+3 Left - - -  • -
31 Female 31+6 Right - - - -
32 Female 28+0 left - - - -
33 Female 30+2 Right - - - -
Mean 436.7(86.5) 477.0(93.6) 24.3(11.5) 40.3(22.1)
Table 5.4 Analysis of N-P complex in individual trials
Studies highlighted in the same colour were undertaken on the same infant on same test occasion.  Standard deviation 
given in parentheses.
128Appendix 8 Traces from individual heel lance trials
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Figure 5.17 individual traces in the contralateral somatosensory cortex following a heel lance
In each trial, the heel lance occurs where the EEG trace begins.  Traces outlined in the same colour were taken from the 
same infant on the same test occasion
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